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A b s t r a c t
During early human pregnancy fetal trophoblasts rapidly invade the uterus. The extent and 
t i m i n g  of this invasion is precisely regulated. A family of matrix degrading enzymes, called the 
matrix metalloproteinases (MMPs) have been implicated as major role players in this process. The 
aims of the research presented in this thesis were to (i) establish a model system using trophoblast 
continuous cell lines to examine the role of MMPs in trophoblast invasion; (ii) investigate the 
factors which regulate expression of MMPs during this invasive process; (iii) study the expression 
of MMPs in vivo and examine the role of MMPs in pre-eclampsia; and (iv) isolate and characterise 
an antibody fragment to MMP-9 using phage display technology.
A model system using trophoblast continuous cell lines was established. These cell lines 
were characterised extensively with regard to a number of properties including cytokeratin and 
vimentin expression, hCG, hPL, invasive ability, MMP and TIMP production. Using this system 
two members of the MMP family, MMP-2 and MMP-9 were identified as important mediators of 
trophoblast invasion in vitro.
The modulation of MMP expression in trophoblast cell lines by cytokines, ECM 
components, hormones and hypoxic conditions was investigated. Expression of the MMP-2 gene 
could not be modulated by any of the factors investigated in this study. MMP-9 expression was 
found to be regulated by certain cytokines and ECM components. In particular IL-l-P was found to 
upregulate MMP-9 expression at the mRNA and protein level, and to increase the invasive ability 
of the cells in vitro.
A pilot scale study of 9 pre-eclamptic and 10 normal placental biopsies demonstrated no 
correlation of MMP expression with disease state. Immunohistochemistry demonstrated the 
expression of MMP-2, MMP-7 and MMP-3 protein in both normal and pre-eclamptic placental 
sections.
Using a phage display library several clones producing soluble single chain antibody 
fragments to MMP-9 were isolated following four rounds of panning against MMP-9 protein, 
however the antibody fragments were found to have low binding affinities.
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Introduction to the Matrix Metalloproteinases
Chapter 1
1. INTRODUCTION
1.1 The Extracellular Matrix
The extracellular matrix (ECM) is a complex and dynamic meshwork of specialized 
glycoproteins and proteoglycans that are secreted and assembled outside cells. As well as providing 
structural support in the form of bone, cartilage, and tendon, the ECM influences many cellular and 
biological processes. It plays a dynamic role in metabolic processes, influencing cellular 
proliferation, differentiation, apoptosis, cell adhesion and migration, and tissue morphogenesis as 
well as serving as a repository for biologically active growth factors. The ECM can be divided into 
two categories : the basement membrane and the interstitial connective tissue. The major 
components of basement membranes are types IV and V collagens, laminin, entactin, and several 
proteoglycans. The major protein of connective tissue matrix is collagen (Mayne and Burgeson, 
1987). In addition to the collagens, interstitial connective tissue also contains fibronectin, elastin, 
chondroitin sulfate proteoglycans, heperan sulfate proteoglycans, tenascin, and hyaluronic acid. 
Laminin and entactin are also found in certain interstitial connective tissues and are not exclusively 
basement membrane components (Hunter et al., 1989).
Both basement membranes and interstitial connective tissue are important structural 
features of embryonic and adult tissues and defects in their synthesis and assembly can have 
profound effects on normal development. The quality and quantity of the ECM matrix depends not 
only on structural components such as collagen, laminin, and proteoglycan, but also on the 
regulated expression of matrix-degrading proteases and their inhibitors. These proteinases and 
inhibitors have, for the most part, been studied in the context of their possible role in tumour cell 
invasion and metastasis. However, it is likely that the abnormal expression of proteinases by 
tumour cells reflects some normally transient and well-regulated expression by a subpopulation of 
precursor cells in the same tissue.
The degradation of ECM proteins can be effected by a variety of enzymatic activities of 
which there are four main classes (Shi et al., 1993) : (i) serine proteinases e.g. plasminogen 
activators; (ii) cysteine proteinases e.g. cathepsins B and L; (iii) aspartyl proteinases e.g. cathepsin 
D and (iv) matrix metalloproteinases (MMP) e.g. MMP-2 and MMP-9. The MMPs, which are the
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focus o f this thesis, are believed to be the primary contributors to this process as a result o f several 
key features: they are secreted into the extracellular space and function under physiological 
conditions; they are highly regulated and frequently induced in areas o f active matrix remodeling; 
and members o f  this family are the only enzymes capable o f denaturing fibrillar collagens. The 
condition o f the ECM at any time and place is influenced by the balance between the levels of 
structural proteins and matrix-degrading proteinases, their inhibitors and activators.
1.2 The Matrix Metalloproteinase Family
The matrix metalloproteinases (MMP) are members o f  a unique family o f zinc-binding 
endopeptidases that are responsible for degradation o f components o f the ECM. They are a 
continually growing group o f  enzymes that have been implicated in both normal cellular processes 
e.g. tissue remodeling and repair (Brenner et a l . , 1989), and in many destructive processes 
including tumour invasion and metastasis (Powell and Matrisian, 1996) and rheumatoid arthritis 
(Dean et a l . , 1989). The proteinases that comprise the MMP family have several distinguishing 
characteristics: The proteins have a  characteristic pattern o f  conserved domains. Proteolytic activity 
is inhibited by tissue inhibitors o f metalloproteinases (TIMPs). The enzymes are either secreted or 
exist as transmembrane pro-enzymes that require activation to exert their matrix degrading activity. 
The active site contains a zinc ion and requires a second metal cofactor such as calcium. Enzyme 
activity is optimal in the physiological pH range. The properties o f the human MMPs which have 
been cloned and sequenced to date are summarised in Table 1.1.
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Table 1.1 Properties o f the human matrix metalloproteinases.
MMP ENZYME NAME
Mol.
Weight
kDlJatenl)
Mol.
Weight
kD(activc)
SUBSTRATES
ACTIVATION 
o f  other MMPs.
MINIMAL DOMAIN MMP
MMP-7 Matrilysin, Pump-1 28 19 Proteoglycans, laminin, fibronectin, 
gelatins, collagen IV, elastin, 
entactin, tenascin.
MMP-1, MMP-2.
H EM O PEX IN  DOM AIN 
MMPs
MMP-1 Interstitial collagenase 55 45 Fibrillar collagens (types 
min,VII,X), gelatin, proteoglycans.
Unknown
MMP-8 Neutrophil collagenase 75 58 Collagens I, n, IH. Unknown
MMP-13 Collagenase-3 65 55 Collagen n. Unknown
MMP-12 Metalloelastase 53 45/22 Elastin, fibronectin, collagen IV. Unknown
MMP-3 Stromelysin-l 57 45 Proteoglycans, laminin, fibronectin, 
collagen ni,IV, V, IX, gelatins.
MMP-1, MMP-8, 
MMP-9.
MMP-10 StromeIysin-2 57 44 Proteoglycans, fibronectin, collagen 
in, IV, V, gelatins.
MMP-8
MM P-11 Stromelysin-3 51 44 Laminin, fibronectin (very weakly). Unknown
FIBRONECTIN DOMAIN 
MMPs
MMP-2 Gelatinase A 72 66 Gelatins, collagens IV, V, VH, X, 
elastin, fibronectin.
Unknown
MMP-9 Gelatinase B 92 86 Gelatins, collagens IV, V, elastin. Unknown
TRANSMEMBRANE 
DOMAIN MMPs
MMP-14 MT1-MMP 63 - Unknown MMP-2
MMP-15 MT2-MMP - - Unknown Unknown
MMP-16 MT3-MMP - - Unknown MMP-2
MMP-17 MT4-MMP - • Unknown Unknown
MISCELLANEOUS
MMP-19 RASI-1 - - Gelatins Unknown
MMP-20 Enamelysin 54 - Amelogenin Unknown
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1.2.1 Domain Structure of MMPs
The MMP family had previously been divided into subclasses with respect to their 
substrate specificity. This classification scheme has become somewhat redundant as new MMPs 
have been cloned and new substrates identified for the enzymes. The latest approach has been to 
classify the MMPs based primarily on the protein domain structure (Powell and Matrisian, 1996). 
All MMPs contain three fundamental domains which make up the structural basis for the entire 
family (Figure 1.1 A). A t the amino terminus is the pre domain that directs the protein for cellular 
export and is rapidly removed prior to secretion. The pro domain contains a highly conserved 
segment o f eight amino acids, PRCGVPDV, which must be removed by cleavage to activate the 
enzymes. Latent MMPs are activated by removal o f this domain, in turn disengaging the cysteine in 
the conserved prodomain from the zinc in the adjacent active site. This model o f activation termed 
the ‘cysteine switch’ mechanism (Van Wart e t a l ,  1990), was based on the ability o f various 
compounds that activate MMPs to disrupt the interaction between the zinc and the conserved 
cysteine either directly or by altering the protein conformation o f  the pro domain. This event allows 
a water molecule to become a forth zinc ligand thus displacing the cysteine. The release o f the pro 
domain from the active site zinc leads to the removal o f the pro domain via an autocatalytic 
mechanism to produce the mature enzymatic form (Figure. 1.1 B). The initial cleavage is 
performed in  v iv o  by other proteases or MMPs, or in some cases plasmin (Powell and Matrisian, 
1996). I n  v i t r o , this activation can be achieved by a variety o f agents including: conformational 
perturbants such as sodium dodecyl sulphate (SDS) and the organomercurials, oxidants such as 
sulfhydral alkylating agents, and in some cases proteolytic cleavage by trypsin (Grant e t a l . , 1992). 
The catalytic site is the third fundamental domain, which contains the active site whose amino acid 
consensus sequence is HEXGHXXGXXHS. The active site holds a zinc ion by co-ordinate 
bonding to the three histidines and a water molecule (Windsor et a l . , 1994). Studies have shown 
that the metalloproteinases contain a second zinc binding site which appears to have a major role in 
stabilizing tertiary structure. Also present are two calcium ions, however these do not appear 
essential for activity but may play a role in inhibitor binding (Yuan e t a l . , 1994). MMP-7 is the 
smallest MMP consisting o f  these three domains and it is tempting to speculate that it is the 
present-day representative o f  the primordial gene.
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Figure 1.1. A : The fundamental domain structure for MMPs. B : Cysteine switch mechanism for MMP activation. The 
pro domain of the latent molecule is folded around so that the cysteine residue can form a complex with the zinc 
molecule. An initial cleavage causes a conformation change in the molecule that disrupts the cysteine-zinc interaction 
and frees the zinc to participate in the proteolytic cleavage. Thus when the cysteine is ‘on’ the zinc, the activity of the 
enzyme is ‘off, hence referred to as ‘the cysteine switch mechanism’ (V an Wart et al., 1990).
In addition to these three MMP domains, the MMP family members have domains that 
generate diversity in their association with substrates and with cellular and matrix components. 
MMP-7 is the only family member to date that does not contain a COOH-terminal domain that has 
homology to a heme binding protein (hemopexin) and the ECM component vitronectin, known as 
the hemopexin domain. This domain has been shown to be involved in mediating associations with 
ECM components and inhibitors but has differing functions in individual family members. The 
hemopexin domains in pro MMP-2 and -9 have been associated with interactions with the 
inhibitors TIMP-2 and TIMP-1, respectively (Baragi et al., 1994, Murphy et a l, 1992). In MMP-1 
and -8, this domain is associated with substrate and inhibitor binding (Bigg et al., 1994). The
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hemopexin domain o f MMP-2 is required for cell surface activation (Ward et a l . , 1994). The 
hemopexin domain is linked to the catalytic domain through a short but variable hinge region; its 
presence in MMP-1 and MMP-8 enables them to cleave fibrillar type I collagen (Hirose et a l . ,
1993). The type IV collagenases MMP-2 and MMP-9 posses fibronectin-like sequences which 
have been shown to be required for gelatinase activity. MMP-9 is the only MMP to contain a small 
region similar to the 0C2 chain o f type V  collagen in the hinge region but the functional significance 
o f this insertion is unclear.
The most recently described members o f the MMP family contain a domain that is 
common to many proteins but is newly characterised in the MMPs. The transmembrane-type (MT- 
) MMPs contain a transmembrane domain near their carboxyl termini which localizes the enzymes 
to the plasma membrane. This domain contains a hydrophobic amino acid stretch which can pass 
through the plasma membrane.
In addition to the transmembrane domains, the MT-MMPs (MMPs 14-17) and MMP-11 
contain a short region between their pro domain and catalytic domain that fits the consensus 
cleavage site for furins, which are protein-processing enzymes and have been shown to function in 
a  number o f  protein maturation pathways (Bresnahan e t a l . , 1990). In MMP-11 this sequence 
allows for internal cleavage o f  this MMP, resulting in secretion o f the enzyme in an activated form 
(Pei and Weiss, 1995). These enzymes cannot apparently be activated by agents such as 
organomercurials but require proteolytic activation by molecules such as furin (Pei and Weiss, 
1995). MT1-MMP and M M P-11 have another unique similarity in that neither enzyme appears to 
efficiently degrade ECM proteins. This observation suggests the possibility that there may be other 
functions associated with MMPs other than degrading ECM proteins directly.
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Figure 1.2 Domain Structure of MMP Family. [ H = hinge domain; F = fur in consensus site; FN = fibronectin-like 
domain; C = collagen-like domain; TM = transmembrane-like domain].
1.2.2 Properties of the MMPs
It is generally accepted that degradation o f the ECM is the end result o f a proteolytic 
cascade involving members o f  the MMP family. Each MMP has a unique yet slightly overlapping 
substrate specificity (Table 1.1). In the past the MMP family had been classified into three 
subclasses with respect to their substrate specificity: (1) the type I collagenases which degrade 
fibrillar collagens; (2) the type IV collagenases which degrade denatured and basement membrane 
collagens, and (3) the stromelysins which degrade proteoglycans and glycoproteins.
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The collagenases, comprising o f  MMP-1, MMP-8, and, MMP-13, target primarily fibrillar, 
but also non fibrillar collagens. Interstitial collagenase (MMP-1) is probably the best characterised 
o f the MMPs. The gene encoding MMP-1 was isolated from a  lamda phage human DNA library 
by Collier e t a l. (1988a). The activated collagenase specifically degrades the native, triple helix of 
type I collagen, as well as types II and HI [collagens types I-DI are known as interstitial collagens, 
hence the name], by making a single, sequence specific cleavage (Miller e t a l . , 1976). The action of 
MMP-1 on collagen results in ‘unwinding’ o f the helical structure to produce a molecule that is 
now susceptible to proteolytic cleavage by other proteinases and gelatinases. MMP-8 or neutrophil 
collagenase was identified and sequenced from a  cDNA library derived from peripheral leukocytes 
o f  a patient with chronic granulocytic leukemia (Hasty et a l . , 1990). It is capable o f cleaving all 
three alpha-chains o f types I, II and HI collagens and has been implicated in the pathology 
associated with rheumatoid and osteo-arthritis (Ho e t a l . , 1994). MMP-13 also known as 
collagenase-3 was cloned from a cDNA library derived from a breast tumour (Freije e t a l . , 1994). 
Increased expression o f MMP-13 in breast carcinoma and the absence o f detectable expression in 
most normal tissues has been shown and a possible role in tumorigenesis is proposed (Freije e t a l . ,  
1994). Analysis o f substrate specificity revealed that type II collagen is preferentially hydrolyzed by 
MMP-13 (Knauper e t a l . , 1996).
The MMPs stromelysin -1, -2, -3, (MMPs -3, -10, -11, respectively), matrilysin (MMP-7) 
and metalloelastase (MMP-3) are all members o f what has been called the stromelysin subclass. 
They can cleave many ECM  components including proteoglycans, fibronectin, collagens, and 
gelatins but have no proteolytic activity for native type I collagen, with the exception o f MMP-11 
which as stated already is a weak protease and has thus far been shown to cleave laminin and 
fibronectin (Murphy e t a l . , 1993). Stromelysin-1 (MMP-3) was identified by Werb and colleagues 
(Chin e t a l . , 1985) as a secreted MMP. The molecule was originally cloned by virtue o f its 
inducibilty by oncogenes and growth factors and was referred to as transin (Matrisian e t a l . , 1985, 
McDonnell e t a l . , 1990). Transin was later shown to be the rat homolog o f human stromelysin 
(Muller e t a h , 1988). Stromelysin-2 (M MP-10) has been identified both in rat and in humans and 
has similar amino acid sequence (75-80% identity) and substrate specificity to stromelysin-1 
(Nicholson e t a l . , 1989). However, the two genes are regulated differently by growth factors. 
Stromelysin-3 (M MP-11) was isolated from stromal cells surrounding breast carcinomas and its
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expression has been associated with the invasive stages o f this disease (Basset et a h , 1990). 
Matrilysin (MMP-7) is the smallest member o f the MMP family and was first isolated by Muller e t 
a h  (1988) from a mixed tumour library in an effort to clone stromelysin-related genes. MMP-7 has 
also been shown to degrade entactin, a basement membrane protein which bridges laminin and 
type IV collagen (Sires e t a h , 1993). The fifth member o f this subclass, metalloelastase (MMP-12), 
was originally isolated and cloned from murine macrophages (Shapiro e t a h , 1992). The human 
homologue called human macrophage metalloelastase was subsequently cloned by the same group 
(Shapiro e t a h , 1993). MMP-12 is specifically associated with mononuclear phagocytes and, as its 
name suggests, is a potent degrader o f elastin (Shapiro e t a l . , 1993).
The type IV collagenases consisting o f MMP-2 and MMP-9, also known as the gelatinases, 
are potent in their ability to cleave denatured collagens and intact type IV collagen. Human MMP-2 
was cloned by Collier e t a h  (1988b). It is a 72-kDa proenzyme and when activated degrades the 
following substrates in order o f preference ; gelatin, types IV, V, VII collagen, and fibronectin. 
Expression o f MMP-2 is widespread and is frequently elevated in malignant tumours. MMP-9 was 
traditionally thought o f as the macrophage gelatinase but its expression has now been described in 
many other cell types including malignant cells, neutrophils, trophoblasts and keratinocytes. MMP- 
9 was cloned from SV40-transformed human lung fibroblasts (Wilhelm e t a h , 1986). It is secreted 
as a  92 kDa proenzyme and when activated degrades gelatins, collagens types IV and V, and 
elastin.
There are currently 4 known MT-MMPs, all o f which have been cloned from human 
cDNA libraries (Takino e t a h , 1995a, Takino et a h , 1995b, Puente e t a h , 1996). Membrane 
localisation is required for the only known activity o f MT1-MMP, MT2-MMP, and MT3-MMP; 
activating MMP-2 on cell membranes surfaces (Sato e t a h , 1994; Puente e t a h , 1996). The 
expression o f MT1-MMP also induced binding o f MMP-2 to the cell surface by functioning as a 
receptor, giving the advantage o f surface localization o f proteinases over pericellular proteolysis 
(Sato and Seiki, 1996). MT1-MMP has been found to be overexpressed in malignant tumour 
tissues, including lung and stomach carcinomas, and has been associated with the activation o f pro- 
MMP-2 in these tissues (Sato et a h , 1994).
Recently three novel members o f the MMP family have been reported, namely M M P-18, 
MMP-19 and MMP-20. MMP-18 is a novel collagenase isolated from metamorphosing Xenopus
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laevis tadpoles, and has essentially identical enzymatic activity towards a collagen substrate as 
human interstitial collagenase (Stolow e t a h , 1996). MMP-19 was cloned from a liver cDNA 
library. This protein exhibits the domain structure characteristic o f previously described MMPs but 
lacks a series o f structural features distinctive o f the diverse MMP subclasses and has been 
proposed to represent the first member o f a new MMP subfamily (Pandas e t a h , 1997). MMP-19 is 
mainly expressed in placenta, lung, pancreas, ovary, spleen and intestine, suggesting it may have a 
specialised role in these tissues. Sedlacek e t a h  (1998) very recently reported the identification o f a 
gene RASI-1 which encodes a protein showing sequence identity with MMP-19 and proposed that 
MMP-19 is a  novel autoantigen with a role in rheumatoid arthritis. MMP-20 also known as human 
enamelysin was cloned from odontoblastis cells and has been shown to degrade amelogenin, the 
major protein component o f  the enamel matrix. Expression o f MMP-20 is highly restricted to 
dental tissues (Llano e t a h , 1997).
In addition to ECM  components, MMPs can cleave precursor forms o f other MMPs, the 
serine proteinase urokinase-type plasminogen activator (PA), and protease inhibitor a-1- 
antitrypsin. MMPs have also been implicated in the activation o f growth factors [e.g. tumour 
necrosis factor (TNF)-a (Gearing e t a h , 1994)] and growth factor receptors [e.g. IL-6 receptor 
(Chambers and Matrisian, 1997)]. A  recent report also describes angiostatin-converting enzyme 
activity o f MMP-7 and MMP-9 by hydrolysing plasminogen to generate angiostatin fragments 
which inhibit angiogenesis (Patterson and Sang, 1997). Novel functions attributed to the MMPs, 
such as those mentioned above, are beginning to challenge the traditional views o f the roles of 
MMPs in biology such that it is no longer sufficient to consider each MMP member only in terms 
o f  its substrate specificity, but also consider the effects it may have on the cell phenotype.
1.3 Regulation of MMP Expression
The activity o f the MMPs is highly regulated, lending support to the idea that they have 
important biological functions. The regulation o f MMP activity is complex and occurs at several 
different levels : (a) at the transcriptional level; (b) at the activity level by processing o f the latent
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precursor to an active enzyme; and (c) total proteinase activity is modulated by the presence of 
TIMPs.
A t the transcriptional level the expression o f the genes for metalloproteinases and TIMPs is 
regulated by a diverse range o f extracellular stimuli, including growth factors, phorbal esters, 
hormones, steroids, and adhesion molecules (Birkedal-Hansen et a l . , 1993). Their expression is 
also regulated by oncogenes and proto-oncogenes (Crawford and Matrisian, 1996). The effect of 
these biologically active molecules seems to be influenced by the cell type, species o f origin, and 
conditions o f cell growth, because not all cells respond to these stimuli similarly. Among the 
members o f the MMP gene family there are many enzymes with very similar substrate specificity, 
however the differences in transcriptional regulation between family members goes some way in 
explaining this apparent overlap. Studies over the past several years have shown that MMPs are 
regulated both positively and negatively at the transcriptional level. The regulation o f MMP at the 
transcriptional level is considered in detail in the introduction to chapter four. In addition to control 
at the transcriptional level, MMPs can be regulated post-transcriptionally by changes in mRNA 
stability (Delany and Brinckerhoff, 1992).
The conversion o f latent metalloproteinases to active enzymes is an additional step at 
which MMP activity is regulated and may involve activation o f a proteinase cascade. Using a co­
culture system with human keratinocytes and dermal fibroblasts, He e t a l. (1989) have suggested 
that the endogenous activator o f metalloproteinases is plasmin, produced from the plasminogen 
precursor by the action o f plasminogen activators. Plasmin can convert both proMMP-1 and 
proMMP-3 to their active forms. MMP-7, MMP-3, M M P-10, and the MT1-MMP can activate 
other MMPs by proteolytic cleavage. Coordinate regulation o f the MMPs and plasminogen 
activators could therefore have synergistic effects. This cascade o f proteolytic events, reminiscent 
o f  the clotting cascade, may serve as a controlled but powerful mechanism to coordinate complete 
degradation o f  multiple components o f the ECM.
Finally, MMP activity on ECM substrates is dependent on the balance between the 
enzymes and their inhibitors, the tissue inhibitors o f metalloproteinases (TIMPs), which are 
reviewed below. The MMPs are components o f a system o f ‘balanced proteolysis’ wherein a finely 
tuned equilibrium exists between the amount o f active enzyme and its inhibitors.
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1.4 TIMPs
The TIMPs are secreted multifunctional proteins that also play pivotal roles in  the 
regulation o f ECM metabolism. Their most widely recognised action is as inhibitors of the MMPs. 
TIMPs constitute a family o f proteins that in humans is currently composed o f 4 members, TIMP- 
1, TIMP-2, TIMP-3 and TIMP-4. These proteins bind non-covalently to MMPs and specifically 
inhibit their enzymatic activity. TIMPs consist of two distinct structural and functional domains. 
The N-terminal domain alone is an efficient inhibitor o f the MMPs through interaction with the 
enzymatic catalytic domain. The C-terminal domain has enzyme binding sites which by interaction 
with the MMP increase the rate o f inhibition o f the enzyme due to the anchoring effect (Slawomir 
e t a l . , 1997).
TIMP-1 is a glycoprotein with an apparent molecular size o f 28.5 kDa which forms a 
complex o f 1:1 stoichiometry with the activated form o f multiple MMPs and is also found 
associated specifically with the latent form o f MMP-9 (Docherty el a l . , 1985). The gene coding for 
TIMP-1 has been cloned and sequenced (Mahtani and Willard, 1988). The secreted protein has 184 
amino acids and six intramolecular disulfide bonds. TIMP-1 is ubiquitous among tissues and 
species and is considered a major regulatory inhibitor in the extracellular milieu. In the early mouse 
embryo, tissue localisation data shows that high levels o f TIMP-1 transcripts are found at the sites 
o f active remodeling, such as developing bone, where its expression overlaps significantly with 
that o f members o f the transforming growth factor-P (TGF-P) family (Flenniken and Williams, 
1990). Early studies investigating the link between TIMP-1 expression and invasive ability in cell 
lines showed that TIMP-1 levels were decreased 10-20 fold in highly invasive as compared to the 
normal or poorly invasive cells (Hicks et a l . , 1984). Later studies linked an increase in invasive 
properties in poorly invasive cells with a reduction in TIMP-1 expression, using antisense TIMP-1 
transfected into Swiss 3T3 cells (Khokha e t a l . , 1989). Human TIMP-1 is known to be identical to 
a glycoprotein isolated as a factor stimulating colony formation by erythroid precursor cells and 
referred to as erythroid potentiating activity (EPA). Other evidence suggests that TIMP-1, in 
particular is a serum mitogen for a wide array o f cultured cells (Hayakawa et a l . , 1992), raising the 
possibility that TIMP-1 may have a more general growth-stimulatory effect on cells. Thus, TIMP-1 
may be functioning simultaneously as a protease inhibitor and growth-promoting factor; a
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multifunctional protein regulating turnover o f  ECM on the one hand and modulating growth 
properties o f  cells on the other.
TIMP-2 is a 21 kDa protein which displays similar inhibitory activities against active 
MMPs as TIMP-1, and in addition TIMP-2 selectively forms a complex with the latent proenzyme 
form o f MMP-2. The secreted protein has 192 amino acid residues and is not glycosylated. TIMP-2 
shows an overall 71% similarity to TIMP-1 at the amino acid sequence level. The homology 
appears closer at the protein level than at the nucleotide level, suggesting that these inhibitors 
diverged early in the evolution o f this gene family (Stetler-Stevenson e t a l . , 1989). The inhibitory 
effects o f  TIMP-2 on cell invasion has been demonstrated in a number o f studies. DeClerck e t a l. 
(1992), demonstrated the inhibitory activity o f  recombinant TIMP-2 (rTIMP-2) on invasion of 
living smooth muscle cell multilayers by HT1080 cells and by a ras-transformed rat embryo 
fibroblast line, 4R. rTIMP-2 also inhibited degradation o f smooth muscle cell matrixes by these 
cells. Albini e t a l . (1991), using a reconstituted basement membrane invasion assay, reported that 
HT1080 tumour cell invasion decreased approximately 85% when exogenous, purified TIMP-2 
was added to the system.
TTMP-3 was cloned in 1994 by Uria e t a l. and was found to be expressed in placenta and 
uterus but not in liver and ovary. TIMP-3 showed low sequence homology with the previously 
known human TIMPs but showed a  high degree o f homology with chicken inhibitor o f MMPs -3 
(ChIMP-3), which was originally isolated as a transformation-induced protein in chicken 
fibroblasts (Staskus et a l . , 1991). TIMP-3 appears to be expressed in normal placental and ovarian 
tissues and in all breast carcinomas examined (Uria e t a l . , 1994). MouseTIMP-3 (mTIMP-3) has 
been shown to have a distinctive pattern o f expression in adult mouse with abundant transcripts 
detected in kidney, lung, and brain but only low levels detected in bone, a prominent location o f 
mTIMP-1 transcripts (Leco e t a l . , 1994) leading the authors to propose that mTIMP-3 functions in 
a tissue-specific fashion as part o f an acute response to remodeling stimuli.
TIMP-4 was recently cloned and characterised by Greene e t a l. (1996) from a human heart 
cDNA library. The putative protein shows 57% similarity to TIMP-1 and 70% similarity to TIMP- 
2 and -3. Tissue expression o f  TIMP-4 in adult human appears limited. Although large amounts of 
transcript were detected in the heart, much lower levels o f expression were detected in the kidney, 
pancreas, colon and testes; no TIMP-4 transcripts were detected in other tissues, again suggesting
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TIMP-4 may function in a tissue-specific fashion. A recent study by Wang et a l . (1997) 
demonstrated the inhibition o f tumour growth and metastasis o f human breast cancer cells 
following transfection with TIMP-4. TIMP-4 has also been shown to bind to pro MMP-2 in a 
similar manner to TIMP-2, which may have physiological significance in modulating the cell 
surface activation o f pro MMP-2 (Bigg e t a l . , 1997).
The existence o f a family o f inhibitors raises several questions as to potential differences in 
the physiological roles o f the inhibitors. The MMPs make up a  gene family themselves, and there 
appears to be both specificity and overlap in their degradation o f ECM  substrates. The proMMP-2- 
TIMP-2 and proMMP-9-TIMP-l complexes may reflect an additional function for TIMPs in 
controlling the activation o f specific latent MMPs. The notion that individual TIMP family 
members may have specific physiological roles is supported by gene expression studies. The 
TIMP-1 gene is highly inducible at the transcriptional level in response to many cytokines, 
hormones, and the tumour promoting agent 12-O-tetradecanoyl-phorbal-13-acetate (TPA), and is 
also sensitive to transformation by the r a s  oncogene (Leco e t a l . , 1994). Likewise TIMP-3 
expression is not only induced in response to mitogenic stimulation but also is subject to cell cycle 
regulation (Greene e t a l . , 1996). In contrast, TIMP-2 expression, like that o f MMP-2 with which it 
interacts, is largely constitutive (Stetler-Stevenson et a l ,  1990b). Where responses o f TIMP-2 to 
stimuli have been observed, the outcomes are opposite to those seen for TIMP-1 (Stetler-Stevenson 
e t a l . , 1990). This offers a selective means for the regulation o f metalloproteinases before and after 
activation. Thus the net proteolysis will depend on a critical ratio between the TIMP family 
inhibitors and the metalloproteinases produced in the same micro environment.
MMPs can also be inhibited by a-2-macroglobulin and al-antitiypsin present in plasma 
(Barret and Starkey, 1973). a-2-macroglobulin is a non-specific inhibitor o f all four classes of 
proteinases, produced by the liver and detectable in normal serum. The large size (750 kDa) o f the 
inhibitor may decrease its tissue penetration and limits its effectiveness as an inhibitor outside the 
intravascular compartment. A number o f new synthetic agents blocking MMP activity have 
recently been developed as anti-cancer therapies, including Batimastat and Marimastat which are 
currently in Phase I/H trials in US, Europe and Canada. Other new agents, currently in clinical trials 
include Bryostatins, which do not directly affect the activity o f MMPs, but can inhibit their 
production by inhibiting protein kinase C (Slawomir e t a l . , 1997).
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1.5 Expression Patterns of MMPs
The expression o f MMPs by a variety o f cell types has been extensively studied and 
implicated as important in numerous pathological processes involving tissue destruction. In fact the 
majority o f MMP family members were first isolated and cloned from tumour-associated tissues. 
These proteinases’ roles in normal tissue formation and remodeling has been less frequently 
studied but initial reports point to complex and highly individualized patterns o f expression for the 
various members o f  the MMP family. The complexity o f expression patterns in normal tissues is 
demonstrated by examples o f  cell type- and tissue-specific regulation, inducible and constitutive 
expression, and discrepancies between in  v itr o  and in  v iv o  studies. While the whole area of 
‘normal’ MMP expression and function is still in its infancy, there are some general expression 
patterns emerging.
MMP expression in normal tissues appears to be restricted to certain tissues at specific 
times, with the possible exception o f MMP-2 expression, which in general appears to be more 
widespread. In developing mouse embryos, MMP-2 is expressed in most mesenchymal-derived 
tissues and highly expressed in newborn lung, heart, and kidney (Reponen el a l . , 1992). The 
enzyme is frequently detected in normal adult tissues and is elevated in cancerous lesions o f these 
tissues (Stetler-Stevenson, 1990a). Although MMP-2 is expressed in many normal tissues, the 
mRNA is generally restricted to connective tissue cells and rarely observed in epithelial cells in  
v iv o . Stromelysin-3 (M MP-11) mRNA is also expressed in connective tissue, but its expression is 
more restricted and has been observed in specific areas such as in developing digits (Basset et a l . ,  
1990) and involuting mammary glands (Lefebvre e t a l . , 1992). In contrast, the mRNA for MMP-7 
has been observed in glandular epithelial cells o f normal mouse small intestine (Matrisian, 1994) 
and the cycling human endometrium, and is not seen in stromal cells o f the same tissue (Rodgers et 
a l . , 1993). MMP-7 is secreted primarily by cells o f epithelial origin and may function in glands and 
ducts as an ‘enzymatic pipe cleaner’(Wilson and Matrisian, 1996).
Hematopoietic cells also show distinct and highly specific patterns o f expression o f MMPs. 
Neutrophils contain a collagenase distinct from MMP-1; neutophil collagenase (MMP-8). The 
expression o f MMPs in cells o f the monocyte/macrophage lineage demonstrates stage-specific 
expression patterns. Promonocytes produce MMP-7 mRNA, whereas activated macrophages 
produce MMP-3 and MMP-1 mRNA (Shapiro e t a l . , 1991). MMP-9 is also expressed in
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hematopoietic cells. Interestingly, other cell types, such as fibroblast and epithelial cells, have been 
shown to produce MMP-9 in culture. I n  s itu  hybridisation studies o f developing mouse embryos, 
however, suggest that the mRNA for this enzyme is restricted to osteoclasts and bone marrow cells 
in  v iv o  (Reponen e t a l . , 1994). Such studies suggest that culture conditions may alter the normal 
expression patterns o f MMPs. Studies o f MMP transcriptional regulation in normal and neoplastic 
cclls offers an intriguing opportunity to understand the convergence o f these pathways and their 
pathological and physiological roles.
1.6 Pathological Roles of MMPs
Over expression o f MMPs has been associated with tumour progression for many years. 
Both MMP-3 and MMP-2 cDNA were originally cloned from transformed cells that exhibited 
increased proteolytic activity relative to parental untransformed lines (Matrisian et a l . , 1985; 
Collier e t a l . , 1988b). A  functional role was assigned to MMPs in tumour invasion mainly by the 
use o f TIMP as an inhibitor o f in  v it r o  and in  v iv o  invasion (MacDougall and Matrisian, 1996, for 
review), demonstrating that tumour MMP expression is required for tumour invasion and 
metastasis. Many oncogenes have been shown to regulate MMP levels, and most MMP s have an 
activator protein-1 (AP-1) transcription element in their promoter, which may mediate this 
response (Gaire e t a l . , 1994). The evidence o f MMP involvement in invasion and metastasis comes 
from three main sources: correlative evidence demonstrating the expression o f  MMPs in advanced- 
stage tumours (Powell and Matrisian, 1996 for review), in  v itr o  models o f invasion, and in  v iv o  
models o f invasion and metastasis (DeClerck e t a l . , 1992, Schultz e t a l . , 1988).
Colon cancer has been one o f  the most studied neoplasms and MMP overexpression has 
been linked to increased invasiveness and metastasis. Witty e t a l. (1995) have provided evidence 
that MMP-7 may have an effect on colon cancer cell growth in an orthotopic model o f colon 
cancer. SW480 human colon cancer cells, originally isolated from a primary tumour, were 
transfected with MMP-7 cDNA under the control o f a constitutive promoter and when implanted 
into the cecum o f nude mice the tumours that arose were faster growing than the nontransfected 
SW480 cells. In the matched cell line SW620, (SW620 cell line was isolated from the same patient 
as SW480, but from a lymph node metastasis) which constitutively secretes MMP-7, antisense
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ablation of the MMP-7 mRNA reduced the number of tumours (Witty et al., 1994). Similar studies 
on MMP expression in other cancer models have correlated MMP overexpression to invasive 
potential o f tumour cells (McElligott et al., 1997, Benhard et al., 1994)).
1.7 Physiological Roles of MMPs
The best defined correlations of MMP expression with normal functions are found during 
trophoblast invasion (Cross et al., 1994); endometrial remodeling (Salamonsen, 1994); ovulation 
(Russell and Findlay, 1995); bone remodeling (Heath et al., 1984); angiogenesis (Fisher et al,
1994) and development (Matrisian and Hogan, 1990). In the following sections, examples of 
metalloproteinase expression in some of these normal cellular events are described and the role of 
MMPs in mediating physiological functions is explored. Although the metalloproteinases are not 
the only proteinases which have been implicated in any or all of the following processes, it is 
beyond the scope of this review to examine the contributions of other classes of proteinases.
1.7.1 Implantation and Placentation
Development of the human fetus depends primarily on the embryo rapidly gaining access 
to the maternal circulation. Trophoblasts cells which are derived from the outer layer of the 
blastocyst have developed mechanisms by which they can invade the uterus and tap into the 
maternal circulation (Figure 1.3) (Cross et al., 1994). In contrast to tumour cell invasion, 
trophoblast invasion is precisely regulated, being confined spatially to the uterus and temporally to 
early pregnancy. A number of investigators have shown that various MMPs are important 
mediators of trophoblast invasion. Fisher et al. (1989) were the first group to show that freshly 
isolated trophoblasts secrete a number of MMPs, some of which varied with the stage of gestation. 
The two type IV collagenases, MMP-2 and MMP-9 which specifically degrade type IV collagen 
and gelatins have been of particular interest in this respect. Several investigators have shown that 
MMP-9 is expressed in trophoblasts isolated from first and second trimesters and that this 
expression decreases by third trimester. Librach et al. (1991) subsequently demonstrated that a 
function-perturbing antibody specific for MMP-9 completely inhibited trophoblast invasion 
implying that MMP-9 was critical for invasion. The role of the MMPs in trophoblast invasion will
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be dealt with in more detail in chapter 3. Trophoblast invasion, because of its eloquently regulated 
nature both spatially and temporally presents a unique contrast to the unregulated invasion seen in 
metastatic cancer and provides an excellent model to study the regulation of MMP expression.
Figure 1.3 Diagram illustrating trophoblast invasiveness during implantation and placental development. Trophoblasts 
derived from the blastocyst breach the basement membrane and uterine epithelium and tap into maternal circulation.
1.7.2 MMP Expression in the Cycling Human Endometrium
Perhaps the most dramatic expression of MMPs in a normal tissue is seen in the cycling 
human endometrium. The uterine endometrium, is regularly shed and regenerated throughout 
reproductive life, implying active and continuous tissue remodeling. This rapid and extensive 
degree o f steroid-mediated tissue remodeling, rivals that of many neoplasias. Rodgers et al. (1994) 
showed that the mRNAs for MMP-1, -3, -10, -11, -2 and -9 were all expressed during the 
menstrual phase in the human endometrium, but displayed differences in cellular distributions. 
MMP-7 was expressed in epithelial cells throughout the tissue. MMP-1 and MMP-9 were 
expressed in stromal cells but were concentrated in the luminal region of the tissue. The transcripts
19
for MMP-11 and MMP-2 were localised throughout the stromal component of the tissue. This 
widespread expression of MMPs in all compartments of this tissue suggested that the concerted 
effort of several MMP family members may play an important role in the breakdown and release of 
endometrial tissue during menstruation.
In addition to the expression of MMP-2 during the proliferative phase, MMP-7 and MMP- 
11 transcripts were detected which may be attributed to the remodeling that occurs during the 
expansion of the tissue. MMP-2 was the only MMP transcript observed during all phases of the 
cycle including the secretory phase when progesterone levels were elevated. The mRNA for all 
other MMPs was absent suggesting an inhibitory effect of progesterone on the expression of each 
of these genes and differences between the MMP-2 promoter and that of the other family members. 
In vitro studies by Bruner et al. (1995) confirmed that TGF-P mediated the progesterone 
suppression of MMP-7 by adjacent stroma. This expression of the MMP family members in a 
globally coordinated but individually distinct manner mediates localised changes in endometrial 
extracellular matrix.
1.7.3 Angiogenesis
Angiogenesis is not only important in embiyonic development, but also in a variety of 
normal and pathological conditions in the adult, including ovulation, bone formation, 
inflammation, wound repair, and tumour growth. The composition of the ECM affects the 
angiogenic response. In order to form a new capillary sprout in response to an angiogenic stimulus, 
endothelial cells must first degrade the basement membrane that surrounds the preexisting 
capillary. The cells then migrate from the vascular wall, penetrating barriers imposed by the ECM, 
towards the angiogenic stimulus. The subsequent events of proliferation of the cells behind the 
leading front, formation of a vascular lumen, and further capillary maturation are also effected by 
ECM composition. Angiogensis is regulated by the presence o f angiogenic factors, including 
fibroblast growth factor (FGF), angiotropin, angiogenin, TNF-a, epidermal growth factor (EGF), 
and TGF-P (Fisher et al., 1994). The penetration of local ECM barriers by endothelial cells 
requires spatially and temporally controlled elaboration o f an array of proteolytic activities 
(Moscatelli and Rifkin, 1988). Cultured capillary endothelial cells synthesise increased amounts of
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MMP-1 in response to preparations known to contain basic-FGF-like angiogenic activities, TPA 
also induces MMP-1 and MMP-3 in cultured endothelial cells (Moscatelli and Rifldn, 1988). 
Mignatti et al. (1989) showed that FGF-induced invasion of cultured bovine capillary endothelial 
cells was inhibited by inhibitors of both plasmin and metalloproteinase activity, demonstrating that 
both the plasminogen-activator-plasmin system and specific metalloproteinases were involved in 
the FGF induced invasion associated with angiogenesis. Fisher et al. (1994) using human umbilical 
vein endothelial cells (HUVEC) treated with phorbal esters detected a prominent induction of 
MMP-1, also induced were MMP-9, and MMP-2 production. Two inhibitors of MMPs, the 
naturally occurring TIMP-1 and the synthetic, peptide inhibitor BB-94 were both effective at 
blocking HUVEC-mediated collagen degradation, invasion and tubule formation. The authors 
showed that the inhibitors were acting directly upon MMP-1, demonstrating that MMP-1 was 
required for angiogensis in vitro (Fisher et al., 1994). Further investigations into the mechanisms 
by which MMPs modulate the ECM such that angiogensis can occur in a precisely regulated 
fashion will continue to clarify the specifics of the angiogenic process.
1.7.4. MMPs in Cellular Processes
Tissue remodeling in any form can involve a variety of cellular events, including 
proliferation, migration, differentiation, and apoptosis. MMPs can participate in these cellular 
activities in a variety of ways. Through their actions, they can alter cell-matrix and cell-cell 
interactions, change cell shape, and release or activate growth factors. These are events which in 
turn can alter cellular processes.
The potential roles for MMPs in cellular proliferation are many. As discussed earlier, 
MMPs are induced by growth factors and oncogenes that also increase the proliferative index of 
cells in vitro. The induction of MMPs in proliferating tissues could facilitate the clearing of 
basement membrane and/or connective tissue matrix components to make room for the multiplying 
cells as they expand. MMP induction may be part of a programme of gene expression designed to 
prepare the tissue for growth. Proteolysis of the ECM could result in release of matrix bound 
growth factors and their receptors, such as FGF and heparin binding EGF (Vlodavsky et al., 1990; 
Whitelock et al., 1996). Another possibility is that MMPs can directly activate growth factors by 
processing them from precursor molecules. MMP-1, MMP-2, MMP-3, MMP-7 and MMP-9
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activate proTNF-a in this manner (Gearing et al., 1994). Similarly MMP-7 causes the release of 
the receptor-binding amino-terminal fragment from high molecular weight uPA, which has been 
shown to be mitogenic and to increase cell motility (Anichini et al., 1994). MMPs may thus affect 
cellular proliferation by a variety of indirect mechanisms.
The nature of the ECM can influence the apoptotic programme in mammalian cells and 
this has lead to the association of MMPs with apoptosis. The prevailing hypothesis is that the 
basement membrane is a survival factor for epithelial cells, and their loss of contact with the 
basement membrane results in programmed cell death. In the breast, a basement membrane rich in 
laminin is required for normal mammary gland development and gene expression (Lin and Bissell,
1993). When mammary epithelial cells are placed in culture without critical basement membrane 
components, they undergo apoptosis (Pullan et al., 1996). In vivo, overexpression of the activated 
form of MMP-3 in the mammary gland of transgenic mice results in loss of basement membrane 
components, and a marked disruption of ECM structure (Witty et al., 1995). Consistent with a role 
for MMPs in modulating programmed cell death via alterations in the ECM, these mice show a 
significant increase in the apoptotic index in mammary tissue (Witty et al., 1995; Boudreau et al.,
1995). Studies by Boudreau et al. (1995) suggested that basement membrane ligations inhibited IL- 
1 p converting enzyme (ICE; the mammalian cell death-inducing gene) expression, and the loss of 
this contact resulted in elevated ICE and induction of the apoptotic pathway. MMPs may also 
activate or release factors involved in the apoptotic process. Fas interactions with its ligand initiate 
apoptosis in T lymphocyte (Ju et al., 1995). Fas is a member of the TNF/nerve growth factor 
receptor family and MMPs have the ability to convert proTNF-a and Fas ligand to active, soluble 
forms, possibly inducing apoptosis.
The MMP family continues to expand with the cloning of the MT-MMPs and the recent 
cloning of MMP-19 and MMP-20. These new additions add more complexity to the field, while at 
the same time opening new avenues of research. The classification of the MMPs by protein 
structure rather than substrate specificity may free the MMPs from the view that they are enzymes 
that only degrade ECM and highlight the increasing complexity of the structure and function of the 
MMPs. This complexity is paralleled in the elaborate yet precise manner in which the MMPs are
regulated in vivo. The examples given o f the physiological roles of MMP are by no means 
exhaustive but serve in demonstrating the subtle yet critical roles the metalloproteinases play in 
many different normal cellular processes.
1. 8 Thesis Overview
The research presented in this thesis examines the role o f MMPs in trophoblast invasion and has 
been divided into four main sections;
• The establishment of a model system using continuous trophoblast cell lines to examine the role 
of MMPs in trophoblast invasion. The trophoblast cell lines were characterised extensively and 
examined for expression of MMPs and TIMPs (Chapter 3).
• An investigation of the effects of cytokines, ECM components, hormones and hypoxic 
conditions on MMP mRNA and protein expression in trophoblast cell lines. The effect of 
cytokines on the invasive ability of the cell lines was also examined (Chapter 4).
• Localisation o f MMP protein expression in vivo by immunohistochemistry of placental 
biopsies. Also, a preliminary investigation of the role of MMPs in pre-eclampsia, correlating 
MMP expression with disease state in 10 pre-eclamptic and 10 normal placental biopsies 
(Chapter 5).
• The isolation and characterisation of soluble single chain antibody fragments to MMP-9 using 
phage display technology (Chapter 6).
As the research described above covers a number of distinct but related topics, this thesis has been 
divided into eight chapters which, it is hoped, will clarify the results. Chapter 1 serves as a general 
introduction to the MMPs. There is a common Materials and Methods section (Chapter 2) and 
Bibliography (Chapter 8). Chapters 3, 4, 5 and 6 each have their own introduction, results and 
discussion sections. Chapter 7 provides an overall summary.
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Chapter 2 
Materials and Methods
2.1 MATERIALS
All general purpose chemicals and reagents used in experimental work were of analytical grade and 
were purchased from Sigma Chemical Company, Poole, Dorset, England; BDH Chemicals Ltd., Poole, 
Dorset, England and Riedal De Haen AG, Seelze, Hannover, Germany.
Cell culture medium, transfection reagent LipofectAMINE and chamber slides were obtained from 
Gibco BRL, Paisley, Scotland.
Foetal calf serum was supplied by Biowhittaker, Verviers, Belgium.
BRI clone was obtained from the NCTCC, DCU, Dublin 9.
Disposable plastics for animal cell and microbiological culture, and 96-well plates were obtained from 
Costar, Cambridge, MA02140, USA.
ED27, ED31 and ED77 cell lines were kindly donated by Douglas Kniss Ph.D., Department of Obstetrics 
and Gynecology, Ohio State University College of Medicine, Ohio, USA.
Be Wo cell line and 9E10 hybridoma cell line were obtained from the European Collection of Animal 
Cell Cultures (ECACC), Porton Down, Salisbury, Wiltshire, England.
BHK cells, transfected BHK cells, riboprobes for MMP-9, and TIMP-1 and -2 standards were obtained 
from Dylan Edwards Ph.D., University of Calgary, Canada.
HT1080 cell line was a gift from Hugh McGlynn Ph.D., University o f Ulster at Coleraine, Coleraine, 
Northern Ireland.
Microbiological media components and PBS tablets were purchased from Oxoid Ltd., Basingstoke, 
Hampshire, England.
The VECTASTAIN ABC kits were obtained from Vector laboratories, Burlingame, CA94010, USA. 
Enzyme labeled anti-mouse and anti-rabbit antibodies, restriction endonucleases, Taq polymerase and 
other components o f RT-PCR reactions were purchased from Promega Corp., Southampton, 
Hampshire, England.
Anti-MMP and-TIMP antibodies were purchased from Oncogene Research Products, Calbiochem, 84 
Rogers Street, Cambridge, MA 02142, USA.
X-ray film, film developer and fixative were purchased from Kodak, D ublin, Ireland.
The anti-fd bacteriophage antibody, DAB, OPDA and NBT/BCIP tablets, L-glutamine, trypsin, 
penicillin/streptomycin and gentamycin were purchased from Sigma Chemical Company.
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Cytokines, 92kDa gelatinase protein and in situ hybridisation reagents were purchased from Boehringer 
Mannheim, Hannover, Germany.
Biocoat Matrigel invasion chambers were obtained from Collaborative Biomedical Products, Becton 
Dickinson Labware, 2 Oak Park, Bedford, MA 01730, USA.
RNA ISOLATOR was obtained from Genosys Biotechnologies, Cambridge, UK
The BCA reagent for protein determination and the FITC labeled anti-mouse antibody were obtained
from Pierce Chemicals, Rockford, IL 61105, USA.
Specific primers for PCR were made to specifications by Genosys, England.
Qiagen kit for preparation of DNA purchased from Qiagen Ltd., Boundary Court, Gatwick Road, 
Crawley, West Sussex, UK
Nissim library was obtained from Cambridge Centre for Protein Engineering, Medical Research 
Council Centre, Hills Road, Cambridge, CB2 2QH, England.
Helper phage VCS-M13 was obtained from Stratagene Cloning Systems, 11099 North Torrey Pines 
Road, La Jolla, CA 92037, USA.
Equipment used is outlined in the relevant methods section
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2.2 METHODS
2.2.1 CELL CULTURE METHODS
All cell culture techniques were performed in a sterile environment using a Holten HB255 laminar air 
flow cabinet. Cells were visualised with an Olympus CK2 inverted phase contrast microscope.
2.2.1.1 Culture of adherent cell lines
ED27*, ED31*, ED77*, BHK, and HT1080 cell lines were maintained in Dublecco’s modification of 
Eagles medium (DMEM) supplemented with 5% (v/v) [DMEM S5] foetal bovine serum (FBS), 2 mM 
L-glutamine, 1 mM N-[2-Hydroxyethl]piperazine-N’-[2-ethanesulfonic acid] (HEPES), gentamycin 
50jjg/ml. BeWo cells were maintained in Hams F-12 nutrient mix supplemented with 10% (v/v) FBS, 
ImM L-glutamine, ImM HEPES, gentamycin 50(ig/ml. All cultures were seeded into 25cm2 and 75 
cm2 tissue culture flasks. As these were all strongly adherent cell lines, trypsinisation was required for 
harvesting cells prior to subculturing. For trypsinisation, the growth medium was decanted and the flask 
rinsed with 3 ml o f phosphate buffered saline (PBS) to remove any residual FBS which contains 
trypsin-inhibitory activity (ota-macroglobulin). 2 ml of fresh trypsin- ethylenediamine tetracetic acid 
(EDTA) (0.025% (w/v) trypsin with 0.02% (w/v) EDTA in 0.15 M PBS, pH 7.4) was then placed in 
each flask and the flask incubated at 37°C for 5-10 min or until all the cells were detached from the 
surface. The cell suspension was decanted into a sterile universal container containing 5 ml growth 
medium and centrifuged at 2000 rpm for 5 min. Cells were resuspended in culture medium at 2 x 105 - 
1 x 1 0  cells/ml, using 20 ml of medium per 75cm culture flask and 10 ml per 25cm flask. All cell 
lines were incubated in a humid, 5% (v/v) CO2 atmosphere at 37°C in an Heraeus cell culture incubator. 
[*Trophoblast cell lines were established as previously described by Diss et al., (1992). Briefly, 
cytotrophoblasts were isolated from first trimester chorionic villi samples (CVS) obtained from patients 
undergoing cytogenetic testing at 9 to 12 weeks gestation. The villi were dissected free from 
surrounding nonvillous tissue, incubated with trypsin for lhr at 37°C, followed by collagenase digestion 
for 2hr at 37°C with agitation to dissociate the cells of the mesenchymal core of the villi. The cells were 
used after several serial passages and exhibited an epitheloid phenotype.]
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2.2.1.2 Culture of cells in suspension
The anti c-myc hybridoma 9E10 was maintained in RPM1 medium supplemented with 10% (v/v) FBS, 
1 mM HEPES, 2 mM L-glutamine, 1 unit/ml penicillin, lfig/ml streptomycin and 5% BRIclone 
(BRIclone is a medium supplement for hybridoma cell lines). Cultures were maintained at densities of 
2.5 x 105 cells/ml, in 75 cm2 flasks. Cultures were passaged by diluting the cells with media. The cells 
were incubated in a humid 5% CO2 atmosphere at 37°C.
2.2.1.3 Cell counts
Cell counts were performed using a Neubauer haemocytometer slide. Trypan blue exclusion dye was 
routinely used to determine cell viabilities. 20/j.l trypan blue was added to lOO i^l cell suspension, and the 
mixture left to incubate for 2 min. A sample of this mixture was added to the counting chamber of the 
haemocytometer and the cells visualised by light microscopy. Viable cells excluded the dye and 
remained clear while dead cells stained blue.
2.2.1.4 Recovery and storage of cells
Long term storage o f cells was achieved by storing the cells frozen in liquid nitrogen and maintaining 
them in a cryofreezer (supplied and serviced by Cooper Cryoservice Ltd.). Cells to be stored were 
centrifuged and the resulting cell pellet resuspended at a concentration of 1 x 106 cells/ml in FBS 
containing the cryopreservative dimethylsulphoxide (DMSO) at a final concentration of 10 % (v/v). 1 
ml aliquots were transferred to sterile cryotubes, and frozen first at -20°C for 30 min, then overnight at - 
80°C and then immersed in the liquid nitrogen. Cells were recovered from liquid nitrogen by thawing 
rapidly at 37°C and transferring to a sterile universal tube containing 5 ml growth media. The cells were 
centrifuged at 2000 rpm for 5 min, resuspended in fresh medium, transferred to culture flasks and 
incubated at 37°C in 5% CO2.
2.2.1.5 Cytokine/TP A/hormone treatment of cells in culture
Cells were routinely cultured for at least 2 passages prior to cytokine, 12-O-tetradecanoyl-phorbal-13- 
acetate (TPA), or hormone treatment. For these experiments, cells were grown until approximately 70% 
confluent after which the growth medium was decanted and the cells rinsed with sterile PBS. 8 ml of 
fresh serum free medium was then added to each 75cm2 flask. The cells were returned to the incubator
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overnight. The following day fresh serum free medium was added and the flasks were supplemented 
with one of the following cytokines or TP A (final concentrations in brackets): interleukin-ip (IL-ip) (5 
ng/ml), epidermal growth factor (EGF) (5 ng/ml), transforming growth factor-P (TGF-P) (5 ng/ml) and 
TPA (100 ng/ml). Hormones were added in the following concentrations progesterone (10"6 M) and P- 
estradiol (10'8 M). The cells were then returned to the incubator for 8 hr, after which the cells were 
harvested for total ribonucleic acid (RNA), or for 24 hr ailer which Ihe conditioned medium was 
collected.
2.2.1.6 Isolation of placental fibroblast cell line
Forty to eighty grams of tissue were removed from freshly delivered placentae and washed in DMEM 
Sio prior to trypsinisation. The tissue was then finely minced and subjected to serial trypsin/DNase 
digestion at 37°C. Cellular supernatants were pelleted and pooled and the trypsinisation stopped by 
cooling to 4°C and by the addition of FBS. The red cells were then removed by the addition of lysis 
buffer. Following serial washes in PBS the cellular pellet was resuspended in growth medium and the 
cell suspension placed in a T75cm2 flask. The cells were cultured over a period of approximately 4 
weeks, at which time a homogenous population of fibroblast cells had overgrown all other cell types.
2.2.1.7 Culturing cells under hypoxic conditions
Cells were cultured until 70% confluent in T75cm2 flasks and serum starved overnight. The flasks (with 
loosened lids) were then placed in a hypoxic chamber. The chamber was sparged with nitrogen gas for 
10 min to expel air and then sealed. An indicator paper was placed in the chamber also, which indicates 
if hypoxic conditions were reached. Standard tissue culture conditions are 5% C(V95% air, and 
hypoxic conditions are approximately 2% O2 /93% N2/5% CO2. The cells were then left for 8 hr at 
37°C. The conditioned medium was collected and RNA isolated.
2.2.2 IMMUNOCYTOCIIEMICAL STAINING
Trophoblast cell lines were characterised by immunocytochemical staining for numerous markers, 
identified by specific antibodies. These antibodies were against cytokeratins 8 and 18 (Dako) used at a 
1:50 dilution, vimentin (Sigma Immunochemicals) at 1:50, human chorionic gonadotropin (hCG)
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(Dako) at 1: 200, human placental lactogen (hPL) (Dako) at 1: 350. Cells were grown overnight on 
chamber slides (Nunc) in standard growth medium. The following day cells were rinsed with PBS and 
fixed for 7 min in a 1: 1 (v/v) mixture of acetone /methanol at -20°C. Primary antisera were diluted in 
PBS and applied for lhr at room temperature (RT). Control slides were incubated with nonimmune 
serum. The a-cytokeratin 8 and 18 antibodies were detected by immunofluorescence using an FITC- 
labeled anti mouse antibody (Pierce). The oilier antibodies were visualised using an avidin-biotin 
peroxidase detection method with kits purchased from Vector Laboratories (Burlingame, CA).
2.2.3 BCA PROTEIN MICROASSAY
In this assay, C u^  reacts with the protein under alkaline conditions to give Cu+, which in turn reacts 
with BCA to give a coloured product. Two separate reagents are supplied in the commercially available 
assay kit : A, an alkaline bicarbonate solution and B, a copper sulphate solution. Working solution is 
prepared by mixing 1 part reagent B with 50 parts reagent A. 200|il o f this solution was added to 10|_il 
test sample or protein standard in wells of a microtitre plate. The plate was incubated at 37°C for 30 
min. The absorbance of each well was read at 560 nm using a Titertek Twinreader Plus microtitre plate 
reader. Protein concentrations were determined from a standard curve in the range 0 -1  mg/ml.
2.2.4 PROTEIN ELECTROPHORESIS
2.2.4.1 SDS Polyacrylamide Gel Electrophoresis (PAGE)
PAGE, in the presence o f sodium dodecyl sulphate (SDS) was performed using the discontinuous
system described by Laemmli (1970) using 10% or 15% (w/v) polacrylamide gels as necessary. The
10% [volumes for 15% gel in brackets] resolving gels and 3% stacking gels were prepared as follows: 
Resolving G e l: 3.3 ml [5 ml] 30%(w/v) acrylamide containing 0.8% (w/v) bisacrylamide,
4 ml [2.3 ml] distilled water,
2.5 ml [2.5 ml] 1.5M Tris, pH 8.8 containing 0.4% (w/v) SDS 
0.1 ml [0.1 ml] 10% (w/v) SDS,
0.1 ml [0.1 ml] 10% (w/v) ammonium persulphate (freshly prepared)
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0.005 ml [0.005 ml] TEMED.
Stacking G e l: 0.33 ml 30% acrylamide solution,
1.4 ml distilled water,
0.25 ml 0.5M Tris, pH 6.8 containing 0.4% (w/v) SDS,
0.02 ml 10% SDS,
0.02 ml 10% ammonium persulphate (freshly prepared)
0.002 ml TEMED.
Samples were mixed with sample buffer (2% (w/v) SDS; 0.08M Tris, pH 6.8; 10% (w/v) glycerol; 
0.2% (w/v) Coomassie Brilliant Blue). The gel was electrophoresed in running buffer, pH 8.3 
containing 0.025M Tris, 0.192M glycine and 0.1% (w/v) SDS at 20 mA per gel using an Atto vertical 
mini-electrophoresis system until the blue dye front reached the bottom of the gel.
2.2.4.2 Gel Staining
2.2.4.2.1 Staining with Coomassie Brilliant Blue
Gels were stained for 2 hr in 0.5% (w/v) Coomassie Brilliant Blue in acetic acid : water : methanol (1 : 
1 0 : 8, v/v/v), and destained overnight in the same solvent system.
2.2.4.2.2 Silver Staining
Following electrophoresis the gel was fixed by incubating for 8 hrs in 5 gel volumes of ethanol:acetic 
acid:water (30:10:60). The following day the gel was soaked twice in 5 gel volumes of 30% ethanol for 
30 min with gentle shaking, then washed 3 times in 10 gel volumes of deionised water for 10 min. The 
gel was then placed in 5 gel volumes o f 0.1% solution of AgNC>3 (freshly diluted from a 20% stock), for 
30 min with gentle shaking. The gel was washed on both sides under a stream of deionised water, 
taking care not to let the gel surface go dry. Next 5 gel volumes of 2.5% sodium carbonate, 0.02% 
formaldehyde was incubated with the gel until stained bands appeared. The reaction was quenched by 
washing in 1% acetic acid for 5 min and washed in deionised water.
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2.2.4.3 Zymography
SDS substrate gels were used to localise enzyme activity by molecular weight. The gel was made by 
incorporating the protein substrate o f interest (gelatin or casein) within the polymerized aciylamide 
matrix. 10 % or 15% acrylamide gels were used and the amounts for one gel are given below, volumes 
for 15% gels are in brackets.
Resolving g e l: 2.5 ml [2.5 ml] Buffer A (1.5 M Tris-HCl, pH 8.8; 0.4% (w/v) SDS)
2.5 ml [2.5 ml] 3 mg/ml gelatin or casein stock
3.3 ml [5 ml] 30% acrylamide stock
1.7 ml [0 ml] distilled water
33 (0,1 [3 3 jj.1] 10% ammonium persulphate (freshly prepared)
5 |il [5jxl] TEMED
Stacking g e l: 0.8 ml Buffer B (0.5 M Tris-HCl, pH 6.8; 0.4% SDS)
0.5 ml 30% acrylamide stock 
2 ml distilled water
33(4.1 10% ammonium persulphate (freshly prepared)
5 (^ 1 TEMED
Samples were mixed 3:1 with 4X sample buffer (10% sucrose; 0.25 M Tris-HCl, pH 6.8; 0.1% (w/v) 
bromophenol blue) and loaded. The gels were run at 20 mA per gel in running buffer (0.025 M Tris; 
0.19M glycine; 0.1% SDS) until the dye front reaches the bottom of the gel. Following electrophoresis 
the gel was soaked in 2.5% Triton-X-100 with gentle shaking for 30 min at RT with one change. The 
gel was then rinsed in substrate buffer (50 mM Tris-HCl, pH 8.0; 5 mM CaCb) and incubated for 24 hr 
in substrate buffer at 37°C. The gel was then stained with Coomassie blue for 2 hr with shaking and 
destained in water until clear bands were visible.
To confirm bands as metalloproteinases, identical gels were run as described above except the substrate 
buffer contained one of the following protease inhibitors: lOmM EDTA (MMP inhibitor), 0.3 mM 
1,10-phenanthroline (MMP inhibitor), 1 mM PMSF (serine proteinase inhibitor), or 1 mM pepstatin A 
(aspartic proteinase inhibitor).
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2.2A.4 Reverse Zymography
For reverse zymography to detect the tissue inhibitors of metalloproteinases (TIMPs), SDS-PAGE gels 
were prepared with the incorporation of matrix metalloproteinases and gelatin into the acrylamide 
matrix of the gel. 15% gels (10 ml volume) were prepared as in section 2.2.3.3 above except that the 
water component of the gel was reduced by 1 ml to adjust for the addition of 1 ml of conditioned 
medium from BHK h92 cells (containing MMPs ). Gels were loaded and ran as above, TTMP standard 
(gift from Dylan Edwards, University of Calgary,Canada) was loaded as a positive control. After 
electrophoresis, gels were incubated in a solution o f 2.5 % Triton-X-100; 50 mM Tris-HCl, pH 7.5; 5 
mM CaCb once for 15 min, then again overnight at RT with gentle shaking. Next day gels, were rinsed 
three times with water, then incubated in 50 mM Tris-HCl pH 7.5 and 5 mM CaCl2 for 24 hr at 37°C to 
allow digestion of the gelatin substrate. Gels were then stained in Coomassie blue for 2 hr and destained 
until the desired contrast was achieved. The majority of the gel does not stain as the gelatin has been 
degraded. Dark bands represent inhibition of gelatin degradation by TIMPs within the sample.
2.2.5 WESTERN BLOTTING
Following electrophoresis as outlined in section 2.2.4.1, the gel was soaked for 30 min in cold transfer 
buffer (0.25 M Tris, pH 8.3; 0.192 M glycine; 20% (v/v) methanol). Nitrocellulose and eight sheets of 
Whatman filter paper were cut to the same size as the gel and soaked in transfer buffer. The proteins 
were transferred from the gel to the nitrocellulose using a LKB 2051 Midget Multiblot Electrophoretic 
Transfer Unit with water cooling for 1 hr at 30 V followed by 1 hr at 60 V. After transfer, the blot was 
blocked for 1 hr in blocking solution [2.5% (w/v) dried milk dissolved in Tris Buffered Saline plus 
Tween [TBST] (10 mM Tris pH 8.0; 150mM NaCl; 0.05% (v/v) Tween 20)] and then incubated 
overnight at 4°C with primary antibody at a suitable dilution in blocking solution (anti-Fd used at 1/750 
dilution, 9E10 used at 1/400 dilution). The following day, blots were washed three times for 10 min 
each with TBST and then incubated for 3 hr gently shaking at RT with a suitable enzyme-labeled 
secondary antibody diluted according to the manufacturers recommendations in TBST (anti-rabbit-HRP 
used at 1/5000 dilution, anti-mouse-HRP used at 1/2000 dilution). Following 3 x 1 0  min washes, the 
blots were developed without shaking at RT with the appropriate substrate solution. For alkaline 
phosphate (AP) labeled antibodies, this was BCIP (175 |Jg/ml) and NBT (500 pg/ml) in AP buffer (0.1
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M Tris, pH 9.5; 0.1M NaCl; 5 mM MgCk). For horseradish peroxidase (HRP) labeled antibodies, the 
substrate diaminobenzidine (DAB) was prepared by dissolving one 5 mg tablet in 15 ml TBS and 
adding fresh hydrogen peroxide (H2O2) to a fmal concentration o f0.024 % (v/v).
2.2.6 IN VITRO INVASION ASSAYS
Biocoat Matrigel invasion chambers provided the cells with conditions that allowed assessment o f their 
invasive property in vitro. The cell culture inserts contained an 8jj.m pore size membrane which has 
been covered with a layer of matrigel which serves as a reconstituted basement membrane in vitro. This 
layer occludes the pores of the membrane blocking non-invasive cells from migrating through the 
membrane. By contrast, invasive cells are able to detach themselves from and migrate through the 
Matrigel treated membrane.
The 6-well plate invasion chambers were removed from 4°C storage and allowed to adjust to room 
temperature and warm (37°C) serum-free culture medium was added to the interior of the inserts and 
allowed to rehydrate for 2 hr at RT. After rehydration the media was removed from the inserts and 
replaced with 2 ml cell suspension in serum-free medium prepared at 3.5xl05 cells/ml. Chemoattractant
2.5 ml (media containing 20% FBS) was added to the bottom wells of the plate. The plates were then 
incubated for 72 hr at 37°C in 5% CO2 incubator. After incubation, the non-invading cells were 
removed from the upper surface o f the membrane by scrubbing with a cotton tipped swab. The cells on 
the lower surface of the membrane were then fixed in methanol for 2 min, stained for 1 min in Mayers 
Haematoxylin and rinsed in tap water several times. The cells and membrane was then dehydrated by 
incubation for 2 min each in a series of ethanol solutions (30, 50, 70, 90, 100% ethanol). The 
membranes were then removed from the insert housing with a scalpel and mounted on slides using 
DPX mounting medium. Invading cells were then viewed under the microscope at 40 X magnification 
and counted. The percentage invasion for each cell line was calculated by counting all of the stained 
cells on the filter underside and dividing by the total number of cells plated.
For experiments investigating the effect of cytokines on invasion, cytokines were added to the media 
used to rehydrate the inserts, the cell suspension, and to the media containing the chemoattractant at the 
concentrations given in section 2.2 .1.5.
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2.2.7 ISOLATION AND ANALYSIS OF RNA
RNA is easily degraded by the ubiquitous RNase enzymes. These enzymes are resistant to autoclaving 
but they can be inactivated by treatment with the chemical diethylpyro-carbonate (DEPC) when it is 
added to solutions at a final concentration of 0.1 %. Solutions containing amines such as Tris cannot be 
DEPC-treated directly as the DEPC is inactivated by these chemicals. These solutions were prepared in 
DEPC-treated water. All other solutions for RNA work were DEPC-treated, and gloves and disposable 
sterile plastics used at all times. Any glassware used was baked overnight at 200°C. Manipulations with 
RNA must be carried out quickly and on ice to help prevent degradation of RNA by endogenous 
RNases.
2.2.7.1 RNA extraction from cultured cells
Total RNA was isolated from equal numbers of cells using RNA ISOLATOR (Genosys 
Biotechnologies), which is a modified version of the single step method of acid guanidinium 
thiocyanate-phenol-chloroform extraction. The cultured cells were lysed directly on the culture flask by 
adding 2 ml of reagent per 75 cm2 flask and incubating for 5 min at RT to permit the complete 
dissociation of nucleoprotein complexes. Phase separation was then achieved by adding 0.2 ml of 
chloroform per 1 ml o f reagent, shaken for 15 seconds and incubated at RT for 2-15 min. The resulting 
mixture was centrifuged at 12,000 rpm for 15 min. Following centrifugation, the mixture separates into 
a lower red, phenol-chloroform phase, an interphase, and the colour-less upper aqueous phase. RNA 
remains exclusively in the aqueous phase whereas DNA and proteins partition to the interphase and 
organic phase. The aqueous phase was transferred to a fresh tube and the RNA precipitated by adding 
0.5 ml of isopropanol per ml of reagent used. Samples were incubated at RT for 10 min and 
centrifuged at 12,000 rpm for 10 min. The RNA pellet was then washed once with 75% ethanol, 
allowed to air dry and dissolved in sterile Tris-EDTA (TE), pH 8.0 (10 mM Tris-HCl; 1 mM EDTA). 
RNA samples were stored at -80°C.
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22.12 Spectrophotometric analysis of RNA
RNA concentration was determined by measuring the absorbance at 260 nm, the wavelength at which 
nucleic acids absorb maximally (Xmax). A 40 (.ig/ml preparation of pure RNA has an absorbance reading 
of 1 unit at 260nm. The purity of an RNA preparation was determined by reading absorbances at 260 
nm, the X,max. for nucleic acids, and at 280nm, the ^max. for proteins and obtaining the ratio of these 
absorbances. Pure RNA with no protein contamination has an Abs26o/Abs28o ratio of 2.0. Lower ratios 
indicate the presence o f protein while higher ratios often indicate residues o f organic reagents.
22.1.3 RNA analysis by gel electrophoresis
To check that the RNA isolated was intact and had not been degraded, samples were run on 1% agarose 
gels. The gels were prepared by boiling the agarose in IX tris borate EDTA (TBE). Once cooled to 
hand-hot, the gel was cast into the Hybaid Horizontal Gel Electrophoresis system. The RNA samples 
(5jil) were prepared for electrophoresis by mixing with 15^1 sample buffer (50% (v/v) formamide; 8.3 
% (v/v) formaldehyde; 0.027 M 3-[N-Morpholino]propanesulfonic acid (MOPS), pH 7; 6.7 mM 
sodium acetate; 0.67 mM EDTA) and 3jal loading buffer (50 % (v/v) glycerol; 1 mM EDTA; 0.4 % 
(w/v) bromophenol blue; l|ig/|il ethidium bromide) and the sample heated for 10 min at 65°C prior to 
loading on the gel. The gel was run at 100V in IX TBE. As ethidium bromide was included in the 
loading buffer, there was no need for further staining and the gel could be visualised directly on a UV 
transilluminator. The presence of 2 strongly staining bands, representing the 28 S and 18 S ribosomal 
subunits, signified intact RNA. Degradation could be seen as a smear running down the length of the
2.2.8 REVERSE TRANSCRIPTION PCR (RT-PCR)
The polymerase chain reaction (PCR) has emerged as a powerful tool for amplifying small quantities of 
deoxyribonucleic (DNA) for analysis. RT-PCR is a modification of the technique which allows analysis 
of small quantities of specific messanger RNA (mRNA). Total RNA is first converted to 
complementary DNA (cDNA) using a reverse transcriptase enzyme. Specific cDNAs are then amplified 
in the PCR by inclusion of the appropriate primers. Details of the primers used are shown in Table 2.1. 
The PCR used was semi-quantitative as a constitutively expressed gene, p-actin, was always amplified
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in the same tube with the MMP target. This acted as an internal control and, by calculating ratios of 
MMP to P-actin, relative amounts of the targets could be determined from reaction to reaction.
2.2.8.1 Reverse transcription
lfig of total RNA (prepared as outlined in section 2.2.7.1) was mixed with 0.5|og oligo dT primers and 
the mixture brought to a final volume o f 5(41 with sterile water. This priming reaction was incubated at 
70°C for 10 min. To this was added 4(d 5X transcription buffer (supplied with the reverse transcription 
enzyme by the manufacturer), 2p.l 100 mM dithiothretiol, 1(4,1 RNasin, l |4l o f a mix of dATP, dCTP, 
dGTP and dTTP each at a concentration of lOmM, 6(4,1 sterile water, and l(il of Moloney murine 
leukaemia virus reverse transcriptase (MMLV-RT). The reaction mixture was incubated at 37°C for one 
hr before being heated to 95°C for 2 min to inactivate the enzyme. The resulting cDNA was stored at 
4°C until required for PCR.
2.2.8.2 Polymerase Chain Reaction
A 45(41 PCR mix was prepared by adding 5(41 of 10X reaction buffer supplied with the Taq polymerase 
enzyme, l(il each of dATP, dCTP, dGTP, and dTTP each at a concentration of lOmM, l|4l (50ng/|4l)of 
each of the forward and reverse primers required in the reaction, 0.5|il Taq DNA polymerase and 38.5(41 
sterile water in a sterile tube. To this reaction mixture was added 5(41 of cDNA prepared as in section
2.2.8.1 and the mixture overlaid with 50(41 mineral oil. The tube was placed on a Hybaid thermocycling 
machine programmed with an initial incubation of 93°C for 3 min, followed by 30 cycles consisting of 
the following sequential steps : 93°C for 90 seconds, anealing temperature as in Table 2.1 below for 90 
seconds and 72°C for 3 min. The PCR products were then removed from under the oil and placed in 
fresh tubes. 15(ul amounts were run on 2% agarose gels as described in section 2.2.8.3 below.
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Table 2.1 Sequence o f primers used for RT-PCR
Target Primer sequence Fragment
size
Optimum 
anealing 
temp. (°C)
Reference
M M P-9 5 ’GGT CCC CCC ACT GCT GGC CCT TCT ACG GCC 3 ’ 
5 ’ GTC CTC A G G  GCA CTG CAG GAT GTC A TA  GGT 3 ’
640bp 54 Onisto et al., 
1993
M MP-2 5 ’ TGA CAT C AA  GGG CAT TTC AGG A G C 3’ 
5 ’ GTC CGC C AA  ATG A AC  GGT CCT TG 3 ’
180bp 53 Shimonovitz 
et al., 1994
M M P-7 5 ’ TGT ATC  CAA CCT ATG GAA ATG 3 ’
5 ’ CGC GCA TCT A CA  GTT ATT T A C 3’
341 bp 47 Witty et al., 
1994
MMP-3 5 ’ CTT TCC AGG GAT TGA CTC 3 ’ 
5 ’ CGG CCA GTA A A A  A TA  C A A 3’
324bp 48 Matrisian et 
al., 1986
TIMP-1 5 ’TGC ACC TGT GTC CCA CCC CAC CCA CAG ACG 3 ’ 
3 ’GGC TAT CTG GGA CCG CAG GG A CTG CCA GGT 3 ’
551 bp 53 Onisto et al., 
1993
TIMP-3 5 ’CTG TGC A A C  TTC GTG GAG 3 ’ 
5 ’ TCG GTA CCA GCT GCA GTA 3 ’
250bp 55 Apte et al., 
1994
P- actin 5 ’ TCA GG A GG A GCA ATG ATC TTG A  3 ’
5 ’ G A A  ATC  GTG CGT GAC A TT  A AG  GAG A AG  CT3 ’
383bp 47-55 Nakajima- 
Iijima et al., 
1985
The primers were chosen so that they amplified sequences specific to the particular gene. Also the P- 
actin primers were chosen to span an intron. This meant that any amplification of genomic rather than 
cDNA would result in larger products than those expected.
2.2.8.3 Agarose gel electrophoresis
A 2% (w/v) agarose gel was prepared by boiling the appropriate quantity of agarose in 100 ml of IX 
TBE buffer, pH 8.2 (0.08 M Tris; 0.04 M boric acid; 1 mM EDTA). Once cooled to hand-hot, the gel 
was cast into the Hybaid Horizontal Gel Electrophoresis system.
Samples for electrophoresis were prepared by mixing with a suitable quantity of 6X gel loading buffer 
(40% w/v sucrose; 0.25% w/v bromophenol blue). Typically 12.5|ul of the PCR reaction mixture was 
mixed with 3 f_il of loading buffer and the samples loaded into the wells of the set gel. The gel was run 
at 100V in IX TBE. The electrophoresis was completed when the blue loading dye had run to within
0.5cm of the bottom of the gel. The gel was then stained in a solution of 0.5 |J.g/ml ethidium bromide
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for 20 min, briefly destained in distilled water, visualised by placing on a UV transilluminator. The gels 
were saved on disc using a UHP Gel Documentation System.
2.2.9 Densitometry
Densitometry o f protein and RT-PCR gels was performed using a BioRad model GS670 imaging 
densitometer with BioRad software Molecular Analyst, version 1.3.
2.2.10 IM M IN O IIISTO CIIEM ISTRY
Immunohistochemical analysis of MMP-9, MMP-2, MMP-7 and MMP-3 was preformed on sections 
obtained from pre-eclamptic and normal placental biopsies using a Vectastain ABC kit from Vector 
Laboratories. The antibodies used are shown in Table 2.2. 5jam formalin-fixed, paraffin-embedded 
tissue sections were provided by Prof. P. Kelehan, National Maternity Hospital, Holies Street, Dublin. 
Prior to immunohistochemistry, the sections were dewaxed and rehydrated by placing in xylene baths 
for four 5 min incubations followed by serial washes in ethanol baths o f decreasing concentration (100, 
80, 60, and 30% (v/v)) for 2 min in each. Endogenous peroxidase activity present in the tissue was 
quenched by incubating the sections for 30 min in 0.3% (v/v) H2O2 prepared in methanol. The sections 
were then washed for 5 min in PBS and blocked by incubation for 20 min with non-immune serum. 
After removing excess serum, the sections were then incubated for 1 hr at room temperature with the 
primary antibody diluted in PBS at the appropriate concentration (see Table 2.2). Following a 5 min 
wash in PBS, the sections were incubated with biotinylated anti mouse solution (kit component) for 30 
min. The slides were again washed for 5 min in PBS. They were then incubated for 30 min in 
Vectastain ABC reagent (kit component) before again being washed for 5 min in PBS. The slides then 
were developed with peroxidase substrate solution (DAB) prepared as outlined in section 2.2.5. After 
suitable colour development, the sections were rinsed in tap water and counterstained with 
haematoxylin. The sections were then dehydrated by passing through a series of ethanol baths of 
increasing concentration (30, 50, 70, 90,100% (v/v)), mounted in DPX mounting medium, and viewed 
using a light microscope.
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2.2.10.1 Microwave method for antigen retrivai
After dewaxing and rehydrating, slides were immersed in lOmM citrate buffer, pH 6.0. The tissue 
sections were microwaved in the citrate buffer for 20 min at high power, ensuring slides are covered in 
buffer at all times. The slides were then allowed to cool in the citrate buffer before continuing with the 
IHC as in section 2.2.10 above.
Table 2.2 Antibodies used for immunohistochemistry
Antibody Against Supplier Source Optimum dilution 
for IHC
MMP-2 (GL8) Celltech Therapeutics mouse monoclonal Ab 1/40 (0.019 mg/ml)
MMP-9 (MAC96) Celltech Therapeutics mouse monoclonal Ab N/S
MMP-9 (Ab-1) Oncogene Research mouse monoclonal Ab N/S
MMP-9 (Ab-2) Oncogene Research mouse monoclonal Ab N/S
MMP-9 (Ab-3) Oncogene Research mouse monoclonal Ab N/S
MMP-7 Gift from L.Matrisian rat monoclonal Ab 1/200
MMP-3 Gift from Syntax rabbit polyclonal Ab 5|ig/ml
TIMP-1 (Ab-1) Oncogene Research mouse monoclonal Ab N/S
TIMP-2 (Ab-1) Oncogene Research mouse monoclonal Ab N/S
N/S - Antibodies were tested but found to be unsuitable for immunohistochemistry (IHC) on paraffin 
embedded tissues.
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2.2.11 PHAGE DISPLAY TECHNIQUES
2.2.11.1 Protocol for use of the Library
Precautions were taken throughout the protocol to avoid carry over of phage from flasks and centrifuge 
bottles, as autoclaving alone is not sufficient to remove all phage contamination. Wherever possible 
devoted pipettes and disposable plastics were used. All non-disposable plasticware was soaked for 1 hr 
in 0.1 M NaOH; 1% SDS followed by extensive washing with distilled water, rinsed in ethanol and 
washed again in distilled water before autoclaving. Glassware used was baked at 200°C for 4 or more 
hours. Only polypropylene tubes were used during centrifugation steps as phage may absorb non- 
specifically to other plastics.
Two bacterial strains were used:
1. E. coli TGI which is a suppressor strain (K12, D(lac-pro), supE, thi, hsdD5/F’traD36,proA+B+, 
lacIq,lacZDM15) for propagation of phage particles.
2. E. coli HB2151 which is a non-suppressor strain (K12, ara,D(lac-pro),thi/F’proA+B+, lacIqZDM15) 
for expression of antibody fragments.
2.2.11.2 To prepare an exponentially growing culture
Phage/phagemid infect F+ E. coli via the sex pili. For sex pilli production and efficient infection E. coli 
were grown at 37°C and used at log phase (O.D. at 600nm of 0.4-0.5). A bacterial colony from a TYE 
plate (1.5% agar; 0.136M NaCl; 1% tryptone; 0.5 % yeast extract) was transferred into 2xTY (1.6 % 
w/v tryptone; 1% w/v yeast extract; 0.085 M NaCl) medium and grown shaking overnight at 37°C. 
Next day, the culture was subcultured by diluting 1 : 100 into fresh 2xTY medium, grown shaking at 
37°C until OD at 600nm was 0.4-0.5 (approximately 2 hr) and then infected with phage.
2.2.11.3 Large scale culture of helper phage
Large quantities of helper phage VCS M l 3 for rescue of phagemid libraries were prepared by infecting 
200(4,1 E. coli TGI at ODeoonm 0.2 with 10|4l serial dilution’s of helper phage (in order to get well 
separated plaques) at 37°C in waterbath without shaking for 30 min. 3 ml top agar (1% tryptone; 0.5%
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yeast extract; 0.17 M NaCl; 0.7% agar) was added and poured onto warm TYE plates. Plates were 
allowed to set and incubated overnight at 37°C. The following day a small plaque was picked into 3 ml 
of exponentially growing culture of TGI (prepared as in section 2.2.14.2) and grown for about 2 hr 
shaking at 37°C. The 3 ml was then inoculated into 500 ml 2xTY in a 2 litre flask and grown as before 
for 1 hr and then kanamycin added to a final concentration o f 50|ig/ml. The culture was grown for a 
further 16 hr after which Ihe bacteria were spun down at 10,000 rpm, 4°C for 15 min. 1/4 volume of 
PEG/NaCl solution (20 % polyethylene glycol 6000; 2.5M NaCl) was added to the phage supernatant 
and incubated for a minimum of 30 min prior to centrifugation at 10,000 rpm, 4°C for 15 min. The 
pellet was then resuspended in 2 ml TE and filter sterilised through a 0.45jam filter. The stock was then 
titered (section 2.2.14.4), diluted to 1 x 1012 p.f.u./ml and stored in aliquots at -20°C.
2.2.11.4 Titering of phage and phagemid numbers
The numbers of phage in a preparation can be quantified using plaque forming units (pfu). This relies 
on the ability of the phage to form plaques of slow growing colonies in a lawn of E.coli. This is due to 
the slower growth of bacteria infected with phage particles. The number of phagmids was estimated 
using pfu’s.
100|il of 10 fold serial dilution’s of the phage to be quantified were made (down to 10'15), and mixed 
with 400p.l TGI in late log phase. The TGI were then mixed with 3 ml top agar and poured onto 2xTY 
agar plates. Plates were grown overnight at 37°C, plaques appeared as small clearings in the bacterial 
lawn, pfu/ml was determined by counting the number of plaques on the plate and determining the 
number per ml o f undiluted phage solution.
2.2.11.5 Growth of the Library
o
50 (j.1 o f the bacterial library stock (about 5x10 clones) was inoculated into 50 ml 2xTY containing 
100j-ig/ml ampicillin and 1 % glucose, grown with shaking at 37°C until the ODeoonm was 0.5 (about 2 
hr). 40 ml o f this culture was used to make a secondary stock of the library as in section 2.2.14.13. The 
remaining 10 ml o f the culture was infected with VCS M l 3 helper phage in a ratio of 1 : 20 (number of 
bacterial cells : helper phage particles) taking into account that 1 OD bacteria at 600nm = around 8 x
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10s bacteria/ml) by incubating without shaking in a 37°C waterbath for 30 min. The infected cells were 
centrifuged at 4,500 rpm for 10 min and the pellet gently resuspended in 30 ml of 2xTY containing 
100|xg/ml ampicillin and 25fxg/ml kanamycin. 270 ml of prewarmed 2xTY containing 100jig/ml 
ampicillin and 25(ig/ml kanamycin was added and incubated shaking at 30°C overnight.
2.2.11.6 Preparing pHENl phagmid particles
The phage were concentrated and any soluble antibodies removed (as in TGI suppression of the amber 
stop codon encoded at the junction of the antibody gene and glU is never complete) by precipitating 
with PEG 6000. The overnight culture from section 2.2.14.5 above was spun at 8,250 rpm for 10 min 
and 1/5 volume PEG/NaCl added to the supernatant, mixed well and left for 1 hr or more at 4°C. The 
solution was then spun at 8,250 rpm for 30 min and the supernatant aspirated off. The pellet was briefly 
respun and any remaining PEG/NaCl aspirated off. After resuspending the pellet in 2 ml PBS, it was 
spun at 4,500 rpm for 10 min to remove most of the remaining bacterial debris. The phage supernatant 
was stored at 4°C for short term storage or in PBS, 15 % glycerol for longer term storage at -80°C. This
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procedure usually yielded 1-5x10 pfu.
2.2.11.7 Selection of phage library
The phage library was selected using sterile 96-well plates coated with MMP-9 protein. The wells (10 
wells were used for each round of panning) were coated overnight with 100 ^1/well of MMP-9 at 
50(4g/ml in sterile 50mM sodium hydrogen carbonate, pH 9.6 at RT. Next day the wells were washed 3 
times with PBS and then blocked with 200\x\ 2% Marvel in PBS (MPBS) for 2 hr at 37°C. Wells were 
washed 3 times with PBS and 1012 to 1013 pfu phage in 2% MPBS added, incubated for 30 min at RT 
shaking gently and then left to stand for at least a further 90 min at RT. Unbound phage were then 
thrown away and the wells washed 20 times with PBST (PBS containing 0.1% Tween-20), then 20 
times with PBS to remove the detergent. Each washing step was performed by pouring buffer in and 
immediately out. The bound phage were eluted by adding 100|al 0.1 M glycine-HCL, pH 2.5 per well 
and incubating for 10 min. Following incubation the contents of the wells were added to a universal 
containing 200(J,11 M Tris, pH 8.0, for quick neutralisation. The eluted phage were then added to 10 ml
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of exponentially growing TGI, incubated for 30 min at 37° C in waterbath without shaking to allow for 
infection. lOOpi o f the infected culture was then taken to make 4-5 100-fold serial dilution’s and plated 
onto TYE plates containing 100|ag/ml ampicillin and 1% glucose and grown overnight at 37°C. The 
remaining infected TGI culture was spun at 4,000 rpm for 12 min and the pelleted bacteria resuspended 
in 0.5 ml of 2xTY and plated on 2 TYE plates containing 100(J,g/ml ampicillin and 1% glucose. Plates 
were grown at 30°C overnight or until colonies were visible.
2.2.11.8 Further rounds of selection
The infected TGI culture growing on TYE plates were loosened in 1 ml of 2xTY with a glass spreader 
and 50|il o f the scraped bacteria inoculated into 50 ml of 2xTY containing 100|ig/ml ampicillin and 1% 
glucose. The remaining bacteria were stored at -80°C. The bacteria were grown with shaking at 37°C 
until the OD6oonm is 0.5 and then used for further selection by : rescuing the phagmid as in section
2.2.14.5 and PEG precipitating as in section 2.2.14.6 (resuspending the second phage pellet in 2 ml 
PBS). 1 ml of this phage was stored at 4°C and the other 1 ml aliquot used for the next round of 
selection as in section 2.2.14.7 and 2.2.14.8. The selection was repeated for another 3 rounds (4 rounds 
in total).
2.2.11.9 Growth of a secondaiy source of the library
By keeping some of the material as a secondary stock there is an endless source of the library. 40 ml of 
exponentially growing bacterial library stock was spun down at 4,500 rpm for 10 min and the cells 
resuspended in as small a volume as possible of 2xTY (about 500jal). The cells were spread on 2 petri 
dishes of TYE containing 1 OOfig/ml ampicillin and 1% glucose and grown overnight at 37°C. Next day 
0.5 ml o f 2xTY, 15% glycerol was added to each dish and the bacteria loosened with a glass spreader. 
This secondary stock of around 1 x 108 library bacteria per 50jil was stored in aliquots at -80°C.
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2.2.11.10 Screening phage particles by ELISA
Populations of phage produced at each round of selection were screened for binding to MMP-9 by 
ELISA, to identify “polyclonal” phage antibodies. Phage from single infected bacterial colonies from 
these populations were then screened by ELISA to identify “monoclonal” phage antibodies. 
Monoclonal phage which were found to have binding activity to MMP-9 had their pHEN phage 
particles rescued and infected into HB2151 to give monoclonal soluble antibody fragments.
2.2.11.11 Polyclonal Phage ELISA
96-well ELISA plates were coated with lOOfal per well of 15|jg/ml MMP-9 protein in 50mM sodium 
hydrogen carbonate, pH 9.6 overnight at RT. The wells were rinsed 3 times with PBS and blocked with 
200(0.1 per well of 2% MPBS for 2 hr at 37°C. Wells were washed 3 times with PBS and IOjj.1 PEG 
precipitated phage from the stored aliquot of phage from the end of each round of selection (about 
1010pfu) made up to 100(j,l with 2% MPBS. This was incubated for 90 min at RT, the test solution then 
discarded and wells washed 3 times with PBS-0.05 % Tween-20, then 3 times with PBS for 30 min. A 
1/750 dilution of anti-fd bacteriophage antibody in 2% MPBS was added for 90 min at RT and again 
washed 3 times with PBS-0.05% Tween-20, then 3 times with PBS. A 1/5000 dilution of HRP labeled 
anti-rabbit antibody was then added for 90 min at RT in 2 % MPBS, again washed 3 times with PBS- 
0.05% Tween-20, then 3 times with PBS. The reaction was developed with substrate solution [one 5 
mg OPDA tablet dissolved in 12.5 ml OPDA buffer (0.15M citrate buffer, pH 5.0) and 5ja,l 30% H2O2 
(added immediately before use)] for 30 min at 37°C and the reaction stopped by adding 50|il 1M 
sulphuric acid. The OD was then read at 495nm.
2.2.11.12 Monoclonal phage ELISA
To identify monoclonal phage antibodies the pHEN phage particles were rescued. Individual colonies 
from the plates after the selection procedure of round 4 were inoculated into lOOjxl 2xTY containing 
100|j,g/ml ampicillin and 1% glucose in 96-well plates and grown with shaking (250 rpm) overnight at 
37°C. A small inoculum, (about 2|il) from this plate was transferred to a second 96-well plate 
containing 200 (il of 2xTY containing 100|ig/ml ampicillin and 1% glucose per well and grown shaking
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at 37°C for 3 hr. Glycerol stocks were made of the original 96-well plate, by adding glycerol to a final 
concentration of 15%, and then storing the plates at -80°C. To each well (of the second plate) 25jal 
2xTY containing 100|ig/ml ampicillin, 1% glucose and 109 piu VCS M l3 helper phage were added. 
The plate was incubated for 30 min at 37°C and then shaken for 1 hr at 37°C. The plate was spun at 
3000 rpm for 10 min and the supernatant aspirated off. The pellets were resuspended in 200\A 2xTY 
containing 100|j.g/ml ampicillin and 50jog/ml kanamycin and grown overnight at 30°C. Next day the 
plate was spun at 3000rpm for 15 min and 100|il o f the supernatant used in phage ELISA as described 
in section 2.2.11.11.
2.2.11.13 Production of soluble antibody fragments
The selected pHENs were then infected into HB2151 and induced to give soluble expression of 
antibody fragments. From each chosen clone 10|_il of phage supernatant was infected into 200\x\ of 
exponentially growing HB2151 bacteria for 30 min at 37°C in waterbath. 1, 10, 100 jil, and 1:10 
dilution of the culture was then plated on TYE containing 100fig/ml ampicillin and 1% glucose, 
incubated overnight at 37°C. Individual colonies from these plates were picked into lOOjal 2xTY 
containing 100p,g/ml ampicillin and 1% glucose in 96-well plates, grown with shaking (300 rpm) 
overnight at 37°C. (A glycerol stock was made of this plate, once it had been used to inoculate another 
plate, by adding glycerol to a final concentration of 15% and stored at -80°C). A small inocula (about 2 
|j.l) was transferred from this plate to a second 96-well plate containing 200|il fresh 2xTY containing 
100(ig/ml ampicillin and 0.1% glucose per well. Plates were grown at 37°C, shaking until the ODeoonm 
is approximately 0.9, then 25|J,1 2xTY containing 100(ig/ml ampicillin and 9 mM isopropyl P-D- 
thiogalactopyranoside (IPTG) (final concentration 1 mM IPTG) was added and cultures grown shaking 
at 30°C for a further 4 - 24 hr (depending on whether periplasmic or secreted antibody fragment 
desired). Next day the plates were spun at 3000 rpm for 15 min and 100|il of the supernatant 
(containing soluble scFv) used in ELISA following the ELISA protocol detailed in section 2.2.11.11, 
except using purified 9E10 antibody (which detects c-myc-tagged antibody fragments) at 1/400 dilution, 
followed by 1/2000 dilution o f HRP-anti-mouse antibody.
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2.2.11.14 Preparation of anti-c-myc antibody (9E10)
The hybridoma cell line 9E10 (ECACC No. 85102202) was passaged in culture medium until 500 ml 
of spent medium had been collected. The media was centrifuged at 2000 rpm for 10 min to remove any 
cell debris and stored at 4°C. After noting the volume of supernatant, it was placed on ice and stirred 
gently. Slowly and with stirring saturated ammonium sulfate (SAS) was added to final concentration of 
40% and left stirring for 30 min. After centrifuging at 8000 rpm for 20 min the pellet was resuspended 
in 20 ml PBS and the 40% SAS cut repeated. The second pellet was then resuspended in 2 ml PBS, 
dialysised against PBS at 4°C for 48 hr with several changes of PBS. The dialysate was stored at 4°C 
and titered to find the optimum dilution for use o f the antibody.
2.2.11.15 Midi-scale induction of soluble antibody fragments
Single colony of positive clone was grown in 100|ol 2xTY containing 100(j.g/ml ampicillin and 1% 
glucose in 96-well plates at 37°C overnight with shaking. 50 |il was then inoculated into 5 ml 2xTY 
containing lOOfig/ml ampicillin and 0.1% glucose and grown at 37°C, shaking until OD6oonm was 0.9. 
The cultures were then spun down at 3000 rpm for 10 min. The pellets were washed with sterile PBS 
and resuspended in 5 ml 2xTY containing 1 mM IPTG and 100 |ig/ml ampicillin (no glucose). Cultured 
were grown at 30°C, shaking for 4 - 24 hr, spun at 8000 rpm for 15 min to remove bacteria and debris. 
After overnight induction’s antibody fragments could be found secreted into supernatant, while shorter 
incubations would produce antibody in the periplasmic space.
2.2.11.16 Dot blot to detect soluble Ab in supernatants from clones positive by ELISA
Using Bio-Rad bio-dot blot apparatus 400|il of supernatant was blotted under vacuum onto 
nitrocellulose for 1 hr. The blot was then blocked for 1 hr in 2% MTBS at RT. The anti-c-myc antibody 
was then applied at 1/400 dilution in MTBST overnight at 4°C. The blot was washed 3 times for 10 min 
in TBST and then incubated with HRP-anti-mouse at 1/2000 dilution in TBST for 2 hr at RT. The blot 
was then washed 3 x 10 min in TBST and washed once in TBS. The blot was developed in DAB 
substrate (one lOmg tablet DAB dissolved in 15 ml of TBS plus 12jj1 H2O2, added immediately before 
use).
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2.2.11.17 Titering of antibody fragments
96-well plate was coated at lO^g/ml MMP-9 in 50mM sodium hydrogen carbonate, pH 9.6 overnight at 
RT (100(41 per well). Next day the plate was washed with PBS and blocked in 2% MPBS for 2 hr at 
37°C. Plate was washed with PBS and 100(41 two fold serial dilution’s of bacterial supernatants were 
added to wells in final concentration of 2% MPBS for 2 hr at RT. Identical samples were analysed, 
except wells had not been coated with MMP-9. ELISA then continued as in section 2.2.11.11 except 
using purified 9E10 antibody (which detects c-wyc-tagged antibody fragments) at 1/400 dilution, 
followed by 1/2000 dilution o f HRP-anti-mouse antibody.
1
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Establishment of a Model System to Investigate the Role of MMPs
in Trophoblast Invasion.
Chapter 3
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3. Introduction
The establishment o f the morphologically and physiologically intimate contact between 
two genetically different individuals, mother and embryo, which takes place during implantation, 
has always exerted a fascination on researchers in biology and medicine. Historically, we owe it to 
Graf von Spec who in 1883 introduced the concept that trophoblasts may play an active and 
cytolytic role in attachment and invasion. This was based on studies using histological analysis of 
implantation sites in guinea pigs (reviewed in Denker, 1978). At the turn of the century the 
possibility o f the involvement o f proteolytic enzymes of the trophoblast or endometrium was 
already under discussion. However, it wasn’t  until the early 1970s which saw a revival of interest 
in this area of research, that proteolytic activity was shown to be associated with trophoblasts 
(Denker, 1978). Developments during the 1970’s and 80’s in cell biology, particularly the 
introduction of in vitro cell culturing, lead to huge advances in this field. The mid 70’s also saw an 
interest in the development o f new concepts in contraception leading to renewed enthusiasm and 
funding for this area of research.
3.1 Introduction to implantation and placentation
In a remarkable series of events, implantation and placental development physically 
connect the mammalian embryo to its mother. Trophoblast differentiation, which results in 
formation o f the placenta, is one of the first critical hurdles the mammalian embyro faces. In 
mammals, the initial developmental decisions set aside three unique extraembryonic linages that 
are the precursors of the placenta. The first differentiation event gives rise to trophoblasts, the 
specialised epithelial cells o f the placenta that physically connect the embryo and the uterus. The 
remaining cells segregate at one pole of the embryo to form the inner cell mass (ICM). Endodermal 
and mesodermal components of the placenta are later derivatives of the ICM. The differentiation of 
ICM cells that give rise to the embryo proper does not begin until the first placental structure has 
formed. Establishing this connection is the embryos first priority, which is essential for its 
subsequent development. Failures in implantation and placental development are clinically 
important. About one third of normal human pregnancies end in spontaneous abortion; 22% of 
such abortions occur before pregnancy is detected clinically (Wilcox et al., 1988). Similarly,
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failures in development during the peri-implantation period account for almost 80% of the 
embryonic loss that occurs in farm animal species (Cross et al., 1991). Even seemingly minor 
defects in placentation can have severe negative consequences and errors in its regulation can result 
in pathological conditions which involve placental overinvasion, e.g. placental accreta (pre- 
m align ant) and choriocarcinoma (malignant), or underinvasion e.g. pre-eclampsia. It is essential 
therefore to gain an understanding of the factors involved in regulating this proccss.
Placental development starts with the process of implantation which constitutes a series of 
events. The first stage involves the establishment of position of the blastocyst within the uterus, or 
attachment. This includes appositional and adhesional events in which the blastocyst first ‘finds’ its 
implantation site and then anchors itself to the surface of the epithelium. Once the blastocyst 
adheres to the uterus, the fetal trophoblast cells, derived from the outer cells of the blastocyst 
rapidly penetrate the endometrium. Soon thereafter, trophoblasts are found mingled with maternal 
decidual cells throughout much of the placental bed, a condition that persists during the remainder 
of the pregnancy. In addition groups of specialized trophoblasts migrate through the decidua, 
invade the walls of the spiral arterioles, and replace the endothelial lining of these vessels. This 
invasive activity peaks during the twelfth week of pregnancy and declines rapidly thereafter. The 
result is the formation of the human hemochorial placenta, in which blood from the maternal 
circulation constantly bathes the fetal chorionic villi.
Human fetal development depends on the embryo rapidly gaining access to the maternal 
circulation. This obstacle is overcome by trophoblast cells, which form the fetal portion of the 
human placenta, by transiently exhibiting an invasive phenotype. In humans, two differentiated 
trophoblast populations exist, syncytiotrophoblasts and cytotrophoblasts, giving rise to villus- and 
extravillus- trophoblast populations that are morphologically and functionally distinct (Cross et al.,
1994). Proliferative cytotrophoblast stem cells are anchored to basement membranes surrounding 
the stromal core o f chorionic villi. There are two types of chorionic villi found at the maternal-fetal 
interface, floating and anchoring villi (Figure 3.1). The freely floating villi are constantly bathed by 
maternal blood, mediating nutrient, waste and gas exchange functions for the developing embryo, 
and are not directly connected to the uterus. The bulk of the placenta consists of floating chorionic 
villi. In floating villi the cytotrophoblast stem cells lie beneath the syncytiotrophoblastic covering 
and are separated from the underlying connective tissue stroma of the villus core, containing fetal
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blood vessels, by a basement membrane (Figure 3.1 A). Cytotrophoblasts in these villi exist 
exclusively as polarized epithelial monolayers. These cytotrophoblasts, which are highly 
proliferative in the first trimester of gestation, differentiate by fusing to form the syncytial layer that 
covers the villus and divide to maintain the complete cytotrophoblast layer present in first trimester 
chorionic villi. As pregnancy continues, fusing of these cells to form the trophoblast syncytium 
gradually depletes this population of cytotrophoblasts cells, possibly because of a decrease in their 
rate of division. Thus, this layer is incomplete by the second trimester of pregnancy and composed 
of isolated, single cells at term.
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F igure 3.1 (A ) Floating villi, cytotrophoblasts located in floating villi lie beneath the trophoblast syncytium and are not 
directly exposed to maternal blood. (B) Anchoring villi, cytotrophoblasts o f  the anchoring villi lie beneath the syncytium 
and extend through the endometrium to line the spiral arterioles, thus attaching the fetus to the uterus.
In contrast, anchoring villi are embedded in the uterus and physically attach the fetus to the 
mother. In anchoring villi, cytotrophoblasts also differentiate into a syncytium that covers most of 
their surface, but at discrete sites subpopulations of cytotrophoblasts leave the basement 
membrane, break through the syncytium and form columns of nonpolarized cells (Figure 3.1 B).
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These columns give rise to the invasive subpopulation o f cytotrophoblast that attaches to and 
invades the uterus and its arterial system. These cells which are also referred to as intermediate 
trophoblasts or extravillus trophoblasts, are found in the pregnant endometrium and the first third 
o f the myometrium (collectively called the placental bed). The process of anchoring villus 
formation, and associated cytotrophoblast invasion of the uterine wall, is extremely active during 
first trimester, resulting in rapid placenlal expansion. Thus, human cytotrophoblast differentiation 
along the invasive pathway is highly unusual in that successful penetration o f the uterine wall by 
cytotrophoblast requires that they transiently express an invasive phenotype similar to that 
displayed by malignant tumour cells.
Many elements o f trophoblast invasion are similar to events that occur during tumour cell 
invasion. The phenotypic change from carcinoma in situ to invasive carcinoma occurs when 
tumour cells acquire the ability to penetrate an epithelial basement membrane and invade the 
underlying stroma (Liotta et al., 1986). Likewise after a brief adherent stage, cytotrophoblast cells 
penetrate the basement membrane of the uterine epithelial cells and invade the stroma and its 
associated arterioles. These similarities suggest that the two invasive processes may share certain 
common enzymatic and cellular mechanisms. However, unlike tumour invasion, trophoblast 
invasion is precisely regulated, confined spatially to the endometrial aspect of the myometrium and 
continues only until midgestation.
At the interface of the villus and the cell column, the organisation of the cytotrophoblast 
changes, from a polarized cell layer anchored on a basement membrane to a multilayered column 
of coherent, nonpolarised cells (Figure 3.2). Where columns contact the uterine wall, they spread 
laterally and penetrate the endometrium. The column structure is then lost, and the cytotrophoblasts 
are present as clusters o f irregularly shaped cells interspersed among maternal leukocytes and 
decidual cells of the endometrium. With deeper penetration the cytotrophoblast clusters consist of 
fewer cells, and single cells are frequently seen within the myometrium. A sub population of these 
extravillus trophoblasts erode the muscular coat and endothelial lining of uterine arterioles and line 
these vascular channels as endovascular trophoblast. This process prevents uterine arterioles from 
responding to maternal vasoactive substances, ensuring a steady supply of maternal blood to the 
placenta (Loke, 1990). Thus invasive cytotrophoblasts contribute to the hybrid vascular network 
that carries maternal blood to the floating villi.
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Figure 3 .2  Diagram o f  the fetal-maternal interface in an early gestation placenta showing floating villi and an anchoring 
villus with an associated cell column, and the uterine wall. Extravillus cytotrophoblasts are invading maternal 
circulation.
The extent o f placental invasion of the uterus differs in various mammalian orders. For 
instance, the epitheliochorial placenta of herbivorous mammals (e.g. horse, sheep) is a relatively 
non-invasive placenta in which the chorionic trophoblast remains closely apposed to the intact 
uterine epithelium. In contrast to this hemochorial placenta of humans and rodents is highly 
invasive. Trophoblast cells as described above breach the uterine epithelium and eventually invade 
maternal vessels to come into contact with maternal blood. Nevertheless, at least a single layer of 
trophoblast cells remains intervening between the maternal blood and the fetal blood vessels. There 
are important features of hemochorial placentas that are unique to human placentation. First there 
is generalised mixing o f maternal and fetal cells in the placental bed such that no definitive 
boundary exists between the fetal trophoblast cells and the decidua. Second, human trophoblast 
invasion is extensive, reaching the first third of the myometrium (Ramsey et ah, 1976). These
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differences exemplify the complexity and interspecies variability in solving the central problems of 
placental formation.
3.2 Culturing trophoblast cells in vitro
Many aspects o f the invasive process cannot be studied by the examination of tissue 
biopsies as this approach does not allow access to the dynamic process, a prerequisite for studies 
designed to shed light on the functional consequences o f the differential expression of certain 
molecules during invasion. Differences in placentation between species means that animal studies 
are of limited value in the interpretation of human placental function and ethical considerations 
severely limit in vivo studies in women. Hence the need to develop alternative in vitro methods. 
Cell culture models allow direct observation of the time-dependent processes of cellular motility, 
and their experimental manipulation. Cell culture methods also offer a reproducible experimental 
system able to sustain long terms studies and provide as many replicate samples as may be 
required. It is unfortunate that recovery of normal extravillous cytotrophoblast in quantities 
sufficient for experimental study poses technical problems. The availability of tissue from early 
gestation placentas was in the past very limited, however this has changed somewhat with the 
introduction and increase of legal abortions in most of Europe and the United States. Attempts to 
establish replicating cultures of normal placental cells in the past met with limited success due in 
part to short survival time of the trophoblastic cells in culture, overgrowth by stromal fibroblasts or 
failure o f the cells to replicate. Most o f these problems have been overcome with improvements in 
cell culture techniques.
A variety of techniques have been used to grow and maintain human first-trimester and 
term placental trophoblasts in culture (Morgan et al., 1985; Kliman et al., 1986; Yagel et al., 
1989a; Dodeur et al., 1990). Most methods employ an enzymatic digestion of the placenta, usually 
undertaken before culturing of mixed cell populations. Alternatively outgrowths from plated 
chorionic villi fragments without enzymatic treatment have also been used. Kliman et al. (1986) 
reported contamination-free functional cytotrophoblast cells obtained by Percoll gradient 
centrifugation o f enzymatically dispersed term placenta by sequential trypsin and DNase 
incubations. However, they did not attempt long-term maintenance of these cells by repeated
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passage. The method developed by Klimen et al. (1986) is still the basis for most isolation methods 
from term or early gestation placentas. Some cultures have been reported to retain trophoblastic 
markers even after several passages in vitro (Yagel et al., 1989a). Various modifications to the 
method of Kliman et al. (1986) have been made, including additional immunopurification steps to 
eliminate cells o f lymphomyleoid origin which may contaminate the cultures (Bischof et al., 1991). 
In studies investigating protease production, immunopurification is important as bone marrow 
derived cells are known to release proteinases. This prompted the development of a technique that 
unequivocally eliminates known sources of extratrophoblastic proteinases, such as monocytes, 
macrophages and other lymphomyleloid cells, using an antibody to leukocyte common antigen 
(LCA) (Bischof et al., 1991, Librach etal., 1991).
The most commonly used replicating human trophoblast cell lines have been derived from 
malignant trophoblast tumours (choriocarcinomas). Examples of choriocarcinoma cell lines 
include BeWo, JEG-3, and JAR. These cell lines have some similarity to trophoblasts, but because 
they are derived from tumours there are also critical differences. Normal trophoblast proliferation 
and invasion of the uterus are strictly regulated whereas choriocarcinomas are not.
There are a number of reports in the literature of long-term trophoblast cultures which have 
been immortalized by viral infection (Logan et al., 1992, Graham et al., 1993, Lewis et al., 1996). 
In an attempt to produce cell lines derived from normal trophoblasts Logan et al. (1992) used a 
temperature-sensitive form of the SV-40 virus to transform primary early-gestation trophoblasts. 
The resulting cell lines were immortalised and mimicked the phenotype of invasive trophoblasts at 
both permissive and nonpermissive temperatures. Graham et al. (1993) reported comparable 
results when they carried out a similar experiment. While these transformed cell lines are useful, it 
is clear that none of the cell lines adequately mimics the phenotype of the normal invading human 
trophoblast cell.
For this purpose, we have characterised an in vitro model in which early-gestation human 
trophoblasts are growing as continuous cell lines. These cell lines were gifts from Dr. Kniss, 
Department o f Obstetrics and Gynecology, Ohio State University College of Medicine, Ohio. 
While other investigators have used first-trimester placental tissue obtained from elective 
pregnancy termination for preparation of trophoblast cultures, Dr. Kniss’s laboratory was the first 
to report the use of first-trimester tissue isolated from transabdominal chorionic villus sampling
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(CVS) (Diss et al., 1992). The impetus for establishing this culture model was the current 
moratorium on the use of any abortus material for research purposes in the state of Ohio. Since 
many CVS procedures for early cytogenetic analysis are performed at Ohio State University 
College of Medicine, it was possible to obtain a large bank of cultures for establishing continuous 
cell lines. All patients gave informed consent for the procedure. First-trimester chorionic villi were 
obtained from patients for medically indicated cytogenetic studies by CVS at 9 to 12 weeks 
gestation under ultrasonographic guidance. Chorionic villi were dissected free from surrounding 
maternal and nonvillus tissues, dissociated with collagenase and trypsin and transferred to tissue 
culture medium. Kniss et al. developed these continuous trophoblast cell lines as a model system to 
study the regulation of glucose and amino acid transport by insulinlike growth factors in the 
placenta (Diss et al., 1992, Kniss et al., 1994). Using immunocytochemical and biochemical 
criteria, they had shown that one representative cell line, ED77, exhibited a trophoblastic phenotype. 
However, complete characterisation of all the cell lines had not been carried out. Because these cell 
lines were continuous cell lines and had been passaged many times we were keen to establish that 
the trophoblastic phenotype had been retained in continuous culture and the cells were suitable as a 
model system to study the mechanisms of trophoblast invasion in vitro. The dissimilarities between 
development in utero and in culture cannot be ignored - the hormonal and anatomic milieu 
provided by the maternal organism is absent in culture. Nevertheless we believe the study of 
trophoblast cells in continuous culture provides a useful model system for trophoblast invasion.
3.3 Mechanisms used by trophoblast cells to invade the uterus
Penetration of one or more basement membranes and the underlying connective tissue 
stroma is a prerequisite for local invasion as well as for metastasis by tumour cells. Similarly in 
pregnancy, erosion of the basement membrane of the uterine epithelium is essential for 
implantation. Invasion o f the underlying stroma and uterine blood vessels, inclusive of their 
basement membranes, is also required for establishment of feto-matemal exchange in the 
hemochorial placenta. Thus, the ability to penetrate basement membranes serves as a reliable 
marker for cellular invasiveness.
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A variety of in vitro invasion assays for cancer cells have been designed. These have 
employed numerous natural basement membrane-containing substrates as well as artificially- 
reconstituted basement membranes (Liotta et al., 1986, Mignatti et al., 1986). Invasion of the 
basement membrane depends on two simultaneous events: breakdown of the various basement 
membrane components and migration of the invasive cell (Liotta et al., 1986).
3.3.1 Matrix Metalloproteinases
The hypothesis that trophoblast invasiveness is associated with proteolytic activity was first 
proposed more than 50 years ago. Experimental evidence was provided much later by Blandau, 
who showed that guinea pig trophoblasts were capable o f digesting a dried gelatin film (Denker, 
1978). A  similar observation was also made for the rabbit blastocyst (Denker, 1978). Evidence for 
human trophoblasts did not come until 1985 when Fisher et al. observed morphological evidence 
of ECM degradation by human cytotrophoblast outgrowths from explants of chorionic villi isolated 
from first trimester but not second trimester placentas. This finding was later confirmed by Fisher 
et al. (1989) in a follow-up study using short-term cultures o f fractionated enzyme-dispersed 
cytotrophoblast cells from first, second and third trimester human placentas. They showed that 
isolated first trimester but not second or third trimester human trophoblasts were able to degrade an 
ECM produced by a teratocarcinoma cell line. Degradation was assessed by the ability of the cells 
to form circular areas clear of matrix and by the spontaneous release of 3H-labeled matrix 
components. They also showed, using substrate gels co-polymerised with gelatin, that cell extracts 
from first trimester trophoblasts presented a more complex pattern of gelatin-degrading enzymes 
than second or third trimester trophoblasts. Since all the enzymes could be inhibited by 1,10- 
phenanthroline and not by other protease inhibitors, this indicated that they were MMPs. These 
studies suggested that the invasive ability of human trophoblast is temporally regulated during 
pregnancy. Surprisingly, human choriocarcinoma cell lines BeWo and JAR exhibited no ECM- 
degrading activity in this study. Similar results were reported by Bischof et al. (1991) who showed 
that expression o f gelatin-degrading enzymes was developmentally regulated using 
immunopurified cytotrophoblast cultures from early and late gestation placentas. The MMPs
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described by Bischof corresponded to some of those described by Fisher, four MMPs of molecular 
weight 97, 94, 64, and 59 kDa. However neither report attempted to identify the enzymes. A more 
recent report by Fisher’s research group (Librach et al., 1991) reported the characterisation of the 
gelatin degrading bands by immunoblotting and identified MMP-2 and MMP-9 as the principle 
players. Non-invasive placental fibroblasts were also shown to produce MMP-2. This study 
demonstrated that MMP-9 is regulated in accordance with the invasive properties of the cells; i.e. 
its expression was highest in early gestation and greatly reduced at term. Such developmental 
regulation was not seen for MMP-2, with similar expression levels of MMP-2 throughout 
gestation. MMP inhibitors and a function perturbing antibody for MMP-9 completely inhibited 
cytotrophoblast invasion in vitro (Librach et al., 1991) leading the authors to suggest that MMP-9 
plays an integral role in trophoblast invasion.
However there have been some conflicting reports published. Autio-Harmainen et al. 
(1992) and Polette et al. (1994) have shown that in vivo invasive extravillus cytotrophoblasts 
express MMP-2 whereas neither the mRNA nor the enzyme was detectable in villous trophoblasts. 
This would suggest that MMP-2 may be contributing to the invasive phenotype. Another study by 
Shimonovitz et al. (1994) reported the in vitro developmental regulation of both MMP-2 and 
MMP-9 in human trophoblasts isolated from first and third trimester placentas. A larger decrease 
in MMP-9 activity from early to late gestation was reported but developmental regulation of MMP- 
2 was also seen, prompting the authors to suggest that both type IV collagenases are important in 
trophoblast invasion. These studies suggest that MMP-2 may also have a critical role in trophoblast 
invasion. A recent study by Hurskainen et al. (1998) localised MT1-MMP mRNA and protein to 
invasive extravillous trophoblasts in placental biopsies leading the authors to propose that MT1- 
MMP may have general importance during trophoblast invasion, acting alone or as a cell-surface 
activator of other proteinases, in particular MMP-2.
The question of what protects the uterus from destruction by an invasive placenta is 
intriguing. Current theories all point to the decidual tissue of the pregnant uterus as assuming the 
protective role. Graham and Lala (1991 and 1992) demonstrated that first trimester human decidual 
cells produce molecules that inhibit trophoblast invasiveness. The molecules responsible for this 
anti-invasive effect were identified as TGF-0 and TIMP-1, since neutralizing antibodies against 
either o f these molecules could prevent the anti-invasive activity. They also showed that the
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mechanism by which TGF-P inhibits trophoblast invasiveness was by induction of TIMP in both 
the decidua and the trophoblasts (Graham and Lala, 1991 and 1992). The presence of TGF-P in 
first trimester trophoblast cultures also resulted in a decrease in MMP-9 activity. This TFG-P- 
mediated decrease in activity was accompanied by a significant increase in TIMP-1 mRNA levels 
(Graham and Lala, 1991). Thus the proteinases potentially responsible for invasion may also 
engender the restriction of implantation, creating an elegant self-regulating process analogous to 
those found in other complex biological systems.
3.3.2 Plasminogen activators
Another class of proteinase, urokinase-type plasminogen activator (uPA), has also been 
shown to be synthesised and secreted by human cytotrophoblasts (Queenan et al., 1987). However, 
inhibition of uPA activity does not limit trophoblast invasion in vitro. Librach et al. (1991) tested 
the effect o f exogenous plasminogen activator inhibitor (PAI) -1, PAI-2, and a polyclonal 
inhibitory antibody to uPA on cytotrophoblast invasion and showed invasion was decreased by no 
more than 40%. Moreover, embryos that lack either a functional uPA gene or the low-density 
lipoprotein receptor-related protein, which is required for uPA receptor internalization, implant 
normally (Carmeliet et al., 1994). These results suggest that u-PA and plasmin play a role in 
cytotrophoblast invasion, but cannot totally account for this process. Since u-PA may have a role in 
the activation of MMPs, this suggests a link between the two classes of proteinases.
3.3.3 Integrin switching during trophoblast invasion
In addition to producing proteinases that degrade the ECM, trophoblasts also change their 
adhesive properties during invasion. The cells recognise their microenvironment through specific 
membrane receptors known as integrins, which mediate the interactions between cells and the 
glycoproteins of the extracellular matrix. Integrins are heterodimeric transmembrane glycoproteins 
composed of an a  and a P subunit. Depending on the a p  combination, integrins will bind to one or 
another glycoprotein of the ECM. So far eight p and fourteen a  subunits have been identified, 
forming a family of about 20 receptors e.g. a5 /p i binds to fibronectin, a6 p i to laminin. Integrin
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receptors can be promiscuous, binding several ligands, and in addition, individual ligands may be 
recognised by more than one integrin (Burrows et al., 1995).
Human trophoblasts undergo three major transitions in their expression of integrins and 
ECM components. This occurs in vivo as the cells leave their basement membrane. Human 
cytotrophoblast stem cells within the villi express a6(34 integrin, a receptor for epithelial laminin. 
As they leave the basement membrane, they down-regulate the oc6p4 integrin and begin to express 
the a5 p i integrin, a fibronectin receptor, along with a fibronectin-rich pericellular ECM. Within 
the uterine wall, they produce a i p i  integrin, a receptor for laminin and type IV collagen (Damsky 
et al., 1992a). The integrin switching that occurs in vivo is recapitulated when villous stem cells are 
cultured. Under these conditions, antibodies to laminin, type IV collagen, or a i p i  integrin inhibit 
cytotrophoblast invasiveness, which suggests that integrin interactions with these ligands promote 
uterine invasion. Conversely, antibodies to the a5 p i integrin strongly enhance invasion, and 
addition o f its ligand, fibronectin, inhibits invasion. These results suggest that the interaction 
between a 5 p i integrin and fibronectin primarily restrains cytotrophoblast invasiveness. The 
regulation of adhesion molecule expression therefore contributes to acquisition of an invasive 
phenotype by cytotrophoblasts.
The aim o f the work presented in this chapter was to establish a model system to investigate the 
role o f MMPs in early gestation trophoblast invasion. Unique continuous cell lines from first 
trimester trophoblasts are first characterised extensively with respect to their cellular origin and 
phenotype. Then, using this system we examine MMP and TIMP expression and identify the key 
role players in this process.
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The trophoblast cell lines ED77, ED31 and ED27 were established from CVS taken at 9-12 weeks 
gestation as outlined in section 2.2.1.1. ED77 had previously been characterised using limited 
epithelial and trophoblast specific markers (Diss et al., 1992). The cell line has been in 
continuous culture since 1992 and it was not known if  it remained positive for the same markers 
since then. The other two trophoblast cell lines ED31 and ED27 have been in continuous culture 
in this laboratory for the past 2 years. We have characterised these two cell lines, ED27 and ED31 
and also a choriocarcinoma cell line BeWo and compared them to the ED77 cell line. These cell 
lines were characterised extensively with regard to a number o f properties including cytokeratin 
and vimentin expression, hCG, hPL, invasive ability, as well as MMP and TIMP production. 
Figure 3.3(A) shows a photograph o f the ED77 cell line in culture. A placental fibroblast cell line 
was also established and characterised.
3.4 RESULTS
Characterisation of trophoblast cell lines
F igu re  3 .3  (A ) Photograph o f  trophoblast cell line E D 77. (B ) Photograpli o f  placental fibroblasts isolated from term 
placenta.
3.4.1 Isolation of placental fibroblasts
Placental fibroblasts were isolated from a term placenta and cultured in vitro as described in 
section 2.2.1.6. The cells were cultured for approximately 10 passages before senescing. Figure 
3.3(B) shows a photograph of the cells in culture, displaying the typical fibroblastic phenotype. 
The fibroblast cell line was a useful control as it was o f placental, but not o f trophoblastic origin. 
A B
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3.4.2 Characterisation of trophoblast cell lines by immunocytochemical staining
The cells were characterised by immunocytochemical staining with numerous specific 
markers as outlined in section 2.2.2. These markers included antibodies to cytokeratin 8 and 18, 
vimentin, hCG, and hPL. All of the trophoblast cell lines stained positive for the low molecular 
weight cytokeratins 8 and 18. Figure. 3.4 shows a photograph of ED27 cells which is representative 
of the staining seen for cytokeratin 8 by all the trophoblast cells, indicating their epithelial 
phenotype. Cytokeratins are expressed by the epithelial, but not the stromal or vascular elements of 
tissues. Decidual cells also do not express cytokeratins. Thus cytokeratin staining can be used as a 
marker for cytotrophoblasts. All of the cell lines, with the exception of the placental fibroblasts 
were negative for vimentin, one of a class of intermediate filament proteins known to be present in 
endothelial cells and fibroblasts. This confirms the lack o f contamination of the cell lines with 
these cell types.
Human trophoblast in the placenta elaborates at least two major protein hormones, hCG 
and hPL. hCG consists o f two nonidentical subunits (a  and P), and hPL is a single chain 
polypeptide, which shares greater than 90% homology with human growth hormone. Invasive 
trophoblasts have been shown to produce hCG (Librach et al., 1991). Intermediate trophoblasts of 
the uterus stain brightly with anti-hPL antibodies (Pijnenborg, 1996). They are commonly used 
markers for trophoblast cells. All of the trophoblast cell lines were positive for these two markers 
indicating their trophoblast origin (Figure 3.5). The results for the characterisation of the 
trophoblast cell lines by immunocytochemistry are summarized in Table 3.1.
Table 3.1 Characterization of trophoblast cell lines by immunocytochemistry.
Placental
FibroblastsMarker Specificity ED77 ED3, ED27 BeWo
Cytokeratin 8 Epithelial cell marker positive positive positive positive negative
Cytokeratin 18 Epithelial cell marker positive positive positive positive negative
Vimentin Mesenchymally- 
derived cell marker
negative negative negative negative positive
hCG trophoblast positive positive positive positive negative
hPL trophoblast positive positive positive positive negative
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F ig u re  3 .4 . Characterisation o f  trophoblast cells. Im m unofluorescence staining o f  E D 27 cells w ith a cytokeratin 8 
sp ecific  m onoclonal antibody (100  X  m agnification).
F ig u re  3 .5  (A ) B eW o cells  stained p ositive for cytokeratin 8 (4 0 X  m agnification). (B ) E D 77 cells stained positive  
for hCG (40X  m agnification).
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3.4.3 In vitro invasion assay
An important biological property of trophoblasts is their ability to invade through extracellular 
matrices upon which they are plated. To examine this, we used an in vitro invasion assay in which 
the ability of trophoblasts to invade artificial extracellular matrix (Matrigel)-coated filters and 
emerge through 8|om pores on the filter underside was accessed (section 2.2.6). Following invasion 
of the matrix, the cells which normally exhibit an epithelial appearance became highly elongated 
with long processes that stretched through the pores and attached to the underside of the membrane 
(Figure 3.6). The ED77 cell line was found to be the most invasive of the three trophoblast cell lines 
examined. The ED31 and ED27 cell lines were also invasive. In contrast the BeWo cells did not 
invade to the underside of the membrane to any extent under the conditions used in this assay. The 
fibroblast cell line was also noninvasive. Figure 3.7 shows the percentage in vitro invasion for each 
of the cell lines.
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F igure 3 .6  ED77 cells on underside o f  membrane following invasion down through MATRIGEL layer. Cells are 
elongated with processes that stretch through pores(40 X  magnification).
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ED77 ED31 ED27 BeWo
F igure 3.7 In vitro invasive behaviour o f  E D 77, E D 31, ED27 and B eW o cell lines. Values are means o f  three 
determinations; bars show standard errors.
3.4.4 Analysis of MMP expression by trophoblast cell lines
Following characterisation o f the cell lines we decided to look at the expression of MMPs by 
substrate zymography in polyacrylamide gels containing either gelatin or casein (section 2.2.4.3). A 
representative zymogram for gelatinase activity is shown in Figure 3.8. This figure shows the 
pattern of MMP expression in the trophoblast cell lines, BeWo and, a cell line BHK92 which has 
been stably transfected with the human MMP-9 gene and constitutively expresses MMP-2. The 
trophoblast cell lines all show a similar pattern of MMP expression and appear to produce both 
MMP-2 and MMP-9. It appears that the ED77 cell line produced slightly more than the other two 
cell lines. In contrast the BeWo cell line produced large quantities of latent and active MMP-2 but 
negligible amounts o f MMP-9. In all of the cell lines there appears to be a higher molecular weight 
band at approximately, 200 kDa, which is thought to be complexes of MMPs. These bands were 
confirmed as metalloproteinases by incubation of the gels in EDTA which inhibited their activity 
(Figure 3.9). The activity was not inhibited by either PMSF or pepstatin A, inhibitors of serine and 
aspartic proteinases, further demonstrating the bands as metalloproteinase (data not shown). RT-
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PCR using specific MMP-2 and MMP-9 primers was also carried out (section 2.2.8) and 
confirmed the results from zymography as shown in Figures 3.10 and 3.11. As casein is specific for 
members o f the stromelysin subgroup, zymography was also carried out using casein as the 
substrate in polyacrylamide gels (section 2.2.4.3), however no additional bands were seen. RT- 
PCR, which is a more sensitive detection method was also negative for MMP-7 (Figure 3.9) and 
MMP-3 (data not shown) confirming the results from casein zymography.
■  M M P-9  
□  M MP-2
F igure 3 .8  Zymographic analysis o f  serum-free culture medium from trophoblast cell lines ED77, ED3], ED27, BeW o, 
and B H K  92 and standard molecular weight markers. M M P-2 and M M P-9 are indicated by arrows. Graph shows the 
relative amounts o f  M M P-2 and M M P-9 as determined by densitometry.
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ED77 ED31 ED27 BeW o B H K 92M
Figure 3.9 Zymographic analysis o f  serum-free culture medium from trophoblast cell lines E D 77) ED3i, ED27, BeW o, 
and B H K  92 and standard molecular weight markers, incubated in EDTA.
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F igure 3 .10 RT-PCR analysis o f  m R N A  from trophoblast and B eW o cell lines using p-actin and M M P-9 specific 
primers
ED77 ED31 ED27 BeWo
180bp MMP-2
F ig u re  3 .11  R T -PC R  analysis o f  m R N A  from  trophoblast and B eW o ce ll lines using sp ec ific  M M P-2 primers
321 bp MMP-7 
250bp B-actin
F igure 3.12 RT-PCR* analysis o f  m RNA from trophoblast and B eW o cell lines using (3-actin and M MP-7 specific 
primers. Lanes as follow s (1) E D 77) (2) ED3i, (3) E D 27, (4) B eW o, (5) lOObp ladder, (500bp m ost intense band), (6) 
positive control, R N A  from SW 620 cell line known to express M M P-7, (7) negative control, (R NA  replaced with 
water), (8) plasmid containing cD N A  for M M P-7 (pCM VM tlAct). *P-actin primers used in this experiment only were 
as follows: 5 ’ CAACTTCATCCACGTTCACC 3 ’, 3 ’ GAAGAGCCAAGGACAGGTAC 5 ’, giving a product size o f  
250bp (Takeshita et al., 1994).
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3.4.5 Analysis of TIMP expression by trophoblast cell lines
Having established that the trophoblast cell lines produced MMPs we decided to look at expression 
of their natural inhibitors, the TIMPs. The activity of the MMPs is physiologically regulated by the 
TIMPs and so the balance between the two is important. Metalloproteinase inhibitor activity in 
conditioned medium from trophoblast cells was examined by reverse zymography as outlined in 
section 2.2.4.4. The presence of TIMPs were seen as dark bands where inhibition of gelatin 
degradation had taken place, the majority of the gel does not stain as the gelatin has been degraded 
(Figure 3.13). TIMP-1 and TIMP-2 standards were also ran on the gel for reference. Trophoblast 
cell lines were found to express both TIMP-1 and TIMP-2 with the ED27 cell line producing the 
largest quantities. Interestingly, the BeWo cells were negative for TIMP-1 and -2 by this method. 
This was confirmed at the mRNA level by RT-PCR using primers for TIMP-1 (Figure 3.14). We 
also examined mRNA for TIMP-3 expression by RT-PCR as it is a much more sensitive method 
than reverse zymography. RT-PCR results confirmed that TIMP-3 is not expressed by any of the 
cell lines (data not shown).
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Figure 3 .13 Reverse zymogram o f  serum free culture medium from trophoblast cell lines E D 77, E D 3i, ED27 and BeW o  
showing the presence o f  TIMP as dark bands. Gel also shows standard molecular weight markers and TIMP-1 and 
TIMP-2 standards. Graph shows the relative amounts o f  TIMP-1 and TIMP-2 as determined by densitometry.
72
M ED77 ED31 ED27 BeWo Ctl
F igure 3 .14  RT-PCR analysis o f  m R NA  from trophoblast and B eW o cell lines using (3-actin and TIMP-1 specific 
primers. Lane labeled M  contains lOObp ladder, with intense band at 500bp. Lane labeled Ctl was negative control for 
RT-PCR reaction (R N A  replaced with water).
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Table 3.2 Summary o f MMP and TIMP expression by the cell lines.
MMP/TIMP e d 77 ED31 e d 27 BeWo
Placental
Fibroblasts
MMP-9 positive positive positive negative negative
MMP-2 positive positive positive positive positive
MMP-7 negative negative negative negative negative
MMP-3 negative negative negative negative negative
TIMP-1 positive positive positive negative ND
TIMP-2 positive positive positive negative ND
TIMP-3 negative negative negative negative ND
ND = not determined.
3.5 DISCUSSION
In this study we characterised three continuous trophoblast cell lines extensively and 
examined the expression of MMPs and their natural inhibitors the TIMPs in these unique cell lines. 
Kniss et al. had previously established these continuous cell lines of trophoblast cells derived from 
first trimester human chorionic villi but had not characterised them. Since these cells were a 
continuous cell line and had been passaged many times we were keen to establish that this 
trophoblast phenotype had been retained in continuous culture and were still suitable as a model 
system to study trophoblasts in vitro. We characterised the ED77, ED31, ED27 and Be Wo cell lines. 
We found that the cell lines maintained their trophoblastic integrity even after many passages in 
culture, as indicated by the presence o f cytoplasmic hCG and low molecular weight cytokeratins. 
Also none of the cell lines were positive for vimentin, thus excluding fibroblastic and endothelial 
contamination. The cells in culture were functionally active as demonstrated by hCG production 
and their in vitro invasive ability.
Using these cells which provided a reproducible in vitro system for investigating the 
biological basis of invasion of trophoblasts, our aim was to identify the specific members of the 
MMP and TIMP families which play a role in trophoblast invasion. We found that two members of 
the MMP family, the type IV collagenases - MMP-2 and MMP-9 were specifically expressed by 
the trophoblast cell lines. Casein zymography, which is specific for members of the stromelysin 
subgroup, showed no additional bands. RT-PCR, which is a more sensitive detection method was 
also negative for MMP-7 and MMP-3 confirming the results from zymography. The 
choriocarcinoma cell line, BeWo produced MMP-2 in larger quantities than the trophoblasts but 
negligible amounts of MMP-9. We also found the BeWo cells to be non invasive using the culture 
conditions and assay described. This was surprising, but is in agreement with a previous study 
where the cells ability to degrade matrix substrates was tested and it was found that the degradative 
ability of the choriocarcinoma cell lines was comparable with that of first trimester placental 
fibroblasts. No profile o f MMP expression was shown for the choriocarcinomas in this paper but 
the placental fibroblasts were shown to produce only MMP-2 (Fisher et al., 1989). Since the BeWo 
cell line was derived from a choriocarcinoma it may give rise to the expectation that its invasive 
behaviour would be more pronounced than that of normal cytotrophoblasts; despite this, no 
invasion occurred in vitro. Similar findings have been reported for other choriocarcinoma cell lines
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(Schor, 1980, Fisher et al., 1989). It is possible that factors required for invasion by the BeWo cells 
from the hormonal milieu provided by maternal cells are not present in vitro, or perhaps long term 
culture of the BeWo cell line has selected a non-invasive phenotype. Similarly the placental 
fibroblasts described earlier were found to produce only MMP-2 and were non-invasive. The 
trophoblast cell lines were capable of invasion and it is likely that the expression of MMP-9 is 
critical for this invasiveness. ED77 was shown to produce the highest levels of MMP-9 and was 
also found to be the most invasive cell line. This was in agreement with previous studies that have 
shown MMP-9 to be produced by trophoblasts in a developmentally regulated manner and 
paralleling invasive ability (Librach et al., 1991, Fisher et al., 1989).
The absence of other members of the MMP family besides the two type IV collagens is 
interesting but perhaps not surprising since type IV collagen is abundant in pre-implantation 
endometrium stroma, and is present in the walls of blood vessels (Aplin et al., 1988). Type IV 
collagen microfibrils have been suggested to play a role in the cross-linking banded fibrils of the 
major collagens and Aplin et al. (1988) speculated that its selective loss might allow local 
expansion o f intercellular spaces while retaining the tissue stability afforded by the major 
collagens. This might in turn give rise to a matrix environment conducive to interstitial migration 
o f trophoblast.
The activity o f the MMPs is physiologically regulated by the TIMPs which bind non- 
covalently to active metalloproteinase and inhibit their activity. Little is known about their role in 
trophoblast invasion and there are only two other reports of TIMP expression by trophoblast cells 
in culture (Graham and Lala, 1992, Bass et al., 1997). Graham and Lala (1992) showed indirectly 
that trophoblasts produced TIMP-1 since a neutralising antibody to TIMP-1 slightly stimulated 
invasion. However they did not attempt to characterise the inhibitors produced by the cells. A 
recent study by Bass et al. (1997) reported the expression of TIMP-3 by trophoblasts in culture, and 
showed the trophoblasts secreted negligible amounts o f TIMP-1 and TIMP-2. Graham and Lala 
(1991) demonstrated that first trimester human decidual cells produced TIMP-1 and TGF-P which 
inhibited trophoblast invasiveness since neutralising antibodies against either o f these molecules 
could prevent the anti-invasive activity. Another study showed that addition of recombinant TIMP- 
1 and TIMP-2 could completely inhibit cytotrophoblast invasion in vitro (Librach et al., 1991). For 
the most part, it has previously been assumed that most metalloproteinase inhibitors that function
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in the placental bed were probably of maternal origin. However, based on the results presented here 
we propose that TIMP produced by the trophoblast cells themselves may have a role in local 
regulation of ECM degradation. In this study the trophoblast lines were found to express TIMP-1 
and TIMP-2, but not TIMP-3. Given that TTMP-l has been shown to form a complex with the 
inactive proform of MMP-9 (Docherty et al., 1985), while TIMP-2 forms a complex specifically 
with the proform of MMP-2 (Stetler-Stevenson et al., 1990b), the expression of these two 
inhibitors is perhaps an in-built auto-regulatory system by trophoblasts. Supporting our hypothesis, 
several recent in vivo immunohistochemical studies of the distribution of TIMP in the human 
placenta reported staining for TIMP-1 and TIMP-2 in extravillous trophoblasts only during early 
gestation (Polette et al., 1994; Ruck et al., 1996). Another possibility is that TIMP may be acting as 
an autocrine growth-promoting factor for the trophoblasts, as has been shown in other systems 
(Hayakawa et al., 1992). The BeWo cell line did not express any TIMPs. A previous study 
examining TIMP expression in choriocarcinoma cell lines JEG-3 and JAR, also reported very low 
levels o f TIMP-1 message (Graham and Lala, 1991). Low level TIMP expression may possibly be 
a feature associated with the loss of regulation inherent with choriocarcinoma. The low level of 
TIMP expression by the BeWo cells conferred no advantage for invasive potential as the cells were 
unable to invade the matrigel. This again suggests that MMP-2 expression alone, even in the 
absence of inhibitors, is not sufficient for an invasive phenotype using the conditions described.
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3.6 SUMMARY
Establishment o f long term cultures of pure first-trimester human trophoblast cells with 
functional integrity should provide reproducible in vitro systems for investigating the biological 
basis o f invasive behaviour by cells. This study was designed to achieve this objective. We have 
shown that long term replicating trophoblast cultures were free of contamination from other cell 
types, as judged by numerous cell-specific markers. Moreover, these long term monolayer cultures 
were proven to be functionally active since, they produced a significant amount of hCG and hPL, 
and were shown to be invasive in an in vitro invasion assay. These cell lines are unique as they are 
the first reported trophoblast cell lines to be established from CVS and we have demonstrated that 
cell lines established from CVS do provide a useful in vitro system for studies of placental 
function. This opens up new avenues for researchers in countries where abortions are illegal or the 
use of abortus material is prohibited.
We found that two members of the MMP family, the type IV collagenases - MMP-2 and 
MMP-9 were expressed by the trophoblast cell lines. The choriocarcinoma cell line, BeWo 
produced MMP-2 in larger quantities but little MMP-9. We also found that the BeWo cells were 
non-invasive under the culture conditions and assay used. The trophoblast cell lines were capable 
of invasion and it is likely that the expression of MMP-9 is critical for this invasiveness. We also 
reported the expression o f TIMP-1 and TIMP-2 by the trophoblast cell lines and no TIMP 
expression by the BeWo cell line.
We propose that in the model system described here MMP-9 is critical for invasion. 
Identifying the autocrine and/or paracrine mechanisms that control the expression of MMP-9 will 
be the next key step in advancing our understanding of the unusual differentiation pathway that 
results in cytotrophoblast invasion of specific portions o f the uterus during the critical early phases 
of pregnancy.
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Modulation of MMP Expression in Trophoblast Cell Lines.
Chapter 4
4.1 Introduction
For a specific protein to be produced by a cell, the gene that encodes it must first be 
transcribed from DNA to mRNA. This mRNA then travels from the cell nucleus to the cytoplasm 
where it acts as a template from which the protein can be generated. The act of transcription is 
subject to regulation by factors within the nucleus. These transcription factors are in turn controlled 
by second messengers, for example cAMP or protein kinase C, changes in the activity of which 
result from cell signaling events which may occur when a cytokine/hormone/integrin binds to its 
receptor on the cell surface. To understand how any particular gene is regulated one must first 
examine its promoter.
4.2 The MMP Promoters
The promoters which control the transcription of protein-coding genes are composed of 
discrete functional modules, each consisting of approximately 7-20 bp DNA and containing one or 
more recognition sites for transcriptional activator proteins (Dynan, 1989). The MMP promoters 
show remarkable similarities with respect to oncoprotein-binding sites (a comparison of the 
promoter sequences of some MMP genes is shown in Figure 4.1). For example, the promoters of 
the human MMP genes, with the exception of MMP-2 and MMP-11, each contain a TP A 
responsive element (TRE), which is a binding site for the Fos/Jun-containing complex, also known 
as AP-1 (Crawford and Matrisian, 1996). The AP-1 site is critical for responsiveness to a wide 
array of signals. Mutagenesis studies have shown that the AP-1 from many MMP promoters is 
required for transcription in response to IL-1 (Fini et al., 1994), TNF-a and TPA (Sato and Seiki,
1993), and fibronectin induction (Tremble et al., 1995), most of which have also been shown to 
induce AP-1 activity (Angel et al., 1991). Antisense c-fos RNA and oligonucleotides inhibit EGF 
stimulation o f MMP-3 transcription (McDonnell et al., 1990) and non-nuclear oncoprotein 
induction o f MMP-1 (Schonthal et al., 1988). Furthermore, a dominant negative c-jun mutant, 
which should activate all AP-1 complexes, inhibited TPA-induced MMP-3 expression in 
keratinocyte cell lines (Domann et al., 1994). Therefore AP-1 activity appears to be necessary for 
MMP transcription under a variety of conditions.
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All o f the MMP promoters aside from that for MMP-2 also contain multiple polyoma virus 
enhancer (PEA3) sites which bind members of the E-twenty-six (Ets) family of nuclear proto­
oncogenes. The PEA3 sites of MMP-1 and MMP-3 promoters have been shown to be important 
for oncogene and TPA-induced transcription (Wasylyk et al., 1991). The existence of a TGF-0 
inhibitory element (TIE) has been demonstrated for a number of MMP promoters (Kerr et al., 
1990). Binding of the TIE appears to repress stimulatory signals supplied by other transcription 
factors for MMP-1 and MMP-3. The exact function of the TIE in MMP-9 is not clear (Sato and 
Seiki, 1993). The c-Fos protein has been demonstrated to be one of the components binding to the 
DNA binding element associated with the TIE.
All o f the MMP promoters except MMP-2 contain a conserved sequence known as the 
TATA box (consensus sequence TATAAAA), located 20-30 bp upstream of the transcription start 
site (+1). Genes without TATA boxes can have variable transcription start sites. MMP-2 although 
lacking a TATA box appears to have two such transcription start sites, 9 bp apart (Huhtala et al.,
1990). The lack o f a TATA box is often associated with so-called ‘housekeeping’ or constitutively- 
expressed genes and the MMP-2 protein is, perhaps, the most widely expressed of the MMPs 
(Crawford and Matrisian, 1995). The MMP-2 promoter does have some regulatory elements; there 
are two GC (consensus sequence GGGCGG) boxes (Huhtala et al., 1990). The AP-2 protein 
appears to mediate transcriptional activation through the second messengers protein kinase C and 
cAMP-dependent protein kinase A (Imagawa et al., 1987).
Despite these general similarities, the MMP promoters differ in their overall arrangement 
of onco-protein-binding elements. Human MMP-9, MMP-1, MMP-3 and MMP-10 promoters 
each contain two AP-l-binding sites, the first AP-1 is approximately 30 bp upstream of the TATA 
box and a second is located at various points upstream (reviewed in Crawford and Matrisian,
1996). Within the MMP-9 promoter, the upstream AP-1 site is the consensus sequence 
(TGAGTCA), whereas in the MMP-3 and MMP-1 promoters, the upstream AP-1 site is the 
nonconsensus sequence, TTAATCA (Sato and Seiki, 1993). The MMP-9 promoter also contains 
three nuclear factor-KB (NFkB) binding sites.
The MMP-9 promoter also differs in that the AP-1, which can be sufficiently activated by 
c-Jun/c-Fos heterodimer, is not itself sufficient for induction of the gene by TPA or TNF-a. Further 
upstream elements, e.g. NFkB, in addition to the AP-1 are required for induction of MMP-9 (Sato
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and Seiki, 1993). Thus the transcription of MMP-9 is regulated by a combination of AP-1 proteins 
with NFieB-like factors, the binding sites for which are not present in the promoter regions of the 
other MMP genes examined to date. This regulatory mechanism is thus thought to control the 
expression o f MMP-9 gene differently from the mechanism which controls the other MMP genes 
which share common stimulants for expression.
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Figure 4.1 A comparison of regulatory elements found in the promoters of MMP genes. Transcription start sites are 
indicated by +1. TATA boxes, AP-1 binding sites, PEA3 elements, AP-2 recognition sites, GC boxes, NFKB-binding 
site, and TIEs have been indicated. The orientation of the PEA3 elements relative to transcription are indicated by
arrows.
Transcription o f MMP genes is associated with sites of tissue remodeling and cellular 
invasion in both normal and neoplastic tissues. The binding sites for the nuclear proto-oncoprotein 
families, Fos, Jun, and Ets, found in most MMP promoters, offers a logical connection between 
MMP transcription and tumour expression. However these cw-elements and trans-acting factors 
also have been shown to be important for MMP expression in normal tissues in response to a 
number o f stimuli. For example, c-fos transcripts have been examined during mouse development 
and found in osteogenic tissues at a time coincident with MMP-l expression (McCabe et al.,
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1995). Also, c-fos, jun  B  and jun  D  are induced at wound sites, and in luminal and glandular 
epithelia o f ovariectomized rats after treatment with estrogen (reviewed in Crawford and Matrisian,
1996). In short, nuclear proto-oncoprotein expression coincides with known sites of normal MMP 
expression.
Most o f the potent stimulators of MMP-1 and MMP-3 gene expression, for example TP A, 
IL-1, or TNF-a, induce the expression of members of the Jun and Fos families (Schonthal et al., 
1988, Brenner et al., 1989). The induction of MMP gene expression by these cytokines is 
prevented by treatment o f the cells with cyclohexamide, demonstrating the requirement for 
ongoing protein synthesis. Furthermore, the induction is down-regulated by glucocorticoids and 
retinoic acid, which have been shown to block binding to the AP-1 binding site by as yet unclear 
mechanisms (Nicholson et al., 1990).
4.3 Regulation of MMPs by Cytokines
In the adult body, MMPs are expressed at low levels in the absence of inflammation, 
wounding or other pathological processes. Transcription of MMP genes is induced or upregulated 
by stimuli such as IL-1, TNF-a, TGF-a/EGF and PDGF, and with some exceptions repressed by 
TGF-P, IFN-y and glucocorticoids. The transcriptional effects of cytokines are mediated through 
complex signaling pathways. Many cytokine effects converge at the AP-1 site through the 
transcription factors c-jun and c-fos (Birkedal-Hansen, 1993). Several cytokine transcriptional 
effects appear to be mediated in part through protein kinase C-dependent signaling pathways as 
was described by McDonnell et al. (1990) for EGF stimulation of MMP-3 mRNA in rat 
fibroblasts, but the detailed mechanism is still not completely understood. Induction of the 
transcription factors c-jun and c-fos is a relatively early event and maximal transcript levels are 
observed within half an hour after stimulation. By comparison, emergence of MMP transcripts 
requires considerably longer, in the range of 3-8 hours. Even longer (14-20 hours) is required for 
emergence of the protein (Birkedal-Hansen, 1993).
Different cytokines induce overlapping yet distinct repertories of MMP and TIMPs in cells, 
and different cell types respond to the same cytokines by expression of unique and distinct 
combinations o f MMP and TIMP genes. For example, IL-ip induces expression of MMP-1 and
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MMP-3 in human fibroblasts but not in foreskin keratinocytes (MacNaul et ah, 1990, Petersen et 
ah, 1987); MMP-9 is repressed by TGF-P in fibroblasts (Kerr et ah, 1988) but stimulated in 
keratinocytes (Salo et ah, 1991); human rheumatoid synovial fibroblasts respond to IL-ip by 
induction of MMP-3, whereas TNF-a induces primarily MMP-1 (MacNaul et ah, 1990); TNF-a, 
TGF-a and EGF as well as TPA induce high level expression of MMP-3 in fibroblasts but MMP- 
10 in keratinocytes (Birkedal-Hansen et ah, 1993). This demonstrates that the response to stimuli 
depends on multiple factors including, cell type, species of origin and conditions of growth, and 
although some general observations can be made, the potential effect of a cytokine on MMP 
expression in a particular cell type cannot be confidently predicted.
Mackay et ah (1992) investigated the effects of IL-1 and TNF-a as well as TPA on MMP 
expression in a wide range of cell lines. MMP-3, MMP-9 and TIMP-1 stimulation in response to 
IL-1 or TNF-a treatment was observed in many human tumour cell lines and in normal HUVECs. 
TPA produced the greatest stimulation, as expected. In a human lung carcinoma cell line TNF-a 
stimulated MMP-9 but not TIMP-1 (Mackay et ah, 1992). Also treatment of human fibroblasts 
with TGF-P resulted in an elevation in TIMP mRNA and protein and a selective reduction in pro- 
MMP-1 protein (Overall et ah, 1989). This type o f disco-ordinate regulation is thought to cause the 
imbalance in proteinase and inhibitor activities which favours ECM degradation by invasive cells. 
The MMP-2 gene did not appear to respond to cytokine or tumour promoter stimulation, even in 
cell lines that responded to tumour promoters with increased production of MMP-1 and MMP-3 
(Collier et ah, 1988b). The effect of EGF on MMPs has been studied quite extensively and has 
been shown to be stimulatory for a number of MMPs in various cell types. Oesphageal cell lines 
have been shown to respond to EGF treatment by upregulating expression of MMP-1, MMP-3, 
MMP-2 and MMP-9 (Shima et ah, 1993)
Negative regulators of MMP gene expression have also been described. TGF-P has an 
inhibitory effect on growth factor- and oncogene- induced rat MMP-3, which is mediated at the 
transcriptional level (Matrisian et al., 1986, Kerr et ah, 1988). TGF-P also represses proMMP-1 
levels (Overall et ah, 1989) and growth factor-induced MMP-1 and MMP-3 mRNA while in the 
same cells it also interacts co-operatively with EGF and bFGF to superinduce TIMP expression 
(Edwards et ah, 1987). Although Chua et ah (1985) reported that TGF-P induced increases in 
MMP-1 secreted by human foreskin fibroblasts. Thus these studies show that the MMP genes can
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be modulated by cytokines, although this regulation differs between cell types. However, little 
research has focused on the effects o f cytokines on MMP expression in trophoblast cells.
The following is a brief description of the cytokines used in the course of the investigations of 
trophoblast cells described later in this chapter. These cytokines were chosen for study because 
they have been reported to be involved in placental development, however their effects on MMP 
expression in trophoblast cell lines has not been established.
4.3.1. Interleukin-1 p
Interleukin-1 (IL-1) is the term for two polypeptides (IL-la and IL-ip) that possess a wide 
spectrum of inflammatory, metabolic, physiological, haematopoietic and immunological activities. 
Although the two forms of IL-1 are distinct gene products, they recognise the same receptor and 
share biological properties. IL-1 belongs to a group of cytokines with overlapping biological 
properties, including TNF-a and IL-6. Known as the pro inflammatory cytokines, they share the 
ability to stimulate T and B lymphocytes, to augment cell proliferation and to initiate or suppress 
gene expression for several proteins. The two forms of IL-1 are initially synthesized as 31 kDa 
precursors, which are cleaved by proteinases to mature IL-1 which is the biologically active form. 
This cleavage is achieved intracellularly by interleukin-converting enzyme (ICE) or extracellularly 
by plasmin or elastase (Sedlacek and Moroy, 1995). Although initially described as a product of 
activated phagocyte, IL-1 has since been shown to be produced by a wide variety of cell types 
including synovial fibroblasts, keratinocyte, astrocytes, decidual and trophoblast cells (Dinarello, 
1988, Librach et al., 1994). This truly pleiotropic molecule has a myriad of effects both in specific 
cells in vitro, and systematically in vivo. A number of functions have been described for IL-1 
including fever, sleep, anorexia, and hypertension and it can also stimulate host defence properties. 
The effects of IL-1 p on trophoblast function have also been studied, particularly its impact on 
hormone production. IL-1 P stimulates secretion of hCG by cytotrophoblasts by activating IL-6 and 
the IL-6 receptor system (Masuhiro et al., 1991). In addition, it stimulates trophoblast aromatase 
activity, as well as the release of corticotropin-releasing factor and adrenocorticotropin hormone 
from the placenta (Petraglia et al., 1990). Since IL-1 and corticosteroids are present in high
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concentrations at the maternal-fetal interface, they are ideal candidate molecules for regulating 
trophoblast production of MMP-9. Finally placental bed immune interactions are probably also 
extremely important in controlling cytotrophoblast invasion. It is likely that IL-1(3 is one of many 
different cytokines that participate in the cross-talk between maternal and fetal cells.
4.3.2. Epidermal growth factor
Epidermal growth factor (EGF; also termed urogastrone) is a 6 kDa, single-chain polypeptide that 
is present in many body tissues and fluids. It is capable of modulating the proliferation and 
differentiated functions o f a variety of cell types ( Blay and Hollenberg, 1989). There are large 
numbers o f EGF receptors in placental tissues. The distribution of the EGF receptor population in 
placenta has been studied by both histological and autoradiographical techniques. Chegini and Rao 
(1985) used light-microscopic autoradiography to identify the sites of 125I-EGF binding in placental 
tissues, and found high levels o f specific binding in the syncytiotrophoblast layer; relatively few 
grains were observed in association with cytotrophoblasts. Using an immunohistochemical 
approach, Maruo et al. (1987) similarly localised EGF receptors in placental tissue to the 
syncytiotrophoblasts. Again cytotrophoblasts, did not show any appreciable staining. The 
prevailing view is that EGF plays a part in the control of trophoblast differentiation (Maruo et a l, 
1987). Another possible role for EGF within gestation is in the regulation of fetal development. In 
this context, the syncytiotrophoblast receptor could serve a transport function, transferring EGF 
from the maternal to the fetal side. Bass et al. (1994) reported experiments showing that neither 
EGF, TGF-a nor any other ligands for the EGF receptor were produced by cytotrophoblasts in 
culture. Therefore, the source of EGF receptor ligand is likely maternal, suggesting that EGF may 
be involved in paracrine regulation of trophoblast differentiation.
43.3 Transforming growth factor p
The transforming growth factors (TGFs) were originally named because of their effects on cell 
phenotype; principally, their ability to promote cell colony formation in suspension culture within 
agarose (Massague, 1985). It is an operational definition rather than a description of their likely
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action in vivo. TGF-P is a disulphide-linked dimer with a molecular weight of 25 kDa. There are 
five isoforms of TGF-P, three of which are found in mammalian tissue (TGF-P-1, 2, 3) (Sedlacek 
and Moroy, 1995). Most of the currently published reports on the activities of TGF-P have dealt 
only with TGF-P 1. In general, TGF-P 1, TGF-P2 and TGF-P3 appear to be functionally equivalent 
in biological activity in vitro. TGF-p 1 is relatively abundant in blood platelets and is produced in 
most tissues, including the placenta (Frolik et al., 1983). It has complex effects on cell growth and 
differentiation. Thus far, however, its participation in placental physiology remains unclear. The 
action of TGF-P is strictly dependent upon both the physiological state of the responding cell and 
the presence of other growth factors. In some cases therefore, TGF-P induces cell proliferation and 
in other cases cell proliferation is inhibited. The biological function of TGF-P may accordingly be 
complex in the whole organism and highly dependent upon the exact context in which it acts. 
TGF-p is an important mediator of the formation of ECM generally, with activities that stimulate 
formation of ECM and inhibit degradation of ECM. TGF-p has been reported to inhibit MMP-1 
and also upregulate TIMP (Edwards et al., 1987).
4.4 Effect of Extracellular Matrix Components and Adhesion Receptors on MMPs
In most biological systems, cells require a substrate of ECM proteins for anchorage and 
attachment and, to derive traction for migration (Turner, 1992). For example, invasion of host 
tissues by cancer cells is dependent on the specific interactions of tumour cell surface receptors to 
ECM or components o f basement membranes such as laminin. The migration of neural crest cells 
in vivo and of epidermal cells at a wound site also requires cell-matrix interactions (reviewed by 
Burrows et al., 1995). It is interesting therefore that during the first trimester of pregnancy, the 
ECM proteins laminin and fibronectin are particularly abundant in the uterus. These proteins are 
distributed pericellularly around each individual decidual stromal cell (Loke et al., 1989b) and are 
also produced by the trophoblast cells (Yagel et al., 1988).
Besides acting as a substrate for adhesion, the ECM can also transmit signals to cells, and 
these signals are now believed to play a pivotal role in the control of cellular behaviour (Hynes, 
1992). It has become clear that integrins can function as true receptors capable of transducing 
signals to the cells interior (Damsky and Werb, 1992b; Burrows et al., 1995). Integrin molecules
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themselves do not have characteristics of signal generating receptors. They lack intrinsic kinase or 
phosphatase domains or sequences suitable for G protein interactions (Juliano and Haskill, 1993). 
Two hypotheses for the mechanisms of integrin-mediated signal transduction exist (Juliano and 
Haskill, 1993), which may be complementary rather than mutually exclusive. Firstly, signaling may 
be generated by integrins binding directly to the cytoskeleton thus promoting reorganisation of the 
cellular architecture. The cytoskeletal frameworks formed may influence adhesiveness, cell shape 
and motility and may also determine how integrin-mediated regulatoiy signals are propagated 
throughout the cell. Secondly, integrin-ligation may trigger specific biochemical signals within the 
cell.
During matrix ligation, integrins cluster at focal adhesion structures and this event may be 
crucial to integrin-mediated signal transduction. Engagement of integrin-matrix receptors with their 
cognate ligands or cross linking of integrins with specific antibodies induces a number of 
physiological changes in the cell, including changes in intracellular pH (Schwartz et ah, 1993), 
intracellular calcium (Pelletier et ah, 1992), increases in tyrosine phosphoiylation (Guan et ah,
1991) and changes in gene expression (Werb et ah, 1989). Ligation of integrins alters the cellular 
pattern of tyrosine phosphorylation (Guan et ah, 1991) and this is thought to be the initial event in 
integrin-mediated signal transduction. An increase in tyrosine phosphoiylation in tumour cells has 
been found to be associated with an increase in their invasion of the surrounding ECM (Mueller et 
ah, 1992). It is therefore possible that similar signaling pathways may be used by trophoblasts 
during migration through the ECM-rich environment of the decidua.
Villous and nonvillus trophoblasts exist in different microenvironments. Villous 
trophoblasts, which are non-invasive, are bound to a basement membrane composed of collagen 
type IV, fibronectin and laminin whereas invasive intermediate trophoblasts, depending on their 
location (proximal or distal), are surrounded by a matrix composed either of modified laminin or 
fibronectin and collagen type IV respectively (Damsky et al., 1992a). As described in chapter 3, 
(section 3.3.3.) trophoblast cells modulate their expression patterns o f integrins and ECM 
components during trophoblast differentiation along the invasive pathway (Damsky et ah, 1992). 
Werb et ah (1989) elegantly demonstrated that signal transduction through the fibronectin receptor 
induced MMP-1 and MMP-3 gene expression in rabbit synovial fibroblasts. Integrins have also 
been shown to regulate MMP-1 expression in human osteosarcoma cell lines (Riikonen et ah,
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1995). Bischof et al. (1991) reported that trophoblasts grown on Matrigel expressed MMP-9 more 
intensely, whereas MMP-2 remained unchanged. They also reported induction of MMP-3 when 
the trophoblast cells were grown on rat tail collagen. The importance of trophoblast-ECM 
interactions, is also supported by Kliman and Feinberg’s report (1990) which demonstrated that 
ECM thickness modulates morphology and proteolytic activity of trophoblasts. Therefore the 
regulation of MMP by matrix receptors may be of great importance for cellular invasiveness.
4.5 Regulation of MMPs by Hormones
Hormonal regulation of MMP expression is perhaps best studied in the cycling 
endometrium (as described in section 1.7.2). In particular, progesterone has been shown to be a 
potent repressor of MMP concentrations both in vivo and in vitro. For example, the MMP genes 
are expressed during the times in the cycle when progesterone concentrations are low i.e. during 
the proliferative and menstrual stages of the cycle (Rodgers et a l, 1994). The mechanism of 
inhibition is not well understood. Progesterone regulation of gene expression has been shown to be 
mediated by direct binding o f the receptor to negative hormone-response elements in the promoters 
of many steroid-responsive genes (Gronemeyer, 1991). An attractive hypothesis is that the MMPs 
are regulated in this manner. While putative hormone-response elements have been identified in 
the promoters of MMP-1, MMP-3 and MMP-7 (Matrisian et a l, 1985, Angel et a l, 1987, Gaire et 
al., 1994), there is no direct evidence that these elements respond to progesterone. At least in the 
case of MMP-7, there appears to be an indirect effect mediated through the paracrine activity of 
TGF-p, which then represses MMP-7 via a TIE element in the MMP-7 promoter (Bruner et al., 
1995).
The effects of estrogen on MMP expression are not well understood. In the rat, removal of 
all endogenous steroid hormones by ovariectomy and adrenalectomy resulted in complete loss of 
collagenase activity and synthesis in the rat uterus (Anuradha and Thampan, 1993). Implantation of 
estradiol wax pellets into these rats brought about a recovery in synthesis of the enzyme to pre- 
ovariectomized concentrations, suggesting that uterine collagenase is indeed under the regulatory 
influence of estradiol. Estrogen has little effect on MMP expression in vitro, although in some
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cases estrogen enhanced the inhibitory action of progesterone on MMPs, presumably through its 
ability to upregulate progesterone receptor production (Hulboy et al., 1997).
4.6 Effect of Hypoxia on MMPs
In mammalian cells that have been studied in this context (e.g. endothelial cells, tumour 
spheroids) hypoxia upregulates the expression of stress (oxygen-regulated proteins), heat shock, 
and glucose-regulated proteins, as well as cytokines and growth factors. These include 
erythropoietin (Bondurant et al., 1986), PDGF B chain (Kourembanas et al., 1990), endothelin 
(Kourembanas et al., 1991), IL-8 (Shreeniwas et al., 1992), vascular endothelial growth factor 
(Shweiki et al., 1992) and glyceraldehyde-3-phosphate dehydrogenase (Graven et al., 1994). The 
cis-acting DNA sequences and the trans-acting transcription factors that regulate the expression of 
these hypoxia-induced proteins are beginning to be elucidated. For example, hypoxia-inducible 
factor 1, a nuclear protein DNA-binding activity induced in hypoxia, upregulates erythropoietin 
production by binding to an enhancer element in the 3’ region of this gene (Wang et al., 1993). 
Hypoxia inducible factor 1 also induces transcription of glycolytic enzymes, which are vital for the 
cells ability to switch from aerobic respiration to glycolysis for energy production (Semenza et al., 
1994). The expression and/or activity of several other transcription factors including Fos and Jun, 
NFkB, and the heat shock transcription factor, also increase in hypoxia (Genbacev et al., 1996).
The studies mentioned above suggest that hypoxia can specifically alter a cells gene 
expression and protein repertoire. Dramatic changes in oxygen content of the placental 
environment normally occur during early gestation. Namely, before the tenth week of pregnancy 
there is little blood flow to the intervillus space, due to the fact that cytotrophoblast invasion is 
largely interstitial, rather than endovascular. As a result the placenta proper is relatively hypoxic 
(Rodesch et al., 1992). By weeks 12-13, cytotrophoblasts begin to substantially remodel the spiral 
arterioles and blood flow to the intervillus space increases dramatically (Rodesch et al., 1992). Pre­
eclampsia, is a disease of pregnancy which alfects 7-10% of all first-time pregnancies. Compared 
with normal pregnancy, in pre-eclampsia cytotrophoblast invasion is shallow and fewer arterioles 
are breached, an important factor with regard to the reduction in uteroplacental blood flow
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observed in this syndrome. It has been hypothesized that the events that normally take place during 
the first trimester o f pregnancy, which convert the relatively hypoxic environment to one that is 
relatively well oxygenated, fail to occur in pre-eclampsia. Whether this could affect the cells ability 
to differentiate and invade remains unknown.
The research presented in the following section attempts to address many of the issues raised 
above. It is primarily concerned with identifying the biological factors and conditions that may 
function in regulating trophoblast MMP expression and, thus, could play a hierarchical role in 
controlling trophoblast invasion.
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4.7 RESULTS
4.7.1 Isolation of total RNA from cell lines
To investigate the effects of various biological modifiers on MMP and TIMP expression we 
examined mRNA levels of target genes and compared them with levels in control untreated cells 
using RT-PCR. This was achieved by treating all the cell lines with the appropriate biological 
modifier for 8 hours (section 2.2.1.5), and isolating total RNA was from all cell lines as described 
in section 2.2.7.1. RNA was quantified as described in section 22 .12 . The integrity of the RNA 
was analyzed by gel electrophoresis as outlined in section 2.2.1.3, and the RNA was later used as 
template in the RT-PCR reaction (section 2.2.8). Figure 4.2 is a representative gel showing the 28, 
18 and 6 S ribosomal subunits demonstrating successful RNA isolation with some degradation. 
This gel shows the RNA isolated following treatment with cytokines to investigate their effect on 
MMP-9 mRNA levels in the ED77 cell line.
2 8 S 
1 8 S
6 S
Figure 4.2. Agarose gel electrophoresis showing intact RNA isolated from ED77 cells ( 5 |ig RNA loaded). The bands 
representing the 28S, 18S, and 6 S ribosomal subunits can be clearly seen.
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4.7.2 Optimisation of PCR reactions.
Each PCR reaction was performed with 2 sets of primers; one set for the gene of interest and the 
other for p-actin. The inclusion of primers for P-actin, a constitutively expressed gene acts as an 
internal control and allows for comparisons to be made between samples. The P-actin primers 
chosen also span an intron and so have the added benefit that any contaminating DNA, which 
could also be amplified, can be identified as it yields a larger product size. The temperature at 
which both sets of primers would anneal during the PCR reaction was determined empirically. The 
results of the optimum annealing temperature during PCR for each set of primers is shown in Table
Table 4.1 Optimum annealing temperatures for primers used.
Target Primer sequence Fragment
size
Optimum 
annealing 
temp. CQ
MMP-9 5 ’GGT CCC CCC ACT GCT GGC CCT TCT ACG GCC 3’ 
5’ GTC CTC AGG GCA CTG CAG GAT GTC ATA GGT 3’
640bp 54
MMP-2 5’ TGA CAT CAA GGG CAT TTC AGG AGC3’ 
5’ GTC CGC CAA ATG AAC GGT CCT TG 3’
180bp 53
MMP-7 5’ TGT ATC CAA CCT ATG GAA ATG 3’ 
5’ CGC GCA TCT ACA GTT ATT TAC3’
341 bp 47
MMP-3 5’ CTT TCC AGG GAT TGA CTC 3’ 
5’ CGG CCA GTA AAA ATA CAA3’
324bp 48
TIMP-1 5’TGC ACC TGT GTC CCA CCC CAC CCA CAG ACG 3’ 
3’GGC TAT CTG GGA CCG CAG GGA CTG CCA GGT 3’
551bp 53
TIMP-3 5’CTG TGC AAC TTC GTG GAG 3’ 
5’ TCG GTA CCA GCT GCA GTA 3’
250bp 55
P- actin 5’ TCA GGA GGA GCA ATG ATC TTG A 3’
5’ GAA ATC GTG CGT GAC ATT AAG GAG AAG CT3’
383bp 47-55
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4.7.3 Effects of cytokines on MMP-9 mRNA.
The MMPs are known to be regulated transcriptionally by a variety of cytokines and oncogenes in 
other systems (McDonnell et al., 1991, Abbas et al., 1991). We decided to investigate the effect of 
a number of cytokines on MMP-2 and MMP-9 expression in these trophoblast cell lines. The 
cytokines chosen had been implicated by a number of other investigators in regulating 
developments at the feto-matemal interface in vivo and the cytokines and/or their receptors are 
known to be present in placental tissue. We looked at the elfect of IL-ip, EGF and TGF(3, and also 
the synthetic tumour promoter TPA on MMP mRNA and protein levels.
The effect of cytokines on MMP mRNA expression levels was investigated using reverse 
transcription polymerase chain reaction (RT-PCR) using specific primers for MMP-2 and MMP-9, 
we also amplified a constitutively expressed gene P-actin. Following treatment o f the cells with the 
various cytokines for 8 hours (section 2.2.1.5), the RNA was extracted (2.2.7.1), reverse 
transcribed to cDNA and amplified for P-actin and either MMP-2 or MMP-9 (section 2.2.8). 
Figure 4.3 shows a representative RT-PCR gel for ED77 showing PCR products for simultaneously 
amplified MMP-9 and P-actin. Gels were then scanned by densitometry as in section 2.2.9. Results 
were then graphed using densitometric readings normalised for p-actin expression. This means that 
any changes detected can be specifically attributed to changes in steady state MMP-9 mRNA 
levels. The three trophoblast cell lines showed a similar pattern o f results with IL-ip and TPA 
having a stimulatoiy effect on MMP-9 mRNA production (Figure 4.4) EGF caused a slight 
upregulation of MMP-9 in all three cell lines. However, TGF-P had no effect in the case of ED31 
and caused a slight inhibition o f MMP-9 mRNA expression in ED77 and ED27.
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Figure 4.3 RT-PCR analysis of mRNA from ED77 trophoblast cells using (3-actin and MMP-9 specific primers 
following treatment with cytokines. Lanes (1) untreated, (2) IL-1 (3, (3) EGF, (4) TGF|3, (5) TPA, (6 ) negative control, 
(7) BHK92 RNA used as positive control. Up-regulation of MMP-9 by IL-lp and TPA (a known inducer of MMP-9) 
can be seen. Graph shows densitometric analysis normalised for p-actin.
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Figure 4.4 Comparison of the effects of cytokines on MMP-9 mRNA expression levels in trophoblast cell lines ED77, 
ED31, and ED27. Graph shows densitometric analysis of gels with RT-PCR products for MMP-9 normalised for (3-actin
4.7.4 Time and Dose response of IL-1 p on MMP-9 mRNA levels
Having established that EL-1 P had a stimulatory effect on MMP-9 mRNA expression we decided 
to characterise this response further and investigate the dose response and time course of IL-ip 
stimulation. To investigate the response of IL-ip at various time points, the cells were treated with 
5 ng/ml IL-ip as outlined in section 2.2.1.5, the RNA extracted (2.2.7.1) at 4, 8, 16 and 24 hours 
post treatment, and mRNA examined by RT-PCR (2.2.8). As shown in Figure 4.5 (A), maximal 
induction of MMP-9 mRNA levels was seen at 8 hours post treatment with IL-ip. It can also be 
seen that mRNA levels were approaching control untreated levels by 24 hours post treatment. 
Increasing concentrations of IL-ip were also tested to see if the response was dose dependent. 
Figure 4.5 (B) shows that treatment with IX  (5 ng/ml) IL-ip upregulates MMP-9 and this effect is 
increased when the concentration of IL-ip is increased to 5X (25 ng/ml) but plateaus above 5X 
concentration o f IL-1 p. No effect is obvious at concentrations lower than IXIL-1 p.
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Figure 4.5 (A) RT-PCR analysis of the time taken after treatment with IL-1 p until effect can be seen in MMP-9 mRNA 
expression levels in ED77 cells. (B) Analysis by RT-PCR of the effect of various concentrations of IL-1 P on MMP-9 
mRNA levels in ED77cells. Concentrations of IL-ip examined were O.IX (0.5 ng/ml), IX (5ng/ml), 5X (25ng/ml), 10X 
(50ng/ml).
4.7.5 Effects of cytokines on MMP-9 activity levels
The upregulation of MMP-9 at mRNA level was investigated further to see if there was a 
corresponding increase in MMP-9 protein levels when exposed to IL-1 p. Cells were treated with 
the various cytokines for 24 hours (section 2.2.1.5), the conditioned medium collected, and 
analysed by zymography (section 2.2.4.3). Figure 4.6 shows a representative zymogram which
9 7
shows stimulation o f MMP-9 protein following treatment with IL-ip in the ED77 cells. This figure 
also shows that MMP-2 protein expression was not regulated by any of these factors. All three 
trophoblast cell lines show similar results (Figure 4.7), with IL-ip increasing the amount of protein 
produced. EGF also caused a small increase in MMP-9 protein levels and TGF-p had little effect 
on MMP-9 protein levels in the trophoblast cell lines (Figure 4.7). With the exception of TGF-P, 
the effect of cytokines on MMP-9 at the protein level appear similar to the effects seen at the 
mRNA level.
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Figure 4.6 .Zymogram showing the effect of cytokines on MMP activity in conditioned medium from E D 7 7  cells. Lanes 
: (1) untreated, (2) IL-ip, (3) EGF, and (4) TGFp. Upregulation of MMP-9 by IL-ip can be seen in lane 2.
98
C d Erl B j F t q f
Figure 4.7 Comparison of the effect of cytokines on MMP-9 protein levels in trophoblast cell lines. Graph shows 
densitometric measurement of MMP-9 bands from zymograms.
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4.7.6 Effects of cytokines on in vitro invasive ability of trophoblast cell lines
Having established that cytokines could modulate MMP-9 mRNA levels and MMP-9 activity, we 
investigated the effects of these cytokines on the in vitro invasive ability of the cell lines. To 
determine this, we used an in vitro assay of invasive potential in which the ability of trophoblasts to 
invade extracellular matrix (Matrigel)-coated filters and emerge through 8(im pores on the filter 
underside was accessed (section 2.2.6). As shown in Figure 4.8 the effect of the cytokines on 
invasive potential reflects the results seen for MMP-9 at the mRNA and protein level. TPA 
produced the greatest increase in invasive ability with approximately a 1.2 fold increase over 
control, followed by IL-1 [3 with approximately a 0.9 fold increase over control untreated cells. EGF 
was found to have only a slight inducive effect on invasive ability (0.2 fold increase over control). 
The effects of TGF-fi were not so clear, with no apparent effect seen in ED77 and ED31 cells but in 
ED27 cells a slight inhibitory effect on invasion was seen.
H E D 7 7  
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Figure 4.8 Effects of cytokine treatment on in vitro invasive ability of trophoblast cell lines, ED77, ED3i, and ED27.
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4.7.7 Effects of cytokines on MMP-9 mRNA levels in BeWo cells
Although no MMP-9 expression could be detected in the BeWo cells (section 3.4.4) we 
investigated whether MMP-9 expression could be induced by any of the cytokines tested on the 
trophoblast cell lines. Interestingly, we found that IL-1 (3 and TP A induced low levels of expression 
of MMP-9 mRNA (Figure 4.9). EGF and TGF-(3 had no effect. This slight induction however was 
not seen at the protein level (data not shown).
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Figure 4.9 RT-PCR analysis of mRNA from BeWo cells using p-actin and MMP-9 specific primers following 
treatment with cytokines. Lanes (1) untreated, (2) IL-1 p, (3) EGF, (4) TGFp, (5) TPA, (6 ) negative control, (7) BHK92 
RNA used as positive control.
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4.7.8 Effects of cytokines on MMP-2 expression
We also examined the effect of cytokines on MMP-2 mRNA expression levels in the trophoblast 
and BeWo cell lines. Unlike MMP-9, MMP-2 mRNA expression levels could not be modulated by 
treatment with any of the cytokines used in this study, regardless of the cell line. Figure 4.10(A) 
shows the BeWo cell line stimulated with a variety of cytokines and TPA and shows no 
stimulation of MMP-2. Likewise Figure 4.10(B) shows ED77 with similar results, demonstrating 
the constitutive nature of MMP-2 expression.
380bp P -actin 
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Figure 4.10 (A) RT-PCR analysis o f  mRNA from BeW o cell line using P-actin and M MP-2 specific primers. Lanes as 
follows: (M ) contains 100 bp ladder, intense band at 500 bp, (1) Untreated BeW o, (2) IL -ip , (3) EGF, (4) TGFp, (5) 
TPA, (6) negative control (RNA replaced with water), (7) positive control, plasmid contain cDNA for MMP-2 used as 
template in PCR. (B) RT-PCR analysis o f  mRNA from ED77 cell line using p-actin and MMP-2 specific primers. Lanes 
as follows: (M) contains 100 bp ladder, intense band at 500 bp, (1) Untreated ED77, (2) IL -ip , (3) EGF, (4) TGFp, (5) 
negative control (RNA replaced with water), (6) positive control, plasmid contain cDNA for MMP-2 used in PCR.
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4.7.9 Effects of Cytokines on TIMP-1 Expression
TIMP-1 has been shown to be inducible in other systems, however little has been published on 
TIMPs in trophoblast cells. We found that TIMP-1 and TIMP-2 were produced by the trophoblast 
cell lines (section 3.4.5) and decided to investigate the effect of cytokines on the expression of 
TIMP-1 in the trophoblasts. Cells were treated with the cytokines (section 2.2.1.5), RNA extracted 
(2.2.7) and analysed by RT-PCR (2.2.8). None of the cytokines used in this study stimulated 
TIMP-1 mRNA levels, as shown in Figure 4.11. However, TPA appeared to repress TIMP-1 
mRNA expression.
1 2  3 4  5  6
Figure 4.11 RT-PCR analysis of mRNA from ED77 cell line using [3-actin and TIMP-1 specific primers. Lanes as 
follows: (1) Untreated ED77, (2) IL-1 (3, (3) EGF, (4) TGFP, (5) TPA, (6) negative control (RNA replaced with water).
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4.7.10 Effects of ECM components on MMP Expression
The interactions of cells with components of the ECM, such as fibronectin, laminin, tenascin, and 
collagens of many types, has been shown to play an important role in tissue remodeling (Liotta et 
al., 1986). We investigated the effect of culturing the trophoblast cell lines on various different 
matrices to determine if specific ECM components may have a role in regulating MMP expression. 
The ECM component laminin was shown to be a strong inducer of MMP-9 mRNA transcripts as 
shown in Figure 4.12. Other ECM components investigated, fibronectin, type IV collagen and type 
I collagen had no obvious effect. ECM components had no effect on MMP-2 mRNA levels (data 
not shown).
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Figure 4.12 Effects of various ECM components on expression of MMP-9 mRNA in ED77 cells. Lanes contain RT- 
PCR products from mRNA isolated from cells grown on (1) plastic, (2) laminin, (3) fibronectin, (4) type IV collagen, 
(5) type I collagen, (6 ) negative control, (7) positive control, mRNA from cell line known to express MMP-9.
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4.7.11 Effects of progesterone and P-estradiol on MMP expression
As steroid hormone regulation of MMPs has been seen in other systems and because pregnancy is 
innately hormone driven we decided to examine the possibility that progesterone and P-estradiol 
regulate MMP expression levels in the trophoblast cell lines. The cells were treated with the 
hormones as described in section 2.2.1.5, and the RNA extracted and analysed by RT-PCR. No 
effect was seen on MMP-9 or MMP-2 mRNA expression levels when either progesterone or P- 
estradiol were added to the cultures, as shown in Figure 4.13 for MMP-9 and data not shown for 
MMP-2.
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Figure 4.13 RT-PCR analysis of the effect exogenously added hormones; progesterone and estradiol. Lanes as follows: 
(1) Untreated, (2) progesterone, (3) (3-estradiol, (4) progesterone and P-estradiol, (5) negative control, (6) positive 
control, mRNA from cell line known to express MMP-9.
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4.7.12 Effect of Hypoxia on MMP activity
It had been suggested that oxygen tension could regulate trophoblasts ability to differentiate and as 
a consequence, to express proteins that are critical to the invasive process (Genbacev et al., 1996). 
We were interested in determining whether a relatively hypoxic environment could affect the 
trophoblast cells ability to express MMPs. Cells were cultured under hypoxic conditions for 24 
hours as described in section 2 .2 .1.7, conditioned medium collected and analysed by zymography 
(2.2.43). Our findings suggest that hypoxia does not affect MMP expression. No difference was 
found between MMP protein expression by trophoblast cells cultured for 24 hours under hypoxic 
or normal oxygen conditions as shown in Figure 4.14. Similar results were seen at the mRNA level 
(data not shown).
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Figure 4.14 Effect of hypoxic growth conditions on MMP activity in ED77 and ED31 cell lines.
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4.8 DISCUSSION
4.8.1 Effects of cytokines on MMP expression
MMP-9 has been shown to be produced by trophoblasts in a developmentally regulated 
manner, trophoblast cells from the first trimester are highly invasive and this invasiveness 
decreases by the third trimester (Librach et al., 1991, Bischof et ah, 1991). In chapter 3 the critical 
role played by MMP-9 was also identified in the trophoblast cell lines described in this thesis. Thus 
studies of the regulatory mechanisms controlling expression of this gene are important for 
understanding the complex process of invasion which takes place during pregnancy. It is highly 
likely that trophoblast differentiation along the invasive pathway is a result of the balanced action 
of growth factors and cytokines on trophoblasts and their surrounding environment. Induction of 
MMP-9 has previously been reported to be associated with invasiveness in many other systems. 
For example, the increased invasiveness of osteosarcoma-derived OST cells implanted in nude 
mice, TNF-a was identified as the inducer for MMP-9 expression in the cells at the mRNA level 
(Okada et ah, 1990). Depending on the cell types, expression of MMP-9 is also stimulated by 
inducers such as TPA, EGF, IL-1, and oncogene products (Sato and Seiki, 1993). Malignant 
tumour cells frequently overexpress MMP-9 and much research has been focused on understanding 
its role in cancer cells (Sato et ah, 1992), however little information is available on factors 
regulating expression of MMP-9 during trophoblast invasion, Since they lie at the maternal-fetal 
interface, trophoblasts could be influenced by factors from either or both compartments. With 
regard to autocrine regulators, trophoblast expression of several cytokine-receptor pairs has been 
described, suggesting that these cells can both produce and respond to EGF, IL-1 p and IL-6 
(Librach et ah, 1994, Shimonovitz et al., 1994).
In the experiments described here, we tested three cytokines, IL-1 (3, EGF and TGFp, 
known to play a role in controlling the growth and differentiation of cells to see whether they affect 
trophoblast expression of MMPs in vitro. Several lines of evidence now support a possible role for 
IL-1 in human trophoblast physiology. First, measurable amounts of IL-1 were found in the 
medium of trophoblast cultures (Masuhiro et ah, 1991, Simon et al., 1994). Second, human 
decidua has also been shown to produce IL-1 (Romero, et ah, 1989). Third, multiple in vitro
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studies have shown potent regulatory effects o f IL-1 on trophoblast hCG, IL-6, and prostaglandin 
E2 production (Masuhiro et ah, 1991, Yagel et ah, 1989b, Shimonovitz et ah, 1995).
In this study we clearly showed that under basal conditions, trophoblasts cells express 
MMP-9. Furthermore, treatment with IL-1 (3 caused approximately a 1.5-fold increase in the steady 
state mRNA level of MMP-9, accompanied by a significant increase in the gelatinolytic activity of 
these cells. This increase in MMP-9 protein levels also lead to a slight increase in the cells in vitro 
invasive ability over untreated cells. These results are in agreement with current theories that 
MMP-9 expression is directly linked to invasive potential (Sehgal et ah, 1998, Bernhard et ah,
1994). The stimulatory effect of IL-1 (3 on MMP-9 in trophoblast cultures corroborates previous 
findings in rat ovary, keratinocytes, and synovial cells (reviewed in Shimonovitz et ah, 1996). 
Recently Librach et al (1994) reported similar results of the effect of IL-ip on MMP-9 in 
trophoblast cells, however only at the protein level. Paulesu et ah (1991), using 
immunohistochemistiy, showed that the syncytiotrophoblast and invasive cytotrophoblasts, but not 
villus cytotrophoblast stem cells, contain immunoreactive IL-ip. Furthermore, staining for this 
cytokine was strongest during the first trimester. In vitro production of IL-1 P by trophoblasts was 
also reported by Librach et ah (1994). They reported that release of IL-1 P by trophoblasts was 
developmentally regulated, with highest levels produced by trophoblasts isolated from first 
trimester placentas and lowest levels from term placentas, paralleling expression of MMP-9. Our 
results indicate that IL-ip may have an important in vivo role in regulating local MMP-9 
production and thus the extent of trophoblast invasion which takes place.
To further characterise the modulation of MMP-9 by IL-ip, time course and dose response 
experiments were carried out by analysing mRNA levels using RT-PCR. Every gene displays a 
characteristic time course of induction following exposure of the cell to the cytokine. These can 
roughly be divided into early-response genes which are rapidly induced (within minutes), 
intermediate-response genes (induced within a few hours), and late-response genes (induced after 
several hours). The timing of genetic responses reflects the period required for functional 
transcriptional activators to be produced and act on their intermediate targets. We examined the 
time course o f the effect o f IL-1 P on MMP-9 mRNA levels. The MMPs are generally accepted as 
being intermediate response genes and this was shown for MMP-9, with a time period of 4 hours 
post addition o f IL-1 P before a change in the mRNA level was seen, which reaches maximal level
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at 8 hours. By 24 hours post treatment the cells mRNA levels were again similar to untreated cells. 
The effect o f IL-ip on MMP-9 transcript levels was also found to be dose dependent. A 
concentration o f 5 ng/ml IL-ip was found to be sufficient to upregulate expression compared to 
untreated cells, with mRNA levels reaching plateau for concentrations greater than 25 ng/ml.
EGF has previously been shown to be a potent upregulator o f MMPs particularly MMP-3 
and MMP-1 in other cell types (McDonnell et al., 1990, Shima et al., 1993). In this study we found 
EGF only had a slight effect on trophoblast MMP-9 mRNA or protein expression. We also saw no 
significant increase in the cells invasive potential when treated with EGF. In placental tissue in vivo 
the EGF receptor population appears to be largely confined to the syncytiotropho blast cells which 
are essentially non-proliferative and noninvasive (Chegini and Rao, 1985, Maruo et al., 1987). 
Since the trophoblasts used here have the phenotype of nonvillus cytotrophoblasts, we would 
therefore expect that they express few EGF receptors and hence it is no surprise that EGF had only 
minimal effect. Although the MMP-9 promoter may contain the elements necessary for EGF 
stimulation of the gene, the level of EGF-receptor expression by the cells will determine the 
response. Another study by Bass et al. (1994) found that EGF increased trophoblast invasion but 
they observed no effects on proteinase production which is in agreement with our findings where 
only a slight up-regulation of mRNA levels was seen.
The three trophoblast cell lines showed almost no change in mRNA/protein levels of 
MMP-9 or in invasive potential over untreated cells when treated with TGF-p, although the ED27 
cells invasive ability was decreased slightly compared to control. Studies by Sato and Seiki, (1993) 
on the promoter o f MMP-9, reported the presence of the TIE element but the inhibitory effect of 
TGF-P on MMP-9 expression could not be demonstrated. This was in contrast to the MMP-3 gene 
where TIE is the element through which TGF-P inhibits the growth factor or oncogene-induced 
expression of MMP-3 (Kerr et al., 1990). Graham et al. (1992) demonstrated that TGF-P blocked 
trophoblast invasion in vitro and attenuated MMP-9 activity by activation of the TIMPs. Studies in 
other cell types have found that TGF-p increased MMP-9 activity (Shimonovitz et al., 1996, 
Overall et al., 1991). TGF-p, on the other hand, decreased the expression of IL-1-induced MMP-9 
enzyme in the ovaiy (Hurwitz et al., 1993). It seems that the activity of TGF-p is not solely 
dependent on the presence of the known TGF-P-responsive elements in the gene’s promoter, and it 
might have alternative signaling pathways in different systems.
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In chapter 3 we found that the BeWo cell line did not express MMP-9 (section 3.4.4) and 
was noninvasive (section 3.4.3). As the BeWo cell line was originally derived from a 
choriocarcinoma, which is a metastatic tumour, we hypothesized that perhaps a factor necessary for 
the promotion of invasion was absent in vitro. To test this hypothesis we investigated whether 
MMP-9 expression could be induced by a variety of cytokines in the BeWo cell line. We found 
that IL-ip induced low level expression of MMP-9 mRNA, though this slight induction was not 
seen at the protein level. However, it demonstrates that it is possible to stimulate expression of the 
MMP-9 gene in the BeWos and we speculate that a process similar to this may also occur in vivo.
Interestingly, EL-ip, EGF, TGF-P and TPA had no effect on either mRNA levels or the 
activity of MMP-2. Although both type IV collagenases show almost identical substrate specificity, 
with the ability to cleave collagen type IV and degrade denatured collagen (gelatin), they have 
significant dissimilarities with respect to the sequence o f their promoter regions, suggesting 
different transcriptional control. The fact that EL-1 P has an effect only on MMP-9 is not surprising. 
Sequencing of the promoter region reveals two AP-1 sequences and three motifs homologous to 
the binding site for NFkB, that is known to mediate IL-ip action (Shirakawa et ah, 1989). 
Interestingly, these binding sites could not be found in the promoter region of MMP-2. This may 
explain the discrepancies in the differential regulation of the two type IV collagenases.
It is important to remember that the actions of cytokines can be profoundly influenced by 
the milieu in which they act and especially by the presence or absence of other biologically active 
factors. Under natural conditions a cell rarely, if  ever, encounters only one cytokine at a time. 
Rather, a cell is likely to be exposed to a cocktail of several cytokines and other biologically active 
agents, the resulting biological action reflecting various synergistic and antagonistic interactions 
among the agents present. TPA was included in this study because its effect on MMP-9 has been 
well documented, however in the placenta it would be physiologically irrelevant. TPA is a known 
inducer o f MMP-9 and has been associated with increased invasiveness in many cell types and this 
study shows trophoblasts are no exception, as it was found to be a potent inducer of MMP-9 
mRNA and protein.
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4.8.2 Effects of ECM components on MMP expression
The interactions of cells with components of the ECM, such as fibronectin, laminin, 
tenascin, and collagens of many types, play an important role in tissue remodeling (Liotta et ah, 
1986). Temporal, spatial, and cell type-specific regulation of the expression of this large variety of 
ECM molecules and their receptors provides a powerful set of mechanisms for generating diversity 
required for the proper orchestration of cell behaviour during invasion and tissue remodeling in 
vivo. Cellular invasion of the basement membrane is a multistep process in which cells recognise 
integral components of this structure and attach to them. Attachment to the basement membrane 
triggers expression of genes necessary for the invasive cells to detach from the basement 
membrane, degrade it and migrate through it. Many integrins are known to be capable of signal 
transduction, mediating between the ECM and the cell interior via its receptor (Shimizu et ah, 
1990). We decided to investigate the effect of culturing the trophoblast cell lines on various 
different matrices on MMP expression. The matrices tested included plastic, laminin, fibronectin, 
type IV collagen and type I collagen.
Although the repertoire of MMPs expressed by the trophoblast cells was not influenced by 
adhesion of the cells to the various substrates, depending on the nature of the substrate, regulatory 
effects were seen. MMP-9 expression was upregulated by laminin but there was no effect on 
MMP-2. Similar results were reported by Emonard et ah (1990), who found that when laminin 
binds to normal as well as malignant trophoblast cells, it stimulates type IV collagenase activity. 
Laminin has also been shown to increase the release of MMP-9 from malignant cells 
(Turpeenniemi-Hujanen et ah, 1986). Binding to laminin, a basement membrane component, may 
be important in cellular attachment to the basement membrane (Terranova et ah, 1983). The role of 
laminin in the attachment o f trophoblasts cells to basement membranes has not been fully 
determined. However, trophoblast cells attach better to laminin-coated substrates than to plastic 
surfaces (Loke el ah, 1989a). Interestingly, trophoblast cells (Yagel et ah, 1988) as well as tumour 
cells (Kleinman et ah, 1987), have also been shown to produce laminin, indicating an autocrine 
form of MMP regulation. The results from this study suggests that trophoblasts binding to laminin, 
which comprises the first step of basement membrane invasion, can induce the second step, namely 
dissolution o f the ECM by MMPs.
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4.8.3 Effects of progesterone and P-estradiol on MMP expression
Hormonal regulation of MMPs is an area of research which has been the focus o f much interest 
recently, particularly in the reproductive system. The reproductive organs are distinctive in their 
requirement for dramatic alterations in structural and functional properties throughout adult life, 
pregnancy being just one such event. As described in the introduction (section 4.5) it is generally 
believed that these changes, which are orchestrated by hormones, are frequently mediated by local 
cytokines and growth factors. Progesterone has been demonstrated to inhibit MMP-9 secretion 
from endometrial cells, myometrium, and cervical fibroblasts (Hulboy et al., 1997). We found that 
progesterone, even in the presence o f p-estradiol, had no effect on MMP-9 niRNA levels in the 
trophoblast cell lines. However, this is in contrast with a recently published paper which reports the 
down-regulation o f MMP-9 expression by progesterone in a dose-dependent fashion by first 
trimester trophoblasts in short term culture (Shimonovitz el al., 1998). This difference in results 
may be due to differences in trophoblast populations between our continuous cell lines and the 
primary trophoblast cells used in that study. It is possible that the continuous cell lines have 
become refractory to the effect of progesterone, due to the length of time they have been in culture. 
P-estradiol was also found to have no effect on MMP expression, p-estradiol has been shown to 
stimulate transcription o f c-jun and junB, components of AP-1 (Hulboy et al., 1997). Since AP-1 is 
an important factor in expression of MMPs, the apparent failure of p-estradiol to strongly affect 
MMP transcription emphasizes the complexity of hormonal regulation of MMP gene expression.
4.8.4 Effect of Hypoxia on MMP expression
Previous studies have suggested that hypoxia can specifically alter a cell’s gene expression and 
protein repertoire (Krtolica et al., 1996, Genbacev et al., 1996). Here, we report the result of an 
experiment in which we analysed the effects of varying the oxygen content of the culture 
atmosphere on MMP expression of trophoblasts in vitro. The impetus for this experiment was the 
dramatic changes in oxygen content of the placental environment that occur during early gestation. 
Rodesch et al., (1992) used a polarographic oxygen electrode to show that the mean oxygen 
pressure o f the intervillus space was 17.9+/-6.9 mm Hg at 8-10 weeks gestation as compared with 
39.6+/-12.3 in the endometrium. By 12-13 weeks the oxygen pressure in the intervillus space was
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60.7+/-8.5 mm Hg, a reflection o f the fact that trophoblasts were beginning to substantially 
remodel the spiral arterioles. Our results showed that hypoxia did not alter the cells expression of 
MMPs. No difference was observed between cells cultured under normal or hypoxic conditions. A 
report by Genbacev et al. (1996) reported that hypoxia decreased trophoblast invasion in vitro, 
however they did not examine MMP expression. It is possible that hypoxia alters some other factor 
that is critical to the balance between the forces that promote or inhibit invasion other than MMPs.
4.8.5 Effects of cytokines on TIMP-1 expression
The TIMP-1 gene has been reported to be inducible at the transcriptional level in response to 
cytokines and TPA in many tumour cell lines (Leco et al., 1994, Stetler-Stevenson et al., 1990b). 
Its regulation in normal cell lines have not been examined to date. We investigated the effect of IL- 
ip , EGF, TGF-P and TPA on TIMP-1 expression at the mRNA level in trophoblast cell lines. All 
three cytokines had no effect on TIMP-1 levels, however TPA down-regulated TIMP-1 expression. 
Although the effect of TPA is irrelevant in vivo, this demonstrates that TIMP-1 expression can be 
modulated. It is also interesting that IL-ip which caused an upregulation of MMP-9 has no effect 
on TIMP-1, since it is this type o f discoordinate regulation in vivo which can tip the balance 
between proteinase and inhibitor activities to favour degradation of the ECM.
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The results presented in this chapter focused on studies of the regulatory mechanisms controlling 
expression of MMP-9, which is important for understanding the complex process of invasion 
which takes place during pregnancy. We have examined the effects of three cytokines on 
trophoblast MMP production as possible regulators of the invasive process. Of those tested, only 
IL-ip had a significant effect, upregulating expression of MMP-9 at both the mRNA and protein 
level, and increasing the invasive ability o f the cells. The trophoblasts were also grown on various 
ECM matrices, and laminin was found to upregulate MMP-9 mRNA expression. Other biological 
modifiers including progesterone, P-estradiol and hypoxic culture conditions were shown to have 
no effect on MMP expression in the trophoblast cell lines.
Considering that the type IV collagenases are developmentally regulated during 
placentation and also the differential response of these two proteinases to cytokine regulation, it is 
tempting to speculate that cytokines and ECM components, in particular IL-ip and laminin are 
involved in controlling MMP-9 activity throughout placentation. Thus, we hypothesized that EL-1 p 
and laminin, produced by the trophoblast cells or the neighbouring decidua, may constitute 
mediators of trophoblast invasion by regulation of the type IV collagenase system. Given the well 
established activity of IL-ip system at the feto-matemal interface (Yagel et al., 1989b, Librach et 
al., 1994), demonstration of regulatory effects of EL-1 p on MMP-9 provides additional indirect 
support to the hypothesis that IL-ip may play a meaningful intermediary role in the trophoblast 
invasion process.
4.9 SUMMARY
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Localisation of placental MMP expression in  v iv o  and investigation of the role
of MMPs in pre-eclampsia.
Chapter 5
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5.1 Structure of The Placenta
During human pregnancy, the uterus and placenta undergo extensive growth and 
remodeling which requires both the degradation and synthesis of ECM components. A description 
of the events surrounding placental formation has already been given in chapter 3 (section 3.1 and 
3.3). As described earlier the trophoblast gives rise to two layers, an inner cytotrophoblastic layer of 
mononuclear cells and an outer syncytiotrophoblastic layer derived by fusion of cytotrophoblastic 
cells to form a continuous multinucleate syncytium in which there is no internal cytoplasmic 
demarcation by plasma membranes. Within a short time, a sponge-like network of spaces called 
inter-villus spaces develops surrounding the syncytiotrophoblasts, initially filled with tissue fluid 
and uterine secretions. Soon afterwards, invasion by the trophoblasts causes disintegration of 
endometrial capillaries expanding the inter-villus spaces and establishing an arterial supply and 
venous drainage system. Primary chorionic villi grow out to the periphery and spread out over the 
interface between the trophoblast and endometrium forming the cytotrophoblastic shell. Side 
branches grow out into the inter-villus spaces, progressively forming the complex villus structure 
characteristic of the mature placenta. By about two weeks after implantation, primitive blood 
vessels begin to develop in the chorionic mesoderm simultaneously with development of the 
primitive embryonic circulatory system, the embryo now being too large to rely on mere diffusion 
for its growth and metabolic requirements. Each villus contains a mesenchymal core containing 
capillaries severed by afferent and efferent fetal blood vessels. Between the villous capillaries and 
the maternal blood is a continuous layer of syncytiotrophoblast cells supported by a layer of 
proliferating cytotrophoblast cells. From the fourth month onwards, the cytotrophoblast layer 
becomes less active and atrophic so that by fetal maturity it is present in very little of the villous 
surface. As more and more branches are added to the villous tree, the villi become smaller and 
smaller and the tissue barrier between fetal capillaries and maternal blood is greatly diminished. As 
the placenta develops, the form of the placenta is essentially established by the end of the fourth 
month after which the placenta grows in diameter, complementing growth in the size of the uterus.
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5.2 Pre-eclampsia
Pre-eclampsia/eclampsia, a disorder unique to pregnancy, is characterised by hypertension, 
proteinuria (protein in urine), generalised edema (clinically evident swelling), and convulsions. It 
occurs in 5% to 10% of all pregnancies, primarily in primigrávidas (first pregnancy), after the 20th 
gestional week and most frequently near term (Smith, 1993). Pre-eclampsia may progress rapidly 
without warning to the convulsive phase termed eclampsia, one of the most dramatic and life- 
threatening complications of pregnancy. In addition to the effects on the mother, there is a 
profound impact on the fetus, resulting in increased perinatal mortality and frequent intrauterine 
growth retardation. Factors associated with an increased risk for this disorder include nulliparity, 
diabetes, chronic hypertension, multiple gestation, and extremes of age (Barron, 1992). A familial 
tendency to pre-eclampsia has been suggested, and studies have provided evidence that the disease 
is heritable (Chesley and Cooper, 1986; Cooper et al., 1988). The specific contribution of 
environmental versus genetic factors is, at present unknown. Immunological mechanisms have also 
been implicated, supported by evidence that pre-eclampsia is associated with the primigavid state, 
pregnancies with a different partner, and women with a history o f using barrier contraception, 
suggesting that previous antigen exposure protects against the disease (Smith, 1993). Pre-eclampsia 
is characterised by derangements in the structure and function o f many organs. Histopathologic 
studies of placental bed biopsies from patients with pre-eclampsia have revealed diminished 
trophoblastic invasion of the uterine spiral arteries (Redman, 1991).
Despite the widespread occurrence o f pre-eclampsia, the underlying cause or causes of this 
disease remain elusive. Recently, several theories have implicated humoral factors, particularly 
those o f placental origin, as initiators o f the disease process. In normal pregnancy, implantation of 
the embryo is followed by migration o f trophoblastic cells into the walls of the uterine spiral 
arteries. These vessels undergo marked remodeling, thereby losing their muscular media in order to 
serve as passive conduits to accommodate a 10-fold increase in uterine blood flow to the growing 
uterus. Invading trophoblasts in the first half of pregnancy are believed to convert these muscular, 
narrow-lumen arteries into distended, thin-walled vessels by replacing their endothelia and 
digesting their subjacent musculoelastic lamina (Robertson et al., 1986). It is thought that this 
process, which normally occurs between the 10th and 20th gestational weeks, fails to occur in pre­
eclampsia and as such is one of the earliest pathophysiologic events in the development of the
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disease. In women with pre-eclampsia the trophoblast migration is inhibited and the spiral arteries 
retain their non-pregnant moiphology (musculoelastic structure and endothelium) which pre­
disposes the spiral arteries to vascular spasm and subsequently restricted blood flow to the 
placental-fetal unit (Serra-Serra et al., 1992). This failure in women who develop pre-eclampsia to 
undergo the normal pregnancy-induced remodeling that converts these vessels to high volume-low 
resistance conduits leads to vascular spasm, restricted blood flow, placental ischaemia and the 
release of toxic substances that enter the maternal circulation, resulting in multi-organ disease. It is 
unclear which factors regulate trophoblastic migration. However, it is our hypothesis that the 
MMPs are expressed abnormally in pre-eclampsia, leading to reduced trophoblast invasion, 
consequently resulting in decreased placental perfusion and the onset of pre-eclampsia.
For many years the placenta has been recognised as an essential component of the disease 
process, underscored by the fact that only after delivery of the placenta do the signs and symptoms 
of pre-eclampsia begin to abate (De Groot et al., 1993). In addition, the disease can also complicate 
some cases of hydatidiform mole where the uterus contains only disordered placental tissue 
(Redman, 1991). Thus, a fetus is not necessary, only the placenta. Since pre-eclampsia is clinically 
manifested as a multiple organ disorder, it has been proposed that reduced placental perfusion 
results in liberation of cytotoxic factors, leading to a generalized activation of maternal vascular 
endothelial cells which, in turn, result in a systemic maternal syndrome. The nature of the 
substances toxic to endothelial cells in pre-eclampsia remains speculative. Because of the critical 
position and actions of endothelial cells throughout the entire vascular tree, dysfunction of these 
cells can lead to multi-organ failure. Figure 5.1 outlines our proposed pathophysiology of pre­
eclampsia.
Since our knowledge of the precise causes of pre-eclampsia is severely limited, therapy up 
to now has been oriented purely toward alleviating symptoms. Several approaches to the lowering 
of blood pressure and improvement of blood flow properties have been proposed, including 
calcium or magnesium supplementation and, most promisingly low-dose aspirin. The premise is 
that small amounts of aspirin produce a greater inhibition of thromboxane production than that of 
prostacyclin in both pregnant women and their fetuses thus preventing or reversing the vasodilator- 
vasoconstrictor eicosanoid imbalance that may underlie much of the pathophysiology of 
endothelial cell injury (Benigni et al., 1989). Delivery is the only definitive therapy for pre­
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eclampsia, all else is palliation. If pre-eclampsia or severe hypertension occurs beyond the 36th 
week o f gestation, a point at which fetal pulmonary maturity has generally occurred, then delivery 
is clearly in the best interest o f both mother and fetus. Delivery is also indicated regardless o f 
gestational age if  there is evidence o f advanced maternal disease or impending eclampsia, because 
progression is virtually inevitable unless the uterus is evacuated.
The first stage o f the disease lies in the placenta at the time o f placentation. The second 
stage, the clinically overt illness, is a  sequel o f placental ischaemia, secondary to spiral artery 
insufficiently. The stage is set during the establishment and development o f placentation in the first 
and second trimesters. Currently the final proof that this model is correct is lacking. However, it is 
clear that studying the placenta and in particular the trophoblasts will reward those who want to 
understand pre-eclampsia better.
Figure 5.1 Proposed pathophysiology o f pre-eclampsia.
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5.3 MMPs and Pre-eclampsia
It is only recently that interest has focused on the role of MMPs in the etiology of pre-eclampsia, 
the premise being that abnormal uteroplacental blood flow in pre-eclampsia might result from 
altered expression of MMPs by trophoblasts. A recent study showed that trophoblasts isolated from 
pre-eclamptic placentas (n=9) failed to modulate MMP-9 expression at the mRNA and protein 
levels compared to cells from normal placenta (n=8). Their invasive potential was also reduced 
(Lim et al., 1997). Graham and McCrae (1996) carried out a similar study on cells isolated from 
normal (n=10) and pre-eclamptic (n=10) pregnancies and reported that cells from both cases 
secreted variable levels o f MMP-9, but the cells from the pre-eclamptic placentas predominantly 
secreted MMP-9 in the inactive form. A report by Kolben et ah (1996) examined MMP-9, MMP-8 
and TIMP-1 levels in placental extracts from control and pre-eclamptic/eclamptic placentas (n=21). 
In pre-eclampsia/eclampsia, they found significantly decreased MMP-9 concentrations in placental 
extracts. No significant difference in placental extract between pre-eclamptic and control groups 
was seen for MMP-8 or TIMP-1. These reports of decreased MMP-9 expression or expression of 
the zymogen form of the enzyme may be the manifestation of impaired compensatory 
transformation processes when there is circulatory placenta dysfunction due to pre-eclampsia.
The aim of this investigation was to localise expression of MMP protein in normal human 
placental biopsies using immunohistochemistry. In addition, we sought to examine potential 
changes in MMP expression in human placental tissue obtained from the pre-eclamptic disease 
state.
120
5.4 RESULTS
5.4.1 Placental Biopsies
Placental biopsies were obtained from the Pathology Department, Holies Street Maternity Hospital, 
Holies Street, Dublin. 9 normal and 10 pre-eclamptic samples were included in this study. All 
tissue sections had been examined and classified by Prof. Peter Kelehan. Status of placental biopsy 
specimens is given in Table 5.1.
Table 5.1 Placental Biopsy Specimens
Section No. Status
12/3/95 Pre-eclamptic
12/6/95 Pre-eclamptic
12/34/95 Pre-eclamptic
12/78/95 Pre-eclamptic
12/127/95 Pre-eclamptic
12/237/95 Pre-eclamptic
12/267/95 Pre-eclamptic
12/420/95 Pre-eclamptic
12/455/95 Pre-eclamptic
12/489/95 Pre-eclamptic
12/54/95 Normal
12/109/95 Normal
12/112/95 Normal
12/142/95 Normal
12/186/95 Normal
12/193/95 Normal
12/345/95 Normal
12/357/95 Normal
12/422/95 Normal
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5.4.2 Characterisation of antibodies by western blot analysis
The three antibodies used in this study; anti-MMP-2, -MMP-7 and -MMP-3 were first tested by 
western blot analysis (section 2.2.5) to ensure that each antibody specifically recognised its antigen. 
A sample of PMA-treated HT1080 conditioned medium spiked with recombinant MMP-7 or 
MMP-3 fusion protein was separated by SDS-PAGE, transferred to nitrocellulose and probed with 
each antibody. It was crucial to determine that the antibodies did not cross react and were suitable 
for immunohistochemistry. Figure 5.2 shows that all three antibodies specifically recognised only 
the antigen to which they were raised, with non-specific staining not detected.
1 2  3
7 2 k D a
4 7 k D a
2 8 k D a
Figure 5.2 Western blots assessing the suitability of three antibodies for immunohistochemistry. Blot (1) probed with 
anti-MMP-7 antibody; (2) probed with anti-MMP-3 antibody; (3) probed with anti-MMP-2 antibody (GL-8).
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5.4.3 Immunohistochemistry
5|j,m sections were cut from formalin-fixed, paraffin-embedded tissue blocks of placental biopsies. 
Prior to probing with the antibody, the sections were dewaxed in xylene and rehydrated by passage 
through a series of graded alcohols. The immunohistochemistry procedure was performed as 
outlined in section 2.2.10. Following development with DAB (positive reaction produced a brown 
colour product), the sections were counterstained with haematoxylin, mounted and viewed. For 
each specimen and antibody, control sections were incubated with pre-immune serum in place of 
the antibody. Little or no background staining was seen in all control sections. A section of each 
specimen was also stained with haematoxylin and eosin (H&E) to demonstrate histological 
features. Figures 5.3-5.10 show micrographs depicting examples o f the staining patterns observed 
and showing the most prominent features of the placental biopsies. In general a similar staining 
pattern was seen for MMP-2, MMP-7 and MMP-3. This consisted of intense staining of 
syncytiotrophoblasts (Figures 5.4, 5.5, and 5.8) and light staining of stromal core areas of chorionic 
villi (Figure 5.6). Staining for MMP-2 was also seen localised around the periphery of fetal villous 
capillaries as shown in Figure 5.7. Specimens recovered from pregnancies complicated by pre­
eclampsia showed a pattern o f staining for MMP-2, MMP-7 and MMP-3 that did not differ from 
that noted for the placental samples recovered from uncomplicated pregnancy (Figures 5.9 and 
5.10).
Four different antibodies to MMP-9 were used in the immunohistochemical procedure. 
However, none were found to be suitable for use on the formalin fixed paraffin embedded sections 
as no staining was achieved with any of the MMP-9 antibodies. Three antibodies were supplied by 
Oncogene Science and the fourth by Cell Tech. All four antibodies were tested at various 
concentrations for varying incubation periods and temperatures but without success. A 
modification of the immunohistochemical procedure which favours antigen retrival (section 
2.2.10.1) in formalin fixed paraffin embedded sections was made but this did not effect the 
outcome. Antibodies to TIMP-1 and TIMP-2 were also found to be unsuitable for 
immunohistochemistry of the formalin fixed sections. The immunohistochemical staining results 
are summarized in Tables 5.2 and 5.3.
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Figure 5.3 Micrographs illustrating features of the placenta from a full term fetus using H&E staining. 
(A) 40X magnification showing the large number o f chorionic villi; (B) 200X magnification shows a 
highly vascularised floating villus surrounded by maternal blood; (C) 400X magnification focuses on 
a fetal capillary in a villus and the capillary’s proximity to maternal blood Cells; (D) 1000X 
magnification again focusing on a fetal capillary showing that there is only a single layer of 
syncytiotrophoblast separating the fetal capillary from maternal blood.
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Figure 5.4 Localisation of MMP-2 staining in floating villi. (A) H&E staining of floating villi; (B) 
MMP-2 staining of syncytiotrophoblasts and stromal core o f floating villi.[40X magnification].
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Figure 5.5 Localisation o f MMP-2 in floating villi of placental biopsy. (A) H&E staining; (B) 
Pre-immune serum used; (C) Staining of MMP-2 in syncytiotrophoblasts of floating villi. 
Counterstained with haematoxylin; [200X magnification].
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Figure 5.6 Localisation o f MMP-2 in stromal core o f villi. (A) H&E staining of stromal core region 
o f villi; (B) MMP-2 staining o f stromal core o f villi, staining can also be seen at outer layer of 
syncytiotrophoblasts. [200X magnification]
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Figure 5.7 Localisation of MMP-2 in placental biopsy. (A) No staining when pre-immune serum 
used in place o f antibody [200X]; (B) Staining for MMP-2 localised at the periphery of villus 
capillary [200X]
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Figure 5.8 Localisation of MMP-3 in floating villi. (A) H&E staining of floating villi; (B) Pre­
munirne serum; (C) Staining of MMP-3 localised to syncytiotrophoblasts and some stromal staining 
in floating villi.[200X magnification].
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Figure 5.9 Comparison o f MMP-2 expression in control and pre-eclamptic placentas. (A) and (B) 
Biopsy from normal placenta (section 12/127/95); (A) incubated with pre-immune serum; (B) MMP-2 
staining o f syncytiotrophoblasts in floating villi. (C) and (D) Biopsy from a pre-eclamptic placenta 
(section 12/375/95); (C) incubated with pre-immune serum; (D) MMP-2 staining of 
syncytiotrophoblasts in floating villi. [200X magnification]
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Figure 5.10 Comparison o f MMP-7 expression in control and pre-eclamptic placentas. (A) and (B) 
Biopsy from normal placenta (section 12/112/95); (A) incubated with pre-immune serum; (B) MMP-2 
staining of syncytiotrophoblasts in floating villi. (C) and (D) Biopsy from a pre-eclamptic placenta 
(section 12/34/95); (C) incubated with pre-immune serum; (D) MMP-2 staining of 
syncytiotrophoblasts in floating villi. [200X magnification]
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Table 5.2 Summary of staining patterns observed for MMP-2, MMP-7 and MMP-3 protein 
expression in normal human placental biopsies.
MMP General Staining Pattern Observed
MMP-2
MMP-7
MMP-3
Predominately strong staining of syncytiotrophoblasts in floating villi, weak staining 
of stromal core areas o f villi, and localised staining around periphery o f fetal blood
vessels in villi.
Moderate staining of syncytiotrophoblasts in floating villi and weak staining of 
stromal core areas o f villi.
Moderate staining of syncytiotrophoblasts in floating villi and weak staining of 
stromal core areas of villi.
1 3 2
Table 5.3 Staining intensity of MMP-2, MMP-7 and MMP-3 in normal uncomplicated and pre-
eclamptic placental biopsies.
Specimen
No.
Status Intensity of MMP-2 
staining
Intensity of MMP-7 
staining
Intensity of MMP-3 
staining
STB villus core STB villus core STB villus core
12/3/95 Pre-eclamptic ++ + ++ _ ++ +
12/6/95 Pre-eclamptic +++ + ++ + ++ +
12/34/95 Pre-eclamptic +++ + ++ + + +
12/78/95 Pre-eclamptic +++ + + _ ++ +
12/127/95 Pre-eclamptic +++ + ++ + ++ +
12/237/95 Pre-eclamptic ++ + + _ + +
12/267/95 Pre-eclamptic +++ + ++ + ++ +
12/420/95 Pre-eclamptic ++ + + + + +
12/455/95 Pre-eclamptic +++ - ++ - ++ _
12/489/95 Pre-eclamptic -H- + + + + +
12/54/95 Normal ++ + + + + +
12/109/95 Normal -H -+ + ++ + + _
12/112/95 Normal +++ + ++ ++ +
12/142/95 Normal +++ + + + + +
12/186/95 Normal ++ + + +++ +
12/193/95 Normal +++ + ++ + ++ +
12/345/95 Normal ++ + + + +
12/357/95 Normal +++ + +++ + + +
12/422/95 Normal +++ + -H- + ++ +
The relative intensity and amount of staining of either syncytiotrophoblasts (STB) or villus core tissue 
in each section was assessed by eye and scored accordingly. indicates no staining observed; ‘+’ 
indicates low levels of staining; ‘++’ indicates moderate staining; ‘-H -+ ’ indicates a high level of 
intense staining.
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5.5 DISCUSSION
In this investigation, we examined the localisation of MMP-2, MMP-7 and MMP-3 in normal human 
placenta. In addition, human tissue obtained from pregnancies complicated with pre-eclampsia was 
evaluated to access potential changes in MMP expression in human placenta obtained from this 
disease state. Our initial hypothesis was that the abnormal uteroplacental blood flow in pre-eclampsia 
(as a result of shallow invasiveness of the uterine arteries) might result from altered expression of 
MMPs by trophoblasts. Ideally placental biopsies would be obtained from young (i.e., first trimester) 
tissue, however it is impossible to predict whether pre-eclampsia will develop later in pregnancy. 
Therefore, in order to study trophoblast from pre-eclampsia-complicated pregnancies, we had to rely 
on material obtained from late (i.e., term or near-term) pregnancies.
A section from each specimen was stained with H&E to demonstrate histological features. 
H&E is the most commonly used technique in animal histology and routine pathology. The basic dye, 
haematoxylin, stains acidic structures a purplish blue. Nuclei, ribosomes and rough endoplasmic 
reticulum have a strong affinity for this dye owing to their high content of DNA and RNA 
respectively. In contrast, eosin is an acidic dye which stains basic structures red or pink. Most 
cytoplasmic proteins are basic and hence cytoplasm usually stains pink or pinkish red. In general, 
when the H&E staining technique is applied to animal cells, nuclei stain blue and cytoplasm stains 
pink or red.
The micrographs in Figure 5.3 illustrate the main structures of normal placenta from a full 
term fetus. At low magnification in micrograph (A), vast numbers of villi can be seen cut in various 
planes o f the section and varying in diameter from main stem villi to very small terminal branch villi. 
Compared with early placenta, the villous pattern of term placenta is much more highly developed and 
Hie average villous diameter much less, reflecting the extensive branching growth of the villi as the 
placenta enlarges. Micrograph (B) demonstrates a villus at higher magnification. Compared to early 
placenta there is marked vascularity of the villous cores and greatly increased villous surface area 
exposed to the inter-villus spaces filled with maternal blood. Micrograph (C) focuses on a small 
branch villus and highlights the proximity of blood in fetal capillaries to maternal blood in the 
surrounding inter-villus space. The trophoblast is reduced to a thin layer of syncytiotrophoblast only 
and the capillaries tend to be located in the periphery o f the core (micrograph (D)).
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Since MMP-9 has been shown to play a critical role in trophoblast invasion it was the MMP 
of most interest to examine in the placental biopsies. Unfortunately, this was not possible with the 
antibodies for MMP-9 which are currently available. Four different commercial antibodies for MMP- 
9 were tested for immunohistochemistry but none were successful on the formalin fixed paraffin- 
embedded sections which were available to us. One of the antibodies, anti-MMP-9 Ab-3 supplied by 
Oncogene Science is marketed as being suitable for paraffin-embedded sections but this was found 
not to be the case in our hands and others (personal communication, Dr. Z. Zeng, Memorial Sloan- 
Kettering Cancer Center). This antibody has successfully been used on frozen sections however we 
unfortunately did not have access to frozen tissue specimens. Steps involved in producing paraffin 
sections are known to cause loss, diffusion, reduction, chemical alteration, or masking of tissue 
antigens, making immunohistochemistry difficult if  not impossible (Herrington and McGee, 1992). 
Formalin fixation o f tissue specimens which involves the formation of methylene bridges between 
amino groups, can also affect antigenic preservation. Formalin is believed to destroy some antigens 
completely, while many others undergo some reduction in number and others are masked by the 
fixation (Herrington and McGee, 1992). We also tested antibodies against TIMP-1 and TIMP-2 
supplied by Oncogene Science, however neither were suitable for immunohistochemistry.
Antibodies to MMP-2, MMP-7 and MMP-3 were successfully used for 
immunohistochemistry. Each antibody specifically recognised its antigen as demonstrated by western 
blot analysis. MMP-2 was found to be expressed in syncytiotrophoblasts and villus core tissue of 
chorionic villi. The positive results for MMP-2 in syncytiotrophoblast, suggest that this cell type could 
be involved in active remodeling o f the villi and modulation o f matrix deposition. It has also been 
proposed that since syncytiotrophoblasts are in direct contact with maternal blood as it perfuses the 
placental intervillous spaces, expression of proteolytic activity by trophoblasts may contribute to the 
maintenance of blood fluidity at this site (Graham and McCrae, 1996). The positive staining of the 
villous fibroblasts for MMP-2 suggests that these cells play an important role in the process of 
production and remodeling o f the villous stroma. In agreement with our findings for MMP-2, Polette 
el ol. (1994) reported that MMP-2 and TIMP-2 mRNAs remained expressed at comparable levels in 
both first and third trimesters, supporting the idea that these molecules in addition to their role in 
trophoblast invasion, may mediate other processes such as extracellular matrix remodeling or vascular 
network establishment. Indeed, placental vascularization development persists during the late
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gestation (Foidart et ah, 1992). Previous studies by Autio-Harmeinen et ah (1992) and Fernandez et 
ah, (1992) are also consistent with MMP-2 expression in term placentas.
MMP-7 protein was localised to syncytiotrophoblasts o f chorionic villi. Weak staining for 
MMP-7 protein was also seen in stromal core areas of villi similar to MMP-2 staining. Only one 
previous study had examined MMP-7 protein localization in placental tissue (Vettraino et ah, 1996), 
and reported MMP-7 to be expressed in cytotrophoblasts and syncytiotrophoblasts during early 
pregnancy but only in cytotrophoblasts by the third trimester. MMP-3 showed a similar pattern of 
expression to MMP-2 and MMP-7, as staining was localised to syncytiotrophoblasts and villous core 
areas. Staining for MMP-3 was not as intense as that for MMP-2. Our results for MMP-3 are in 
agreement with other studies where MMP-3 was detected in syncytiotrophoblasts of last gestation 
placental biopsies (Vettraino et al., 1996; Fernandez et ah, 1992).
Specimens recovered from pregnancies complicated by pre-eclampsia showed a pattern of 
staining for MMP-2, MMP-7 and MMP-3 that did not differ from that noted for the trophoblast 
samples recovered from uncomplicated pregnancy. There are no published reports investigating 
MMP-2 protein expression in placental biopsies from pre-eclamptic placentas. However, a study by 
Polette et ah (1994) examined expression of MMP-9 and MMP-2 by cells of early and term human 
placenta. They reported that first trimester trophoblast produced MMP-2 which was expressed less at 
term in these cells, and MMP-9 was no longer detected at term in these cells. For MMP-3, our results 
are in agreement with a study by Vettraino et ah (1996) who reported similar results for MMP-3 
expression in normal and pre-eclamptic placentas. However Vettraino et ah (1996) reported that 
MMP-7 was over expressed and was produced by more cell types in placentas from pregnancies 
complicated by pre-eclampsia, leading the authors to speculate that the proteolytic activity of MMP-7 
might contribute to the pathology of the condition. This study was based on only 4 pre-eclamptic 
specimens. Our finding for MMP-7 are in contrast to this but are based on the results from 10 pre­
eclamptic samples which may be more representative o f the disease state.
Thus it can be concluded from our study o f MMP-2, MMP-7 and MMP-3 expression in term 
placental biopsies that no correlation can be made between the expression levels o f these three MMPs 
and the pre-eclamptic disease state. It should be kept in mind, however, that the histological findings 
in the placental biopsy at term represent the end result of invasive events of early pregnancy. Therefore
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a study of pre-eclamptic specimens from early gestation might have been more informative had it been 
possible to do so.
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5.6 SUMMARY
Human pregnancy is associated with extensive growth and remodeling o f the uterus and 
placenta. Restructuring o f these tissues during specific stages of gestation has been shown to involve 
the degradative activity o f various MMPs. In this investigation, we used immunohistochemistry to 
identify the cellular localisation of MMP-2, MMP-3 and MMP-7 in human tissues recovered from 
uncomplicated term pregnancies. Our results show prominent expression of all three MMPs in 
syncytiotrophoblasts and stromal core areas of chorionic villi at full term. We have shown that the 
cells composing the human placenta express the necessary MMPs to facilitate growth and tissue 
remodeling in the physiological progress o f human gestation.
In normal human pregnancy, invasion of the uterus and its arterial system by trophoblasts 
extends through the entire decidua and the adjacent third of the myometrium. In the pregnancy related 
disorder pre-eclampsia, trophoblast invasion is limited to the superficial decidua, and few arterioles 
are breached. Since trophoblast invasion is abnormally shallow in pre-eclampsia, it is likely that some 
component of the invasion process is altered. The purpose of this study was to assess potential 
changes in MMP expression within human placenta in pre-eclampsia. Placental biopsies from normal 
pregnancies and those complicated by pre-eclampsia were stained with the anti-MMP antibodies. The 
results show that expression of MMP-2, MMP-3 and MMP-7 by trophoblasts in pre-eclamptic 
specimens was similar to MMP expression in normal uncomplicated pregnancy specimens. Therefore, 
no correlation can be made between the expression levels of these three MMPs and the pre-eclamptic 
disease state.
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Isolation and Characterisation of Antibody Fragments to MMP-9 using Phage
Display T ech nology
Chapter 6
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6.1 Introduction to Antibodies
Antibodies are a modular weapon system of humans created by evolution to identify any 
foreign intruder. The genetic material for this huge ‘library’ o f different antibodies is stored in the 
B-cell pool o f human lymphatic tissue. With no advance knowledge of the molecular shapes of the 
foreign molecules (antigens) to be encountered in a lifetime, a ‘catch-all’ molecule or set of 
molecules has evolved. This antibody repertoire, in humans is generated by recombination events 
from a relatively small number of germline genes and is believed to contain antibodies recognizing, 
with moderate affinity, virtually any antigen. The rearrangement of the V gene segments creates a 
repertoire of virgin B cells, each displaying a single antibody species. Cells are selected by 
encountering and binding of antigen, and are triggered to differentiate to short-lived plasma cells 
that secrete antibody and to long-lived memory cells that persist in lymph nodes, spleen, and bone 
marrow. Many cycles o f somatic mutation and selection of the antibody-producing cells in the 
presence of antigen then act to increase the affinity and abundance of a specific antibody.
The antibody molecule is made up of two identical heavy (H) and two identical light (L) 
chains held together by interchain disulfide bonds (Figure 6.1 A). There are two major classes of L 
chains, called k  and X. Both H and L chains can be divided into variable (V) and constant (C) 
regions. The antibody molecule consists of two Fab regions responsible for antigen binding and an 
Fc region responsible for effector functions that eliminate antigen. The Fab fragment consists of the 
entire light chain [composed of the variable (Vl) and constant (Cl) domain] and the first two 
domains o f the heavy chain, the Vh and the C rI domains (Figure 6. IB). The smaller Fv fragment 
consists o f V r and V l domains combined. The antigen binding site of an antibody is formed by two 
domains, the Vh and V l chain variable domains which are on different polypeptide chains. These 
two variable domains can be expressed on the same polypepetide if they are joined artificially by a 
flexible linker to form single chain Fv fragments (scFv). Three hypervariable regions, the 
complementarity-determining regions (CDRs), located on both the heavy and light variable chains 
are crucial for antigen binding. The great diversity o f the natural antibody repertoire is achieved by 
combinatorial association of many variants of these CDRs.
In 1988 Better and colleagues, demonstrated that single antibody-binding fragments (Fab 
and Fv) o f an antibody molecule could be expressed in E. coli. The following year, several groups
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Figure 6.1 A schematic diagram of the antibody molecule and its fragments. (A) Structure of IgG antibody, showing 
arrangement of heavy and light chains. (B) Antibody fragments including Fab, Fv and scFv.
demonstrated that antibody genes could be amplified using PCR (reviewed by Orlandi et al., 1989). 
These two discoveries paved the way for the generation of combinatorial antibody libraries. The 
combinatorial libraries from which the first antigen-selected antibodies were retrieved were 
expressed in phage A, (reviewed by Burton, 1991). Although the construction of libraries in phage A, 
was successful, the screening system was not optimal. This system, based on filter lift, was limited 
by two major factors. Firstly, screening was laborious and required a large amount of antigen.
H chain-
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Secondly, the properties of certain antigens caused them to stick to the filters in the absence of 
antibodies and thus resulted in false positive clones. These problems have been overcome with the 
advent of novel technology using filamentous bacteriophage which can display the antibody 
fragment on their surface and contain the genetic information for the antibody within the phage 
particle (Winter et al., 1994). This technology gives access to rapid and efficient screening 
procedures and provides a direct link between the protein expressed and its genetic code.
6.2 Biology of the filamentous bacteriophage
A number of filamentous phage have been identified which are able to infect a variety of 
gram negative bacteria. They have a single-stranded, covalently closed DNA genome which is 
encased in a long cylinder of coat proteins. The best characterised of these phage are M13, fl, and 
fd, which infect E. coli. containing the F conjugative plasmid. The genomes of these three 
bacteriophage have been completely sequenced and are 98% homologous (Hill and Petersen, 
1982), and are collectively referred to as Ff phage.
Infection of E. coli by Ff phage is initiated by the specific interaction of one end of the 
phage with the tip of the F pilus. This pilus is encoded by genes on the F conjugative plasmid. The 
F pilus is required for the conjugal transfer of the F plasmid DNA or chromosomal DNA 
containing the integrated plasmid DNA into recipient bacteria lacking the plasmid DNA. It consists 
of a protein tube which is assembled and disassembled by a polymerization and depolymerization 
process from pilin subunits in the bacterial inner membrane. In the case of phage infection, it is 
thought that the end of the phage attached to the pilus tip is brought to the bacterial membrane 
surface by depolymerisation of the F pilus. There, the major capsid proteins of the phage integrate 
into the membrane and the phage DNA is translocated into the cytoplasm. In the cytoplasm, 
bacterial enzymes synthesise the complementary strand and convert the infecting phage DNA into 
a supercoiled, double-stranded replicative form (RF) molecule. This molecule serves as a template 
for transcription and translation from which all of the phage proteins are synthesised. Some of the 
phage products, in concert with bacterial enzymes, direct the synthesis of single-stranded phage 
DNA which is converted to additional RF molecules. The production of phage proteins increases 
with the accumulation of these RF molecules. Capsid proteins and other phage proteins involved in
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the assembly of the particle become integrated into the cell envelope. Proteins involved in DNA 
replication remain in the cytoplasm. When the phage specific single-stranded DNA binding 
protein, pV, reaches the proper concentration, it sequesters the newly synthesized phage single­
stranded DNA into a complex. The DNA in this pV-DNA complex is not converted to RF but 
rather is assembled into new phage particles.
Assembly occurs at the bacterial envelope, at a site where the inner and outer membranes 
are in close contact. During the assembly process, the molecules of the pV single-stranded binding 
protein are displaced and the caspid proteins assemble around the DNA as it is extruded through 
the envelope. Assembly continues until the end of the DNA is reached and the phage is released 
into the media. The assembly process is tolerated quite well by the host, as the infected bacteria 
continue to grow and divide with a generation time approximately 50% longer than that of an 
uninfected bacteria.
The genome of the phage encodes 11 genes (gl- gXI), the protein products (pI-pXI) of 
which function either in DNA replication (pH, pX), the formation of capsid proteins (pin, pVI, 
pVn, pVIH, p IX) or assembly proteins (pi, pIV, pV, pXI). The wild type Ff phage particle is 
approximately 6.5 nm in diameter and 930 nm in length. The DNA is encased in a somewhat 
flexible cylinder composed of approximately 2700 pVm monomer units. At one end of the 
particle, there are about 5 molecules each of pVII and pIX. The other end contains approximately 5 
molecules each of pm and pVI (Figure 6.2).
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Figure 6.2 A schematic representation of the bacteriophage particle, showing the location of the capsid proteins.
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As a consequence of their structure and life cycle, the phage have served as valuable tools 
for biological research. Since replication of DNA or assembly of the phage is not constrained by 
the size of the DNA, phage are excellent cloning vehicles. The result of an insertion of foreign 
DNA into a nonessential region merely results in a longer phage particle.
6.3 Principles and applications of phage display
The display of peptides and proteins on the surface of bacteriophage represents a powerful 
new methodology for carrying out molecular evolution in the laboratory. The ability to construct 
libraries of enormous molecular diversity and to select for molecules with predetermined properties 
has made this technology applicable to a wide range of problems. The origins of phage display date 
to the mid-1980s when George Smith first expressed a foreign segment of a protein on the surface 
of bacteriophage M l3 virus particles. As a test case he fused a portion of the gene encoding the 
EcoRI endonuclease to the minor capsid protein gene gin (Smith, 1985). Using a polyclonal 
antibody specific for the endonuclease, Smith demonstrated that phage containing the EcoRI-pHI 
fusion could be enriched more than 1 0 0 0 -fold from a mixture containing wild-type (nonbinding) 
phage with an immobilized polyclonal antibody. From these first experiments emerged two 
important concepts. First, using recombinant DNA technology, it should be possible to build large 
libraries (i.e., 108) wherein each phage displays a unique random peptide. Second, the methodology 
provides a direct link between phenotype and genotype. That is, every displayed molecule has an 
addressable tag via the DNA encoding that molecule. Within a few years of Smith’s experiments 
the first phage-displayed random peptide libraries were assembled (Cwirla et al., 1990; Scott and 
Smith, 1990), accompanied by reports that properly folded and functional proteins could also be 
displayed on the surface of M13 (McCafferty et al., 1990).
Perhaps one of the most impressive aspects of phage display is the variety of uses for the 
technology, including mapping epitopes of monoclonal and polyclonal antibodies, generating 
immunogens, identifying peptide ligands, mapping substrate sites for proteases and kinases, 
directed evolution of proteins, cDNA expression screening, and of course isolation of high affinity 
antibody fragments. One of the more powerful applications of phage-display has been in the arena 
of antibody engineering. It has been possible to express both Fab and scFv antibody fragments on
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the surface of Ml 3 viral particle with no apparent loss of their affinity and specificity (McCafferty 
et ah, 1990; Barbas et ah, 1991). The coding regions of the Vl and Vh chains can be obtained from 
naive mice (Gram et ah, 1992), immunized mice (Clarkson et ah, 1991), or germline genes 
(Hoogenboom and Winter, 1992). Antibodies to diverse antigens have been successfully isolated 
using phage display technology including elongation factor EF-la, immunoglobulin binding 
protein and rhombotin-2 oncogene protein (Winter et ah, 1994).
6.4 Phagmids
In the immune system, the B-cell provides a ‘genetic display package’, with antibody 
expressed (displayed) on the outside of the cell to encounter and bind to antigen and the genes 
encoding the antibody contained within. In recent years, vectors have been developed that allow the 
display of foreign peptides on the surface of the filamentous phage particles (Cesareni, 1992). By 
insertion of specific oligoneucleotides, or entire coding regions into genes encoding specific phage 
capsid proteins, chimeric proteins can be produced which are able to be assembled into phage 
particles (Winter et ah, 1994). This results in the display of the foreign protein on the surface of the 
phage particle.
By combining the best features of plasmids and the phage, new cloning vectors called 
phagmids have been constructed. They contain the replication origin and packaging signal of the 
filamentous phage together with the plasmid origin of replication and gene expression systems of 
the chosen plasmid. Phagmids can maintain themselves as plasmids directing expression of the 
desired proteins in the bacteria. Infection with a filamentous helper phage activates the phage origin 
of replication and the resulting phagmid single-stranded DNA is encapsulated into phage-like 
particles using helper phage proteins.
A variety of vectors have been used for the presentation of antibodies on the phage surface, 
examples include pHENl and pCOMB3. The display sites most commonly used are within genes 
HI or Vin (Figure 6.3). Many short peptides and a variety of proteins have been displayed at the N- 
terminus of mature pIU. Phagmid vectors comprise the pHI fusion, as well as plasmid and phage 
origins of replication and antibiotic resistance markers. Helper phage e.g. VCS M13 provide the 
other functions for single-stranded replication and packaging. Helper phage are poorly packaged in
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competition with phagmids due to a defective origin of replication (Vieira and Messing, 1987). 
VCS M13 also confers kanamycin resistance on their hosts. Because the phagmid pill fusion 
competes with the helper phage pin for incorporation into the phage coat, the majority of the phage 
particles display none or only one antibody molecule (Lowman et al., 1991). Once the helper phage 
has made single-stranded phagmid DNA and packaged it in a bacteriophage coat, the phagmid is as 
infectious as a bacteriophage, however it cannot replicate to form infectious units without the aid of 
the helper phage.
In a number of vectors, there are drug resistance genes which have been introduced by 
bacterial transposons, in the case of pHENl there is an ampicillin resistance gene. Also several 
vectors have been engineered to express short peptide ‘tags’ which can be recognised by particular 
monoclonal antibodies. One such sequence is the c-myc epitope, EQKLISEEDLN, which is 
recognised by monoclonal antibody 9E10 (Evan et al., 1985). In the pHENl vector, the c-myc 
epitope is upstream of the cloning site in gene M; this arrangement is useful in detecting chimeric 
pin molecules on western blots and verifying that full length chimeric molecules exist on phage.
Suppressed stop codons (amber codons) have also been placed between displayed protein 
domains and pDI. When such recombinants are propagated in a suppressor carrying bacterial strain 
such as TGI, virus particles are produced incorporating the chimeric protein domain pm into the 
capsids. In TGI this amber codon is read as glutamic acid and a fusion between antibody and gene 
m is produced (Kay et al., 1996). After screening phage populations for virus particles with certain 
properties (based on the particular protein domain displayed), individual isolates can be introduced 
into bacteria strains that lack suppressors (e.g. HB2151). In these hosts there is efficient 
translational termination at the stop codon in the chimeric gene m, consequently the protein 
domain is secreted by itself (Kay et al., 1996). This has been a very effective means of generating 
soluble forms of the desired protein, for example antibodies as described by Hoogenboom et al.
(1991). The vector pHENl can be used in this manner for the direct expression of the antibodies as 
soluble fragments, as an amber stop codon is encoded at the junction of the antibody gene and gene
In pHENl the production of the pin fusion is under the control of the lacZ promotor which 
is inhibited by glucose and induced by isopropyl-P-D-thiogalactosidase (IPTG). Because the 
expression of gene m prevents infection with helper phage, the bacteria harboring the phagemid
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vectors are grown in the presence of glucose. After infection with helper phage the bacteria are 
grown in the absence of glucose and presence of IPTG, consequently sufficient antibody-pin fusion 
is produced for packaging into phage.
Fusion to gene VIII
Fusion to gene III
Figure 6.3 Comparison of two different M13 phage-display vectors and viral proteins. The displayed proteins are fused 
to either proteins HI or VIII on the surface of the phage, depending on where the foreign DNA has been inserted in the 
phage genome. [Black boxes and spheres correspond to the foreign genetic elements and their encoded peptides, 
respectively, other symbols as described in Figure 6.2],
6.5 Construction and Screening of Antibody Display Libraries
Libraries can be generated from the genetic material of both immunized or non-immunized 
animals or humans (Huse et ah, 1989; McCafferty et ah, 1990). Alternatively they may be 
constructed from naive (Marks et ah, 1991), synthetic or semi-synthetic genes (Barbas et ah, 1992; 
Lemer et ah, 1992). The source of mRNA may be B-lymphocytes from the spleens of 
hyperimmunised mice or from human B-lymphocytes obtained from peripheral blood or other 
lymphoid tissues such as tonsils or spleen if available. Once RNA has been extracted cDNA must 
be synthesized using reverse transcriptase. Reverse transcription uses a short RNA:DNA hybrid 
region as template and this can be generated on the RNA using random DNA hexamers or chain- 
specific primers which anneal with the various constant region. Having generated cDNA this is
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used as a template for PCR. PCR amplification is carried out using primers complementary with 
the ends of the heavy- and light-chain variable regions. Alignment of known variable domain gene 
sequences demonstrates that there are regions of conservation within the variable domain, 
particularly at the 5’ and 3’ termini. This has lead to the determination of species-specific 
consensus sequences which have been used in the design of PCR primers. In this way whole 
repertories of antibody genes have been prepared by PCR. After PCR the various reactions from 
within a group can be mixed to give three pools (heavy, k  and A chains). The separate heavy- and 
light-chain fragments are converted to a single-chain Fv gene by inserting a DNA sequence 
encoding a flexible linker peptide. The assembly of the VH, VL and linker fragments is carried out 
by PCR and is driven by homologies at the ends of the various fragments. The 3’ end of the heavy 
chain is complementary to the 5’ end of the linker and the 3’ end of the linker DNA is 
complementary to the 5’ end of the light chain (Kay et al., 1996). This PCR step also introduces 
restriction enzyme sites at the termini for cloning. The products are cloned into an appropriate 
vector and electroporated into E. coli TGI cells.
The scFv fragments expressed on the surface of the phage are screened against antigen- 
coated microtitre wells. This procedure is called ‘panning’ and is depicted in Figure 6.4. Following 
incubation with the phage preparation, unbound phage are removed by washing and discarded. 
Bound phage, those expressing a scFv which is specific for the antigen are eluted with acid. The 
eluted phage are amplified by transformation of E.coli and infection with helper phage. The 
panning procedure is repeated 3-5 times, each time enriching for those phage bearing antigen- 
binding scFvs. For each round the ratio of antigen-binding phage to non-binding phage is 
increased. For example, 1/5000 clones were positive from a library made from a human 
immunized with tetanus toxoid, however following one, two, and three rounds of panning the 
frequency increased to 1/4,7/10 and 9/10, respectively (Kay et al., 1996).
Following panning, individual colonies can be assayed directly for the ability to bind the 
antigen as a phage particle by immunoassay techniques such as ELISA. Phage that have bound an 
immobilised ligand via the expressed antibody (phage-antibody) are detected using an antiserum 
raised against bacteriophage fd. The principle component recognised by this antiserum is gene VIII 
protein of which there are approximately 2,800 copies, making up the bulk of the capsid, giving a 
convenient amplification system. Having detected positive phage clones, these can be transferred
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into HB2151 which will give soluble expression of the antibody. Again these clones can be tested 
by ELISA, this time using an anti-c-myc antibody, which can recognise the c-myc tag on the scFv, 
to detect bound phage.
Phage displaying. 
scFv fragment
Antigen
/Y"- /t-fì |%An
/ T l 3=3..
Phage screened by panning 
on immobilized Antigen
♦ Wash away non­
binding phage
♦
Amplify enriched library and repeat panning and amplification
Figure 6.4 Outline of sequence of events in antibody phage library construction and panning procedure.
6.6 Nissim Library
The Nissim phage display antibody library was first developed in 1994 by Nissim et al. at MRC, 
Centre for Protein Engineering, Cambridge. This library was constructed from diverse repertories 
of rearranged human Vh gene segments from a bank of 50 cloned human Vh gene segments 
(Tomlinson et al., 1992). The human synthetic library was constructed as in Hoogenboon and
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Winter (1992) using PCR primers designed to introduce VH-CDR3 of random sequence varying in 
length from 4 to 12 residues. The PCR products from each of the amplifications encoding the nine 
different CDR3 loop lengths were pooled, cut with Ncol and Sail, and cloned into Ncol-Xho I-cut
7pHENl -VX3 to provide nine phagmid libraries, each containing at least 10 clones. The in vitro Vh 
genes were paired with a single unmutated VX.3 light chain gene segment. Each library was rescued 
separately with helper phage VCS-M13, then pooled with each other, and with two earlier libraries 
(Hoogenboom and Winter, 1992), each of at least 107 different clones and encoding loops of five
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or eight residues to create a single pot library of > 1 0  clones.
The Nissim library has been used to isolate immunochemical reagents to a range of 
antigens. From the same ‘single pot’ repertoire, phage were isolated with binding activities to each 
of 18 different antigens. These antigens included haptens, foreign and self- antigens, including 
secreted proteins (lysozyme and ovalbumin), cell surface proteins (T cell receptor), intracellular 
proteins from the cytoplasm (thyroglobulin), proteins from the lumen of the endoplasmic reticulum 
(BIP) and proteins from the nucleus (p53) (Nissim et ah, 1994). Both phage and scFv fragments 
secreted from infected bacteria were used as monoclonal and polyclonal reagents in western blots. 
Furthermore, the monoclonal reagents were used for epitope mapping and for 
immunocytochemical staining of cells (Nissim et ah, 1994).
6.7 Antibodies to MMP-9
MMP-9 has been implicated in many diseases involving ECM degradation (Brenner et ah, 1989; 
Powell et ah, 1996; Dean et al., 1989). As described in chapters 1 and 2 of this thesis, MMP-9 is 
thought to have a critical role in mediating trophoblast invasion during placentation (Fisher et ah 
1989; Librach et ah, 1991). In chapter 5 we sought to investigate the role of MMP-9 in vivo using 
immunohistochemistry of placental biopsies. However, currently available antibodies to MMP-9 
were not suitable for performing immunohistochemistry on the formalin fixed paraffin-embedded 
sections. scFv fragments have been shown to perform better in penetrating tissue sections than 
whole IgG molecules because of their small size ( Huston et ah, 1993).
In vivo the MMPs are secreted in a latent form and must be cleaved to yield an active 
degradative enzyme. Isolation of antibodies which specifically recognize the active form of this
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enzyme has proved elusive by conventional methods, however this is essential as it is detection or 
localization of the active enzyme that is most clinically relevant. The display of repertoires of 
antibody fragments on the surface of filamentous bacteriophage offers a new way of making 
antibodies with predefined specificities and isolating veiy rare antibodies. Nissim et al. (1994) 
speculated that phage may recognize different epitopes, or at least those with a different bias, from 
monoclonal antibodies. For example, phage display technology isolated a novel antibody to p53 
which recognized a sequence that no isolated monoclonal antibody had been capable of detecting, 
however, it remains to be seen whether this proves to be the case in general.
We set out to use the Nissim library to isolate novel scFv antibody fragments to MMP-9. It 
was hoped to characterise these fragments using BIAcore analysis. Real-time biospecific 
interaction analysis (BIA) is a general technique for observing the progress of biomolecular 
interactions as they occur. One of the interacting components is immobilized onto a sensor chip 
surface, and the change in the surface concentration resulting from binding of the other component 
is measured using surface plasmon resonance. We sought to isolate antibody fragments specifically 
against active MMP-9 (i.e. not detecting latent enzyme) which would be suitable for 
immunohistochemistry on paraffin-embedded sections.
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6.8 RESULTS
6.8.1 Analysis of MMP-9 Protein
Our first consideration was the source of MMP-9 protein to be used for the panning procedure. Rather 
than go through lengthy purification protocols we chose to obtain the commercially available 
‘Gelatinase, 92 kDa’ available from Boehringer Mannheim (Cat. No. 1758900). This MMP-9 protein 
was purified from human blood. To assess the purity of the MMP-9 protein, it was analysed by SDS- 
PAGE as described in section 2.2.4.1 and silver stained as in section 2.2.4.2.2. The protein appeared 
as a single homogenous band at 92 kDa (Figure 6.5). The purity of the protein was essential to ensure 
that antibody fragments were isolated specifically to MMP-9 and not to any contaminating antigens 
present in the preparation.
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Figure 6.5 SDS-PAGE silver stained gel showing purity of MMP-9 protein. MMP-9 was loaded at a concentration of 1 ng.
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6.8.2 Assessing the Activation State of the MMP-9 Protein
The MMP-9 protein supplied by Boehringer Mannheim was in the latent 92 kDa form. However, in 
order to isolate antibody fragments specific to the active form of the protein ( 8 8  kDa) some of the 
protein required activation. This was achieved by freeze-thawing which resulted in the loss of the pro 
domain of the protein leaving the 8 8  kDa active form (Figure 6 .6 ). A sample of MMP-9 which 
consisted of a mixture of active and latent forms was used for panning. Freeze-thawing was chosen as 
the means of activation, rather than chemical or biological activation treatments (e.g. APMA or 
trypsin) which avoided the need to purify the protein from these agents which might have 
contaminated the subsequent panning procedure.
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Figure 6.6 Zymogram showing active and latent forms of MMP-9 protein. Lanes (1) 1.5 ng MMP-9 protein after freeze- 
thawing, containing a mixture of active and latent MMP-9, (2) 15 ng MMP-9 protein after freeze-thawing, containing a 
mixture of active and latent MMP-9, (3) 15 ng MMP-9 protein prior to freeze-thawing, containing only latent MMP-9. As 
indicated the molecular weight of latent MMP-9 is 92 kDa and active MMP-9 is 88 kDa.
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6.8.3 Assessment of Enrichment Following Panning
To monitor the success of the panning procedure (section 2.2.11.7) samples of polyclonal phage 
populations were taken at the end of each round of panning. These samples were tested by phage- 
antibody-ELISA (section 2.2.11.11) to determine if enrichment for phage specifically binding to 
MMP-9 after successive rounds of affinity selection had occured. Figure 6.7 shows a schematic 
representation of the phage-antibody-ELISA used. During each round of panning non-binding phage 
were washed away and binding phage were eluted, reinfected in E. coli and amplified prior to another 
round of panning. Therefore the concentration of binding phage should increase after each round. 
Figure 6 . 8  graphically represents this enrichment. After 4 rounds of panning sufficient enrichment had 
been achieved, as a 1 0  fold increase in binding activity was observed compared to the pre-selected 
library. Phage from the fourth round of panning were used for subsequent analysis.
Phage antibody ELISA
HRP-conjugated anti-rabbit antibody
anti-fd bacteriophage antibody (rabbit)
phage with scFv fusion to p ill
1
MMP-9 protein coated on plate
Figure 6.7 Schematic representation o f Phage-antibody-ELISA.
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Figure 6.8 Graph showing enrichment results from polyclonal phage populations collected after each round of panning as 
determined by phage-antibody-ELISA.
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6.8.4 Monoclonal Phage-Antibody-ELISA
Having determined that the panning procedure was successful by testing polyclonal phage samples, 
we then tested monoclonal phage from single colonies selected from round 4 by phage-antibody- 
ELISA (as in Figure 6.7) for binding activity to MMP-9 (section 2.2.11.12). 52% or 42 of the 82 
clones tested were found to be positive. Positive clones were classified as those which gave 
approximately 10 fold higher absorbance readings over control wells in ELISA. The absorbance 
results of 20 representative positive clones are shown in Table 6.1.
Table 6.1 Phage-antibody-ELISA absorbance results for 20 clones.
Clone No. Abs.@492nm
TG1-1 1.863
TGI-2 1.665
TGI-4 1.807
TGI-5 1.837
TGI-9 1.687
TG1-13 1.569
TG1-14 >2 . 0 0 0
TGI-15 1.264
TG1-17 1.761
TGI-20 >2 . 0 0 0
TG1-22 >2 . 0 0 0
TGI-23 1.892
TGI-24 1.522
TGI-25 1.606
TGI-28 1.655
TGI-32 1.993
TG1-36 1.999
TG1-37 1.095
TG1-40 1.645
TG1-41 1.833
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6.8.5 Preparation of Anti c-myc Antibody
Having identified individual positive phage antibody clones, the next step was to produce soluble 
antibody fragments. The soluble scFvs cannot be detected by the anti-bacteriophage Fd antibody (used 
in the previous phage-antibody-ELISAs) as they are secreted as soluble proteins no longer fused to the 
phage pin coat protein. These soluble fragments were detected using anti-c-myc antibodies which 
detected the c-myc tag incorporated into the scFv fragment (described in section 6.4). The anti-c-myc 
antibodies were produced by the hybridoma cell line 9E10 and secreted into the culture medium as 
described in section 2.2.1.2. The antibodies were isolated from the medium by ammonium sulphate 
precipitation as described in section 2.2.11.14. After precipitation the antibodies were tested by dot 
blot analysis. C-myc tagged proteins were immobilized onto nitrocellulose, incubated with anti-c-myc 
antibodies and detected using anti-mouse-HRP conjugated antibodies. Figure 6.9 shows that the anti- 
c-myc antibodies were present and functional.
1 2
Figure 6.9 Dot blot to detect anti-c-myc antibodies. Dot (1) 5 ul of c-myc-tagged protein sample immobilised onto 
nitrocellulose, incubated with anti-c-myc antibodies and, then detected with anti-mouse-HRP conjugated antibodies and 
detected with DAB. Dot (2) Negative control, BSA immobilised onto nitrocellulose instead of c-myc-tagged protein.
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6.8.6 Monoclonal Soluble-scFv-Antibody-ELISA
The 42 phage clones which tested positive by phage-antibody-ELISA in section 6.8.4 were then 
infected into E. coli HB2151 and induced for soluble expression of scFv antibody protein as described 
in section 2.2.11.13. The nomenclature for each phagmid was retained when transferred from E. coli 
strain TGI to strain HB2151, e.g. when the phagmid from clone TG1-4 was transferred to HB2151 it 
was labeled HB2151-4. These clones were then tested by soluble-scFv-antibody-ELISA for binding 
activity to MMP-9 (section 2.2.11.11). Figure 6.10 shows a schematic representation of the soluble 
scFv-antibody-ELISA. After transferring from TGI to HB2151, 72% or 30 of the 42 clones tested 
produced soluble scFv fragments with binding affinity to MMP-9, as determined by soluble scFv- 
antibody-ELISA. However, positive clones only gave absorbances approximately 5 fold higher than 
control wells, considerably lower than phage-antibody-ELISA results. Table 6.2 shows the scFv- 
antibody-ELISA absorbance results for the 10 clones with greatest binding affinity for MMP-9. These 
1 0  clones were analysed further in subsequent experiments.
Soluble scFv ELISA
anti-c-myc antibody (mouse)
HRP-conjugated anti-mouse antibody
scFv with c-myc tag
mmp-9,, MMP-9 protein coated on plate
Figure 6.10 Schematic representation o f scFv-antibody-ELISA.
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Table 6.2 Soluble-antibody-ELISA absorbance results for top 10 clones.
Clone No. Abs. @ 492nm
HB2151-4 1.333
HB2151-15 0.947
HB2151-18 0.821
HB2151-22 0.945
HB2151-25 1.231
HB2151-27 1.136
HB2151-28 1.050
HB2151-35 0.762
HB2151-39 0.946
HB2151-41 0.879
Hie specificity of the scFv fragments were tested by coating the wells with other proteins including 
BSA and the closely related metalloproteinase family member MMP-7. Clones HB2151-4 and-41 
showed slight binding activity to MMP-7, however, for all other clones no non-specific binding was 
detected over background (data not shown). Clones HB2151-4 and-41 were not analysed further.
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6.8.7 Optimisation of Soluble scFv Fragment Expression
As the levels of scFv in the culture supernatant were quite low we decided to look at periplasmic 
lysates as the source of scFv. A time course study of the production of scFv fragments after the 
addition of IPTG was carried out and the results are shown in Figure 6.11. The scFv fragment can be 
seen at 31 kDa which is the expected molecular weight of a scFv fragment. For expression of scFv in 
culture supernatant; 18 hours post induction gave optimum results, while for periplasmic scFv 
production 4 hours post induction was chosen as optimum. Periplasmic lysates were found to produce 
higher levels of scFv without the liquid handling problems associated with using culture supernatants 
and were used in subsequent experiments.
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Figure 6.11 SDS-PAGE gel showing concentrations of scFv from clone HB2151-35 produced into the supernatant or 
periplasm at various time points (in hours) post induction.
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6.8.9 Detection of scFv fragments by dot blot analysis
All of the clones were examined by dot blot analysis to ensure the c-myc tag was intact and could be 
detected by anti-c-myc antibodies followed with anti-mouse-HRP conjugated antibodies. Figure 6.12 
shows that all the clones tested had a functional c-myc tag present. This was confirmed by western 
blot analysis, where the periplasmic lysates were separated by SDS-PAGE, transferred to 
nitrocellulose and incubated with the anti-c-myc antibody (section 2.2.5). Figure 6.13 shows a single 
band at 31 kDa for the scFv fragments, confirming that scFv fragments were present in the lysates and 
the c-myc tag was present.
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Figure 6.12 Dot blot analysis with 200|il culture supernatant from each clone (clones numbers HB2151-15, HB2151-18, 
HB2151-22, HB2151-25, HB2151-27, HB2151-28, HB2151-35, and HB2151-39) blotted onto nitrocellulose, probed with 
anti-c-myc followed by anti-mouse-HRP conjugated antibody. Clones were tested in duplicate and negative controls are also 
shown.
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Figure 6.13 Analysis of periplasmic lysates by SDS-PAGE and western blot. (A) SDS-PAGE gel 
stained with coomassie blue showing proteins present in periplasmic lysates for the 5 clones. (B) 
Western blot of the same samples probed with anti-c-myc showing single band at 31 kDa for scFv 
fragment. Lanes contain periplasmic lysates from clones : (1) HB2151-22, (2) HB2151-27, (3) 
HB2151-28, (4) HB2151-35, (5) HB2151-39.
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6.8.11 Titering of positive clones
The clone which gave the highest binding activity in section 6 .8 . 6  (HB2151-35) was titered by scFv- 
antibody-ELISA. This involved serial dilution of the scFv in order to determine the lowest 
concentration of antibody fragment which could be used to generate a detectable difference in 
absorbance over background. As shown in Figure 6.14 clone HB2151-35 gave an antibody titre of 
approximately 1 in 100 dilution. This titre was too low to proceed with affinity ranking by BIAcore 
(Pharmacia Biosensor). A titre of approximately 1 in 1000 would be necessary for BIAcore analysis.
1/Dilution
Figure 6.14 Graph of absorbance at 492nm vs. reciprocal dilution of scFv antibody from clone HB2151-35 showing 
antibody titre of approximately 1 in 100 dilution.
6.8.12 Use of the isolated scFv fragments as Immunological Reagents
Periplasmic lysates from all eight positive clones were tested by dot blot and western blot for binding 
activity to MMP-9. None of the clones tested were sensitive enough to detect the MMP-9 protein, 
even when high concentrations of MMP-9 protein were loaded (up to 15jj,g) (data not shown). Dot 
blots were carried out to ensure that the denaturing conditions of the PAGE were not affecting the
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conformation of the MMP-9 protein, which might have prevented the scFvs recognising the protein. 
Figure 6.15 shows the comparison between a commercially available anti-MMP-9 antibody and the 
scFv from clone 35. No bands were detected by the scFv however the commercial antibody could 
detect 5 jig of MMP-9 protein. Chemiluminescence, a more sensitive method of western blot 
detection gave similar results. Westerns were also attempted using culture supernatants which had 
been concentrated 10 fold against PEG (to promote multimerization of scFv); using monoclonal 
phage-antibodies (because of the signal amplification afforded by the coat protein); and using 
polyclonal phage-antibodies however all of these were not successful (data not shown).
We also attempted immunohistochemistry using both soluble and phage-antibody scFvs. Placental 
biopsy sections, as well as BHK- H92 cells (which were known to express MMP-9 protein) were 
grown on slides and were tested with the scFvs, however there was no significant difference over 
background staining (data not shown).
Figure 6.15 Western blots both loaded with 5|xg MMP-9 protein. (1) Blot was probed with the commercial Ab-1 anti- 
MMP-9 antibody from Oncogene Science, detecting two bands for active and latent MMP-9. (2) Blot was probed with the 
scFv fragment produced by clone 35, no bands detected.
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6.9 DISCUSSION
The fusion of peptides, or larger protein fragments, to the amino terminus of filamentous phage 
protein HI, allowing display without disturbing the infective capacity of the phage, is one of the basic 
principles of phage display. This technology gives access to rapid and efficient screening procedures 
and provides a direct link between a protein presented at the surface of a phage and the corresponding 
genetic information packaged within the phage particle. Antibody phage display libraries may be 
generated from immunized or naive sources. Immunization enriches the mRNA for Vh and Vl genes 
encoding antigen binding activities (Winter and Milstein, 1991) but requires a different library for 
each antigen. By contrast, the use of larger and more diverse repertoires from V genes, rearranged in 
vitro (Hoogenboom and Winter, 1992) allows the isolation of antibodies of different binding 
specificities, without immunisation, from the same library as proposed by Milstein (1990). The 
Nissim library is one such ‘single pot’ library.
The wealth of knowledge currently available on antibodies has paved the way for the creation 
of antibodies entirely outside their natural host. To construct a synthetic antibody library, V genes are 
assembled by introducing a predetermined level of randomization of CDRs into germ line V-gene 
segments. The areas of synthetic diversity are chosen to correspond to areas of greatest natural 
sequence diversity of the primary antibody repertoire. From structural studies it has become apparent 
that five of the six CDR regions (all but the CDR3 of the heavy chain) have limited structural 
variation, and frequently follow a certain standard fold (Chothia and Lesk, 1987). The greatest 
structural diversity is found in the loop most central to the antigen combining site, the CDR3 of the 
heavy chain. This loop is diverse in composition and in length owing to the in vivo recombination 
procedure. The antibody CDR region may be partially randomized using PCR-based methods as in the 
Nissim library where 4 to 12 residues on the CDR3 were randomized and cloned for display as a scFv 
with a human X light-chain. From this library many antibodies to haptens, and one against a protein 
antigen were isolated (Nissim et al., 1994).
Developing antibodies in bacterial systems has practical advantages. For example, large 
amounts of phage-antibody or soluble antibody fragments sufficient for analysis can be produced after 
overnight growth from stocks. The stocks themselves are easier to establish and maintain than 
eukaryotic cell line stocks. Growth for production quantities of reagent are considerably simpler, faster 
and cheaper. Unlike traditional hybridoma techniques for generating antibodies, recombinant methods
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immortalize the genes rather than the cells. However, even though E. coli allow folding of 
recombinant proteins and assembly of homo- or heterodimers (Winter and Milstein, 1991), there are 
biological limitations related to the host. It is well known that E. coli cannot glycosylate proteins or 
perform post-translational modifications like phosphorylations which often occur in eukaryotic 
systems. However, these limitations are common to all prokaryotic expression systems.
Our initial aim was to isolate antibodies which specifically recognised the active form of 
MMP-9 using phage display technology. This has proven elusive by conventional techniques of 
immunizing animals for polyclonal sera or by hybridoma technology. We hoped this might be 
possible using phage display technology as the affinity based selection and amplification inherent in 
this technology means that even rare phage (< 1 / 1 0 7) may be isolated over several rounds of panning 
(McCafferty et al., 1990). In addition Nissim et al. (1994) had speculated that phage libraries could 
lead to the selection of a different spectrum of epitopes from natural immune systems. For example, 
mouse antibodies to human p53 bind to two main immunodominant regions of the protein, at the N- 
terminal region and at the C-terminal region. The epitope recognised by the anti-p53 scFv fragment 
lies outside these regions, which allowed the identification of a new epitope of p53 (Nissim et al. 
1994).
The purity of the protein used in the panning procedure is critical since phage are chosen for 
subsequent amplification based on their ability to bind to the protein coated on the plate. Therefore, 
any contaminants present would dictate the affinity selection and scFv would also be isolated to them. 
The purity of the MMP-9 protein was analysed by silver staining and found to give a single 
homogenous band at 92 kDa indicating the absence of contaminating proteins and its suitability for 
use as an antigen for the affinity selection procedure. The MMP-9 protein was supplied in the latent 
form as the 92 kDa proenzyme. We used a mixture of active and latent forms of MMP-9 protein for 
affinity selection. This was achieved by freeze-thawing the protein which caused cleavage of the pro 
domain from the protein leaving the smaller active form ( 8 8  kDa). A mixture of active and latent 
protein was used for panning with the hope that scFv might be isolated to both forms of the enzyme. 
Activation was accomplished by freeze-thawing the protein, which did not require addition of 
compounds such as APMA or trypsin, which would have required removal from the protein prior to 
the panning procedure. The library was subjected to four rounds of panning against MMP-9 protein. 
The ratio of MMP-9 binding phage to non-binding phage was increased over each successive round of
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panning. Three to five rounds of panning were recommended (Nissim et al., 1994), and four rounds 
was found to be sufficient. All subsequent analysis was carried out on clones isolated from the fourth 
round of panning. 52% of phage-antibody monoclones tested were found to have binding activity to 
MMP-9. An important issue to keep in mind is that the displayed protein domain is susceptible to 
proteolysis. While M13 phage are resistant to many proteases (i.e. trypsin, chymotrypsin) (Schwind et 
al., 1992), the displayed protein domains are not. Stocks of recombinant phage can lose their 
displayed element in hours to days when stored at 4°C in culture supernatant and this would result in 
false negative results. For short-term experiments monitoring binding properties of particular phage 
isolates, fresh (i.e. 6-18 hour) culture supernatants were used whenever possible. The pHENl vectors 
encoding these positive scFv were rescued and transferred into the non-suppressor strain HB2151. 
Due to the amber codon in pHENl, HB2151 produce soluble scFv.
72% of these clones produced soluble scFv which had binding affinity to MMP-9, however 
the soluble scFv had considerably lower activity than the corresponding phage-antibody clones. In 
addition, not all clones which had tested positive as phage antibodies resulted in clones positive for 
soluble scFv antibody production. Nissim et al. (1994) also reported that for each of the antigens used 
in their study, they could isolate phage clones with binding activities, while they were sometimes 
unable to detect binding of the encoded scFv fragments using bacterial supernatants. This may reflect 
the amplified detection of the phage by virtue of the 2,800 subunits of the phage pVIII coat, if so a 
more sensitive assay should be used for the soluble fragments. It might also reflect the greater binding 
avidities afforded by multivalent display on phage and the moderate binding affinities of the
7 omonmeric scFv fragments from primary phage repertoires of 10 '10 clones (Hoogenboom and 
Winter, 1992; Griffiths et al., 1993).
The production of soluble scFv was investigated and isolation of scFv from periplasmic 
lysates four hours after induction with IPTG was found to be optimum. While scFv could be found in 
the culture medium after longer induction periods there was the associated difficulty of concentrating 
down the large culture volumes. Periplasmic lysates on the other hand could be generated in small 
volumes avoiding the liquid handling difficulties. It has been reported that scFv fragments in 
supernatants could be more readily detected by concentrating the supernatant, or by multimerization of 
the fragments. Although scFv fragments can associate to form dimers in bacterial supernatants 
(Griffiths et al., 1993), and the dimers have greater binding avidities to solid phase antigen,
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concentration may also drive the formation of multimers. Presumably, multimerization is promoted by 
dissociation of Vh and VL domains of the same chain, followed by pairing with another chain. 
Aggregation of moderate affinity scFv is probably important for their use as immunological reagents 
as it enhances the avidity of binding and slows the rate of dissociation during washing (Nissim el al., 
1994). We concentrated scFv fragments in bacterial supernatant by reverse dialysis against PEG to 
1/10 their original volume. However, this did not lead to any significant improvement in binding 
affinity.
The scFv were found to be specific for MMP-9. Two clones showed slight cross reactivity 
when tested against MMP-7, which is a closely related family member and this may be due to 
sequence homology between the MMP-9 and MMP-7. For clone HB2151-35 titering of the scFv gave 
a very low titre of 1/100 indicating poor binding affinity of the scFv. This titre was too low to proceed 
with characterisation by BIAcore analysis, which would have provided real time kinetic information.
The scFv were tested for their suitability as immunological reagents. They were unable to 
detect high concentrations of MMP-9 protein by dot or western blot analysis. We initially tested the 
scFv by western blot analysis and in order to ensure that the denaturing conditions of the 
electrophoresis procedure were not affecting the scFv recognising the MMP-9 protein, dot blots were 
also carried out. These were however also unsuccessful. Western blots were attempted using 
periplasmic lysates, as they had a higher concentration of scFv. We also tried concentrated bacterial 
supernatant but again these were unsuccessful, Phage-antibodies were also tested but these did not 
detect protein by western or dot blot analysis. We then examined the possibility of using polyclonal 
phage-antibodies as polyclonal antisera can be more effective than monoclonal antibodies for some 
applications. The higher avidity of these sera gives increased sensitivity. Polyclonal populations of 
phage can be obtained after elution from an antigen-binding process. These populations may contain 
antibodies directed against a number of different epitopes, and are the equivalent of a polyclonal 
antibody serum with the notable difference that they can be grown in vitro repeatedly. Western blots 
using polyclonal phage antibodies were also unsuccessful.
The isolated scFv were used for immunocytochemistry on cells grown on slides. These cells 
were known to express MMP-9 protein and served as positive controls. The scFv showed no specific 
binding to MMP-9 protein over background staining. Consequently, these scFv could not be used for 
immunohistochemistry. It is possible that the isolated scFv only recognise MMP-9 protein bound to a
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solid support such as plastic as this is the only format in which a response was seen using the scFvs. 
The affinity selection procedure was also carried out using MMP-9 coated onto plastic microtitre 
plates, thus selecting clones which recognise the protein in that format. Many proteins when adsorbed 
directly to solid phase by hydrophobic interaction, are altered in their three-dimensional structure 
(Butler, 1995), potentially creating different epitopes.
Although the scFv fragments against MMP-9 isolated from the library were of low affinity it 
is possible to improve the affinity and specificity of specific antigen-binding scFv fragments isolated 
from combinatorial libraries. The clones may be manipulated using various strategies (artificial 
affinity maturation). One strategy is ‘chain shuffling’ (Kang et al., 1991). Chain shuffling involves 
combining a given chain from an isolated clone with complementary unselected chains. Alternative 
strategies for the refinement of clones involve mutagenesis and reselection. The enhancement of 
affinity in vivo can be contributed by a single point mutation, or several mutations (Berek and 
Milstein, 1987). Hypermutation of the genes corresponding to antibodies of low affinity should be 
easy to imitate in vitro. Point mutations could be introduced into the V genes by many techniques, for 
example, by using error-prone polymerases, PCR amplification through a large number of cycles, 
biased ratios of nucleotides triphosphates or ‘spiked’ oligonucleotide primers. Multiple mutations 
could be targeted throughout the body of the gene simultaneously, or to each of the hypervariable 
loops (Ward et al., 1989). Ideally we would like to hypermutate specific segments of DNA within 
cells rather than in isolated DNA, and at the same time express the products on the cell surface, and 
select in a Darwinian fashion variants of steadily increasing affinity. Animals are superb at this job, 
and it will not be easy to compete with their efficiency. We may learn to imitate the animal strategy, 
but in the meantime for the production of high-affinity antibodies we will normally do better by 
stealing hypermutated V genes from immunized animals.
The binding affinities of the antibody fragments isolated from the Nissim library were 
disappointing, however, similar results have been seen by others working with the Nissim library 
(personal communication Dr. B. Manning and Tony Killard, BEST Center, DCU). An alternative 
phage display antibody library with a larger repertoire of antibody clones known as the Griffiths 
library has recently become available from the MRC. This library not only contains in vitro 
randomized CDR3 of heavy chains but also of the CDR3 in the X light chain, leading to much larger 
repertoires (1010) than had previously been possible. The synthetic repertoire of Fab fragments was
1 6 9
generated by recombination of heavy and light chain repertoires in bacteria using a process known as 
combinatorial infection. Soluble antibodies from this library have a histidine-myc tag which allows for 
purification using immobilised affinity chromatography. This library has also been used in our 
laboratory, but has so far yielded no positive results.
Although heralded as one of the greatest biological technologies of the 21st century, phage 
display has yet to live up to its promise. It has now been over a decade since phage antibody 
technology was introduced. However, the number of antibodies which have so far reached the market 
place has been minimal. Although unpublished, there is general recognition in the research 
community that there are serious difficulties, such as library instability, with the present generation of 
phage display vectors. The potential of the phage display system will only be fully realized when 
libraries with greater numbers of individual recombinants can be generated. The amplification step 
between rounds of panning with the phage display vector is associated with a number of problems 
even with pre-absorption steps, it is difficult to isolate a rare clone when its frequency is lower than the 
nonspecific background binding to the antigen affinity matrix. For the present at least, it seems that an 
antibody which specifically recognises active MMP-9 remains the holy grail of MMP antibodies.
Two emerging technologies could have the potential to ‘compete’ with phage display. Firstly, 
transgenic mice in which the human germ-line repertoire has replaced the animal’s repertoire in part 
or totally (Jakobovits, 1995), however both screening and antigen limitations argue against it. 
Secondly, and of greater interest and potential are phage-free in vitro translation library systems in 
which expression on ribosomes is coupled to selection (Kawasaki, 1994). Such approaches are still 
only in their infancy and will require further developments before being readily applicable.
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6.10 SUMMARY
We sought to isolate scFv fragments against MMP-9 using the Nissim library, a naive synthetic phage 
antibody library. Approximately 108 scFv antibody producing E. coli TGI clones underwent 4 rounds 
of affinity selection (panning) to MMP-9 according to Nissim et al. (1994). Samples of polyclonal 
phage populations taken after each round of panning were tested by phage-antibody-ELISA and 
showed excellent enrichment of binding activity to MMP-9. To identify monoclonal phage antibodies 
the pHEN phage particles were rescued and 82 individual clones from round 4 were screened by 
phage-antibody-ELISA against MMP-9. 42 of the 82 clones (52%) were found to be positive. These 
positive phage clones were then infected into E. coli HB2151 and induced for soluble expression of 
scFv antibody protein. The production of antibody in the periplasm and supernatant was assessed. 
After transferring to HB2151 72% of clones produced soluble scFv fragments when tested by scFv- 
antibody-ELISA against MMP-9 protein. Culture supernatants were also tested by western blot 
analysis using an anti-c-myc antibody which detects the c-myc tag on the scFv fragment. Bands could 
be seen at 31 kDa for the scFv protein. Antibodies from clones with the greatest binding activity by 
ELISA were titered and found to be in the range of 1/100 dilution. Unfortunately, the scFv antibody 
titre was too low for further characterisation by BIAcore analysis. The binding affinity of the 
fragments was also too low for use as immunological reagents for western blots or 
immunohistochemistry.
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Chapter 7 
Final Summary
Final Summary
During early human pregnancy fetal trophoblasts rapidly invade the uterus. The extent and 
timing of this invasion is precisely regulated. The family of matrix degrading enzymes, called the 
matrix metalloproteinases (MMPs) have been implicated as major role players in this process. The 
research presented in this thesis was focused on investigating the expression, regulation and 
localisation of the MMPs involved in mediating trophoblast invasion. The aims of this research 
were to establish a model system using trophoblast continuous cell lines to examine the role of 
MMPs in trophoblast invasion. Using this model we sought to identify the factors which regulate 
expression of MMPs during the invasive process. We investigated the expression of MMPs in vivo 
and examined their role in pre-eclampsia. We also attempted to localise MMP-9 expression in vivo 
using an antibody fragment isolated using phage display technology.
Establishment of long term cultures of pure first-trimester human trophoblast cells with 
functional integrity provide reproducible in vitro systems for investigating the biological basis of 
invasive behaviour by cells. We have shown that long term replicating trophoblast cultures were 
free of contamination from other cell types, as judged by numerous cell-specific markers. 
Moreover, these long term monolayer cultures were proven to be functionally active since, they 
produced a significant amount of hCG and hPL, and were shown to be invasive using an in vitro 
invasion assay. These cell lines were unique as they were the first reported trophoblast cell lines to 
be established from CVS. We have successfully demonstrated that cell lines established from CVS 
do provide a useful in vitro system for studies of placental function. This opens up new avenues of 
research for investigators in countries where abortions are illegal or the use of abortus material is 
prohibited. We showed that two members of the MMP family, the type IV collagenases; MMP-2 
and MMP-9 were expressed by the trophoblast cell lines. The choriocarcinoma cell line, BeWo 
produced large quantities of MMP-2 but little MMP-9. We also found that the BeWo cells were 
non-invasive under the culture conditions and assay used. The trophoblast cell lines were capable 
of invasion and it is likely that this is due to the expression of MMP-9. We proposed that in the 
model system described here MMP-9 is critical for invasion. We also reported the expression of 
TIMP-1 and TIMP-2 by the trophoblast cell lines but no TIMP expression by the BeWo cell line. 
Although it had previously been assumed that most metalloproteinase inhibitors that function in the
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placental bed were probably of maternal origin, our results suggest that TIMP produced by the 
trophoblasts themselves may have a role in local regulation of ECM degradation.
Studies of the regulatory mechanisms controlling expression of MMP-9, are important for 
understanding the complex process of invasion which takes place during pregnancy. We examined 
the effects of three cytokines, IL-ip, EGF and TGF-p on trophoblast MMP production as possible 
regulators of the invasive process. Of those tested, only EL-1 p had a significant effect, upregulating 
expression of MMP-9 at both the mRNA and protein level, and increasing the invasive ability of 
the cells. The trophoblasts were also grown on various ECM matrices, and laminin was found to 
upregulate MMP-9 mRNA expression. Other biological modifiers including progesterone, 0- 
estradiol and hypoxic culture conditions were shown to have no effect on MMP-9 expression in the 
trophoblast cell lines. Expression of the MMP-2 gene could not be modulated by any of the factors 
investigated in this study, however due to the similarity of its promotor sequence to housekeeping 
genes this is not surprising. Considering that the type IV collagenases are developmentally 
regulated during placentation and also the differential response of these two proteinases to cytokine 
regulation, we speculated that cytokines and ECM components, in particular IL-ip and laminin are 
involved in controlling MMP-9 activity throughout placentation.
Human pregnancy is associated with extensive growth and remodeling of the uterus and 
placenta. Having shown using our tissue culture model system, that the degradative activity of 
MMPs are important in trophoblast invasion in vitro, we sought to extend our study to examine 
their role in vivo. Using immunohistochemistry the cellular localisation of MMP-2, MMP-7 and 
MMP-3 was identified in human tissues recovered from uncomplicated term pregnancies. Our 
results show prominent expression of all three MMPs in syncytiotrophoblasts and stromal core 
areas of chorionic villi at full term. These MMPs may be involved in active remodeling of the villi 
and/or modulation of matrix deposition. We have shown that the cells composing the human 
placenta express the necessary MMPs to facilitate growth and tissue remodeling in the 
physiological progress of human gestation. Interestingly, MMP-3 and MMP-7 were not expressed 
by the continuous trophoblast cell lines. However, the trophoblast cell lines originate from first 
trimester cytotrophoblasts which are not present at term. It may also be possible that the trophoblast 
cell lines lack some paracrine factor in culture which might stimulate the expression of MMP-7 
and MMP-3 in vivo.
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In normal human pregnancy, invasion of the uterus and its arterial system by trophoblasts 
extends throughout the entire decidua and the adjacent third of the myometrium. In the pregnancy 
related disorder pre-eclampsia, trophoblast invasion is limited to the superficial decidua, and few 
arterioles are breached. Since trophoblast invasion is abnormally shallow in pre-eclampsia, it is 
likely that some component of the invasion process is altered. Potential changes in MMP 
expression within human placenta in pre-eclampsia were assessed. Placental biopsies from normal 
pregnancies and those complicated by pre-eclampsia were stained with the anti-MMP antibodies. 
The results showed that expression of MMP-2, MMP-3 and MMP-7 by trophoblasts in pre­
eclamptic specimens was similar to MMP expression in normal uncomplicated pregnancy 
specimens. Therefore, in placental biopsies at term, no correlation could be made between the 
expression levels of these three MMPs and the pre-eclamptic disease state. Unfortunately it was not 
possible to examine MMP-9 protein expression in this study.
Having failed to find a commercially available antibody to MMP-9 which could be 
successfully used for immunohistochemistry of formalin fixed paraffin embedded tissue specimens 
we sought to isolate scFv fragments against MMP-9 using phage display technology. The Nissim 
library, a naive synthetic phage antibody library was obtained from the MRC, Cambridge. The 
library of approximately 108 scFv antibody producing E. coli TGI clones underwent 4 rounds of 
affinity selection to MMP-9. Excellent enrichment of binding activity to MMP-9 was seen after 
panning. Individual clones from round 4 were screened by phage-antibody-ELISA against MMP-9 
and 52% were found to be positive. These positive phage clones were then infected into E. coli 
HB2151 and induced for soluble expression of scFv antibody protein. The production of antibody 
in the periplasm and supernatant was assessed. After transferring to HB2151 72% of clones 
produced soluble scFv fragments against MMP-9 protein. Culture supernatants were also tested by 
western blot analysis using an anti-c-myc antibody and bands were seen at 31 kDa for the scFv 
protein. Antibodies from clones with the greatest binding activity by ELISA were titered and found 
to be in the range of 1/100 dilution. Unfortunately, this scFv antibody titre was too low for further 
characterisation by BIAcore analysis. The binding affinity of the fragments was also too low for 
use as immunological reagents for western blots or immunohistochemistry. This was 
disappointing, however, similar results have been seen by other investigators working with the 
Nissim library. Although the scFv fragments against MMP-9 isolated from the library were of low
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affinity it could be possible to improve the affinity and specificity of the scFvs using various 
artificial affinity maturation strategies such as chain shuffling.
Trophoblast invasion, due to its eloquently regulated nature both spatially and temporally 
presents a unique contrast to the unregulated invasion seen in metastatic cancer and provides an 
excellent model to study the regulation of MMP expression. Elucidating the mechanisms which 
control the MMPs in normal processes such as in trophoblast invasion may hold the key to 
unraveling their role in many pathological conditions. The next decade of research holds great 
promise for understanding the role of these enzymes in normal physiological functions in the body, 
and could lead the way for the use of MMP-related therapies in the treatment of ECM degradation- 
related diseases.
I
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